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ABSTRACT 
 
Oxygenase enzymes catalyze a remarkable variety of challenging biological transformations 
using molecular dioxygen (O2) as a cosubstrate. Oxygenases make possible the direct reaction of 
ground-state triplet O2 with organic singlet substrates, a transformation that is spin-forbidden by 
quantum mechanics. The set of chemical processes by which enzymes overcome this forbidden 
reaction are collectively termed ‘O2 activation.’ The result of oxygenase reactions is incorporation 
of one or both atoms of O from O2 into the organic substrate. Because of the critical role of 
oxygenases in many fundamental biological processes, an understanding of the catalytic and 
regulatory mechanisms that underlie O2 activation is required for the development of new 
medical, industrial, ecological and agricultural technologies. Non-heme iron oxygenases use 
mononuclear iron or diiron cofactors that are not coordinated in a porphyrin scaffold. This 
dissertation focuses on structural and mechanistic studies of three non-heme iron enzymes. The 
first, protocatechuate 3,4-dioxygenase (3,4-PCD), is an archetypal aromatic ring-cleaving 
oxygenase from soil bacteria that uses the oxidized form (Fe
3+
) of the iron cofactor to react with 
O2. It is a member of one of only two enzyme families that use Fe
3+
 to activate O2. CmlA is a 
diiron cluster-containing oxygenase that is involved in the non-ribosomal peptide synthetase-
mediated biosynthesis of the antibiotic chloramphenicol. It catalyzes the first step in this pathway: 
the β-hydroxylation of an amino acid precursor of the antibiotic. The third enzyme, CmlI, also 
uses a diiron cluster cofactor and catalyzes the final step in chloramphenicol biosynthesis by 
converting the arylamine group of the chloramphenicol precursor to its arylnitro analog. Herein, 
we report the determination of the X-ray crystal structures of the two most critical oxygenated 
intermediates in the 3,4-PCD catalytic cycle and characterize the reaction of the enzyme with 
diagnostic substrates. This work confirms mechanistic proposals that have existed since the 1960s 
and lays the groundwork for future studies. In the last two chapters of the dissertation, we report 
the X-ray crystal structures of CmlA and CmlI and compare their structures to other diiron 
cluster-utilizing enzymes. We also discuss the insights gained into their catalytic and regulatory 
mechanisms. 
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INTRODUCTION 
 
Metalloenzymes in biological O2 activation 
 
Roughly one third of all characterized proteins require metal cofactors in order to function; these 
are referred to as metalloproteins. Metal cofactor-utilizing enzymes (metalloenzymes) are present 
in all three domains of life
1-3
 and serve a staggering variety of critical biological roles including 
global biogeochemical cycling (N, C, S, H)
4-8
, photosynthesis 
9
, human drug metabolism
10-12
, 
natural products biosynthesis
13
, immune response 
14
, DNA repair
15
, oxygen transport, aerobic and 
anaerobic respiration
5, 16
 and more. Metal cofactors can be divided into two very general classes: 
(i) redox-inert metals such as the alkali and alkali earth metals and (ii) redox-active transition 
metals. In most cases, metals of the former group serve structural, signaling, and hydrolytic 
catalytic roles and will not be discussed in detail here. The focus will instead be on enzymes that 
utilize the latter group of transition metals as catalytic cofactors to facilitate reactions between 
molecular dioxygen (O2) and organic substrates. 
 
Oxygenase enzymes and O2 activation. All of terrestrial life is bathed in a sea of O2, but the 
extreme reactivity of dioxygen (as witnessed in an uncontrolled fire or explosion) is held in check 
by the ground-state electronic structure of the O2 molecule. This potent reactivity is a double-
edged sword—although dangerous when activated in an uncontrolled fashion to “reactive oxygen 
species” in vivo, the tremendous oxidizing power also lends itself to fantastic chemistries when 
harnessed and controlled. Controlled O2 activation is the hallmark of oxygenase enzymes. 
Oxygenases are defined as those enzymes in which O2 is the electron acceptor in the catalytic 
reaction, and one or both O atoms of O2 are incorporated into an organic substrate. Oxygenases 
belong to several subclasses of the oxidoreductase group of enzymes, which catalyze a wide 
variety of oxidation:reduction reactions. Oxygenase enzymes that integrate a single O atom or 
both O atoms into another substrate are termed monooxygenases and dioxygenases, respectively. 
Oxygenases catalyze tremendously challenging biological oxidations including site- and stereo-
specific mono- and dihydroxylations, desaturation, and carbon-carbon bond-cleavage reactions. 
The structural and catalytic mechanisms by which oxygenases activate O2 and control the 
subsequent reactions is the focus of this dissertation. 
2 
 
 Some of the most important early studies of oxidative bacterial catabolism and 
oxygenases were performed by the researchers Osamu Hayaishi, Roger Stanier, Stanley Dagley, 
and others
17-20
. The discovery and biochemical characterization of the first oxygenase enzyme, 
catechol 1,2-dioxygenase (then called pyrocatechase), dates back to the early 1950s
17
. Prior to the 
detailed characterization of this enzyme, it was generally believed that O2 could never be directly 
incorporated into organic substrates, and functioned solely as an oxidizing agent
21
. Instead, it was 
hypothesized that water was invariably integrated into the product, following the oxidation of 
substrate by O2. Early experiments with 
18
O2 isotopic labelling using the enzymes catechol 1,2-
dioxygenase
22
 and mushroom phenol hydroxylase
23
 definitively showed that O atoms from 
molecular O2, not solely water, could be directly incorporated into organic substrates. 
 
O2 activation by metal and organic enzyme cofactors. Why do nearly all oxygenases utilize 
transition metal or redox-active organic cofactors to activate O2? The chemical logic behind this 
strategy is explained by looking at the electronic structure of O2. The ground-state configuration 
of the molecule has two unpaired electrons in the highest occupied π* molecular orbitals, leading 
to a triplet di-radical ground state with a net spin of S = 1 (Fig. 1, left). The triplet nature of the O2 
molecule is the key factor which results in its reactive inertness under normal conditions. The 
direct reaction of triplet O2 with singlet organic molecules—which have only spin-paired 
electrons and an overall spin of S = 0—is spin-forbidden by quantum mechanics. Thus, although 
the overall reaction of O2 with most organic substrates is thermodynamically favorable, the 
reactions are kinetically controlled by the incompatibility of the electronic ground-states of the 
reactants. In order to catalyze these reactions, oxygenases “activate” the O2 molecule and/or 
organic substrate to a more reactive state. 
 Several general strategies for activating O2 to react with organic molecules exist
21, 24
 (Fig. 
1, right): (i) electronic excitation of the O2 from a triplet state to the higher-energy singlet state 
which can then directly react with other singlet molecules, (ii) one electron (e
-
) reduction of the 
O2 molecule by a metal or an external reductant to a reactive singlet superoxide radical state  
(O2
•-
), (iii) two e
-
 reduction of O2 and proton transfer to generate a singlet (hydro)peroxo (O2
2-
 / 
HO2
-
), or (iv) direct transfer of electrons from an organic substrate to O2 via a metal cofactor with 
vacant d orbitals (here the metal acts as a spin-capacitor and inverter to circumvent the spin-
3 
 
forbidden reaction between the substrates)
25
. Strategy (i) is essentially unavailable to most 
biological catalysts as the singlet excited state lies an intractable 22 kcal mol
-1
 higher in energy. 
However, strategies (ii), (iii), and (iv) are utilized by oxygenases. This makes apparent the need 
for a metal cofactor: electron transfer to O2 is a critical step in the activation of the molecule. 
Transition metals such as iron are able to fill this role because their partially filled d orbitals allow 
them to act as electron transfer conduits and in a redox capacity. Reduced metals such as Fe
2+
 are 
also able to directly bind O2. 
 The source of the e
-
 for O2 reduction varies widely depending on the family of enzymes. 
For instance, in the case of oxygenases with dinuclear metal cluster cofactors and Rieske 
enzymes, electrons are exogenously delivered by a cognate redox-partner protein such as a 
ferredoxin (Fd) or flavo-iron-sulfur protein, with the electrons ultimately deriving from 
 
 
Fig. 1: Molecular orbital diagram of O2 (left) and various activated forms of O2 (right). The 
π*2px, 2py antibonding orbitals are the highest occupied molecular orbitals of O2. 
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NAD(P)H
26-31
. These proteins deliver two reducing equivalents to the oxygenase component of 
the redox chain. In contrast, in the mononuclear α-ketoglutarate (α-KG)-dependent or aromatic 
ring-cleaving families of enzymes and others, organic (co)substrate is itself the source of the 
electrons
32, 33
. Most classes of oxygenases utilize a transition metal to facilitate the reaction 
between O2 and organic substrates. However, some enzymes with redox-active organic cofactors 
such as flavins also catalyze oxygenase reactions
34
. There are also some oxygenases that do not 
require any metal or organic cofactor, although their substrate range is considerably more 
limited
35
. In these systems, the organic substrates themselves are sufficiently redox-active to 
activate O2 for reaction. 
 
The non-heme iron family of oxidases and oxygenases 
 
Before exploring the variety of non-heme iron enzymes, it is important to briefly mention one of 
the largest families of oxygenases: the heme-containing cytochrome P450s. These enzymes are 
monooxygenases and catalyze a tremendous variety of different biological transformations in 
nearly all avenues of aerobic life
10
. These enzymes were among the first oxygenase systems to be 
characterized in biochemical detail
36, 37
 and are still being studied today
38, 39
. Cytochromes utilize 
a heme cofactor, where the metal is coordinated by four modified pyrrole groups that are part of a 
porphyrin scaffold. The term ‘non-heme’, then, refers to enzymes that utilize iron that is not 
coordinated by a porphyrin prosthetic group. 
 
Mononuclear non-heme iron oxygenase and oxidase enzymes. Mononuclear non-heme iron 
enzymes are those that utilize a single iron ion in the active site as a catalytic cofactor. This broad 
class of enzymes includes the aromatic ring-cleaving enzymes
32, 40
, cysteine dioxygenases
41
, 
lipoxygenases
42
, aliphatic carbon-carbon bond-cleaving enzymes
43, 44
, Rieske oxygenases
29, 45, α-
KG and pterin-dependent hydroxylases and halogenases
33, 46
, and some oxidases
47, 48
. The 
coordination mode of the metal ion varies within this family, but by far the most commonly 
encountered motif is the ‘facial triad,’ which is discussed in more detail in subsequent sections.  
The ferrous cofactor is the reactive form in all mononuclear non-heme iron enzymes, with two 
notable exceptions being the intradiol ring-cleaving dioxygenases and lipoxygenases
25
. 
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Dinuclear iron-cluster containing oxygenase and oxidase enzymes. As suggested by the name, 
the diiron non-heme enzymes have active sites containing a catalytic dinuclear iron cluster. The 
diiron family of enzymes is broad, containing the bacterial multicomponent monooxygenases 
(BMMs)
49-53
, the R2 subunit of class I ribonucleotide reductases
54
, acyl-acyl carrier protein (acyl-
ACP) desaturases
55
, arylamine oxygenases
56, 57
, and various other hydroxylases
58-62
. In most of 
these enzymes, the diiron cluster is coordinated in a “ferritin-like” 4-helix bundle structure. The 
metal-coordinating motifs nearly invariably contain clusters bridged by μ-oxo or hydroxo ions 
and/or protein carboxylates and the metal ions are coordinated by protein-derived His and 
carboxylate ligands, though the number, ratio, and geometric arrangement of these ligands varies 
dramatically between enzymes. With the exception of myo-inositol oxygenase 
59
, the diferrous 
form of the cluster is the state that reacts with O2. 
 
Common O2 activation strategies and redox logic. The fundamental mechanism by which O2 is 
activated can be reduced to a series of controlled electron and proton transfer steps. Protons play 
a critical part in this process, as they neutralize the buildup of negative charge on the O2 molecule 
as it becomes reduced and thus more anionic. The timing and site of proton delivery is critical in 
driving catalytic progression and determining the nature of the activated O2 species that is 
formed. O2 reduction occurs in discrete one- or two-electron steps and, as noted above, the source 
of these electrons varies. Although the details of the oxygenation mechanism and the catalytic 
role of the protein environment differ greatly between the classes of non-heme iron enzymes, O2 
activation conforms to one of several canonical pathways
63
. This section will illustrate some of 
these pathways and provide examples as observed in biological systems. 
(a) Iron-superoxide intermediates (Fig. 2) 
 One e
-
 reduction of the O2 molecule results in formation of a superoxide anion radical 
(O2
•-
). The most common mechanism by which superoxide is formed is by direct reaction of O2 
with a ferrous metal center, resulting in a Fe
3+
-superoxide species (Fe
3+
- O2
•-
). Such species are 
commonly encountered as transient intermediates on the way to a peroxo or high-valent iron-oxo 
intermediate, and are only rarely kinetically stable enough to be characterized in detail
59, 64, 65
. 
Only in the diiron enzyme myo-inositol oxygenase (MIOX) has direct evidence for the 
involvement of a Fe
3+
-superoxide species been obtained
59
, but several mononuclear enzymes
65-68
 
have been proposed to utilize iron-superoxides in a similar fashion. MIOX catalyzes the four e
-
 
oxidation of myo-inositol substrate with concomitant O incorporation to generate D-
glucuronate
59
. This enzyme utilizes the mixed-valence cluster in the Fe
2+
/Fe
3+ 
state (Fig. 2A-(i))  
6 
 
  
Fig. 2: Proposed catalytic mechanisms for selected enzymes that use a superoxo intermediate 
for substrate attack. (A) Myo-inositol dioxygenase (MIOX)
59, 69
. (B) Homoprotocatechuate 
2,3-dioxygenase (2,3-HPCD)
64, 71, 72, 125
. The orange arrows show 2 e
-
 transfers and green 
arrows show 1 e
-
 transfers or radical recombinations. 
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to react with O2 to form a Fe
3+
/Fe
3+
-superoxide species (Fig. 2A-(ii)) which then reacts directly 
with the organic substrate by hydrogen atom abstraction to generate a hydroperoxo species and 
substrate radical (Fig. 2A-(iii))
59
. The hydroperoxo is proposed to then undergo homolytic 
scission and recombination with the substrate radical, resulting in either substrate 
hydroperoxylation or hydroxylation depending on where the scission occurs
69
. The hydroxylation 
path is shown in Figure 2A-(iii) to (v). To date, this is the single characterized example of a diiron 
enzyme that uses the Fe
3+
/Fe
3+
-superoxide state to catalyze C-H bond activation. 
There are several examples of mononuclear oxidases and oxygenases that use a Fe
3+
- or 
Fe
2+
-superoxide species to react with substrate. Two examples are the oxidases 1-
aminocyclopropane-1-carboxylic acid oxidase
67
 and isopenicillin N-synthase
66
. These enzymes 
are proposed to use the species to directly oxidize substrate to a radical via hydrogen atom 
abstraction, followed by further oxidation and (de)cyclization of the substrate to generate product. 
Fe
3+
-superoxide species are also proposed to be utilized by cysteine dioxygenases, 
hydroxyethylphosphonate dioxygenase and the Rieske enzyme benzoate dioxygenase to perform 
the initial oxidation of substrate
65, 68, 70
. The Fe
2+
-utilizing ring-cleaving dioxygenase 
homoprotocatechuate 2,3-dioxygenase (2,3-HPCD) generates a Fe
2+
-superoxide species that 
reacts with substrate. This Fe
2+
-superoxide is generated by an electron transfer from substrate to 
O2 in which catechol is oxidized to semiquinone and O2 reduced to superoxide (Fig. 2B-(ii))
71
. 
The superoxo radical then recombines with the semiquinone radical to generate an Fe
2+
-
alkyl(hydro)peroxo (Fig. 2B-(ii) to (iii)) that drives the ring-cleavage reaction following 
heterolytic O-O bond scission (Fig. 2B-(iv) to (v))
64, 72
. A Fe
3+
-superoxide species has also been 
trapped in 2,3-HPCD but is only stabilized in a mutant of the enzyme when it is reacted with the 
alternative substrate 4-nitrocatechol
64
. However, this reaction results in hydrogen peroxide 
production and substrate oxidation to a quinone rather than ring-cleavage. If such a species is 
generated as a precursor to the Fe
2+
-superoxide, it may simply be too short-lived to detect
71
. 
(b) Iron-peroxo intermediates (Fig. 3) 
The two e
-
 reduced form of O2, peroxide, is also a commonly encountered intermediate 
on the pathway to more potent oxidants. However, iron-peroxide species are also themselves 
recognized as capable of acting as organic oxidants in a variety of enzyme systems. The key step 
leading to the formation of peroxo-level intermediates is reduction of the O2 molecule by two e
-
. 
As such, the reactive Fe
2+
/Fe
2+ 
cluster state of diiron enzymes provides a convenient mechanism 
by which to transfer the two reducing equivalents necessary to form the peroxo intermediate. The 
result is a Fe
3+
/Fe
3+
-peroxo (or “diferric-peroxo”) species. Not all peroxos are created equal,  
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Fig. 3: Proposed catalytic mechanisms for selected enzymes that use a peroxo intermediate for 
substrate attack. (A) Aldehyde-deformylating oxygenase (ADO)
61
. An alternative mechanism 
to the one shown has also been proposed
77
. (B) Arylamine oxygenases
56, 57, 73
. The orange 
arrows show 2 e
-
 transfers and green arrows show 1 e
-
 transfers or radical recombinations. 
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however, and the coordination geometry and electronic properties of the resulting species varies 
between enzymes
57, 60, 73-75
, as does their reactivity. 
Several diiron enzyme systems have been described that generate a peroxo-level species 
that reacts directly with organic substrates. Deoxyhypusine hydroxylase (DOHH), an enzyme 
involved in regulating cell proliferation, is purified in the Fe
3+
/Fe
3+
-peroxo state. The peroxo state 
of the enzyme is highly stable and has been crystallographically and spectroscopically determined 
to be a cis µ-1,2-peroxo
60, 76
. The structure of a cis µ-1,2-peroxo is shown in Fig. 3A-(ii). The 
DOHH peroxo is proposed to directly react with the protein substrate. The cyanobacterial 
aldehyde deformylating oxygenases (ADOs) generate a peroxo-level intermediate (Fig. 3A-(ii)) 
that is proposed to attack the terminal electrophilic carbon of the fatty aldehyde substrate, a 
process that leads to deformylation and alk(a/e)ne formation (Fig. 3A-(iii))
61, 74, 77
. In order to 
explain the observed ADO product distribution, the formation of a high-valent intermediate (Fig. 
3A-(iv) to (v)) has been theorized to form following deformylation
61
. The arylamine-oxidizing 
enzymes AurF and CmlI
57, 73
 can generate relatively long-lived Fe
3+
/Fe
3+
-peroxo species upon 
exposure of the reduced Fe
2+
/Fe
2+ 
state to O2 under certain conditions (Fig. 3B-(ii)). The proposed 
catalytic pathway for the first cycle of arylamine oxygenation is shown in Fig. 3B. Arylamine 
substrates have been shown to react directly with the CmlI peroxo
57
, suggesting that it is the 
species that effects the initial oxidation, or that substrate binding induces conversion of the 
peroxo to a more reactive species. The peroxo in these enzymes is proposed to have a geometry 
distinct from the µ-1,2-type peroxos encountered in several other diiron enzyme systems
78-81
. A μ-
η1:η2 peroxo has been proposed for CmlI and is shown in Fig. 3B-(ii). These latter two enzyme 
examples elegantly showcase the ability of the peroxo to act as both a nucleophilic (ADOs) and 
electrophilic reactant (arylamine oxygenases).  
Peroxo intermediates are also formed in the mononuclear iron enzymes but most often 
they are generated following O2 activation and after substrate has already been oxidized. Peroxos 
have only been directly trapped and characterized in extradiol ring-cleaving dioxygenases
71, 72, 82
 
and the Rieske enzyme benzoate dioxygenase
83
. They have also been proposed to occur in the 
catalytic cycles of various other mononuclear enzymes
65, 84-88
. In many of these cases, peroxos 
would be generated following the initial generation of a Fe
3+
-superoxo followed by substrate 
oxidation. Hydrogen atom abstraction from substrate would result in a metal-hydroperoxo (see 
Fig. 2A-(iii))
68, 89, 90
. Alternatively, direct attack of activated O2 on organic substrate generates an 
alkylperoxo or peroxohemiketal
72, 86
. The alkylperoxos generated in ring-cleaving enzymes decay 
to lactone or anhydride intermediates
25, 72, 91, 92
 whereas many of the peroxos in other systems have 
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been observed to (or are proposed to) undergo O-O bond cleavage to generate high-valent 
intermediates that effect substrate oxygenation
86-88, 93, 94
. In some cases, direct transfer of the 
activated hydroperoxo moiety to substrate (“hydroperoxylation”) has been proposed as an 
alternative oxygenation mechanism
69, 95
. 
(c) High-valent Fe4+- or Fe5+-oxo/hydroxo intermediates (Fig. 4) 
One of the key differences in the enzyme systems that access high-valent iron 
intermediates is that these systems utilize a total of four reducing equivalents to activate O2 prior 
to O2 attack on the substrate
96, 97
. This mechanism results in O-O bond scission before the 
substrate is oxygenated and the formation of Fe
4+
- or Fe
5+
-oxo/hydroxo species. For example, in 
the diiron methane monooxygenase hydroxylase, a total four reducing equivalents are injected 
into the O2 moiety, breaking the O-O bond and converting the reactive Fe
2+
/Fe
2+
 cluster to 
Fe
4+
/Fe
4+
. The analogous process in the mononuclear enzymes—which lack a second metal to 
store the additional electrons—requires 2 e- oxidation of an organic cosubstrate or an exogenous 
source of 2 e
-
 to generate the full 4 e
-
. During O2 activation, the mononuclear iron cofactor cycles 
from the Fe
2+
 state to Fe
4+
. 
A critical step leading to the formation of high-valent intermediates is scission of the O-O 
bond of the metal-bound peroxo moiety. The cleavage mechanism varies between enzymes and 
several versions have been identified. The first is reductive scission of the O-O bond driven by 
electron donation/transfer to the peroxide moiety from the metals (e.g. the Fe
3+
/Fe
3+
 cluster 
converts to Fe
4+
/Fe
4+
)
81, 98, 99
. Alternatively, cleavage can be driven by nucleophilic attack of one 
O atom of the peroxo on an electrophilic substrate
61, 74
. Decay can also be induced by protonation 
of the peroxo itself
100
 or a first-sphere iron ligand
101, 102
. The latter could engender a ligand and/or 
peroxo rearrangement that drives O-O scission
98
. The result of the scission is a dinuclear 
Fe
4+
/Fe
4+
 or Fe
3+
/Fe
4+
 cluster with terminal or bridging oxo ligand(s). In the case of most 
mononuclear enzymes, the reactive substrate-oxidizing species contains a single ferryl (Fe
4+
=O) 
or Fe
4+
-hydroxo unit. Such species are among the most potent chemical oxidants generated in all 
of biology and are tasked with performing the most demanding of oxygenation reactions. 
Fe
4+
/Fe
4+
-oxo/hydroxo and mononuclear Fe
4+
 intermediates have been characterized in a few 
enzyme systems and biomimetic inorganic model compounds
86, 103-108
. High-valent intermediates 
are also proposed in ADO and the arylamine oxygenases following initial substrate attack by the 
peroxo (see Fig. 3A-(iv) to (v) and 3B-(iii) to (iv)) but have not been trapped for study. 
In the diiron-cluster containing enzymes, the most remarkable of the high-valent 
intermediate is the bis-μ-oxo Fe4+/Fe4+ cluster of soluble methane monooxygenase hydroxylase  
11 
 
  
Fig. 4: Proposed catalytic mechanisms for selected enzymes that use high-valent iron species 
for substrate attack. (A) Soluble methane monooxygenase hydroxylase (sMMOH)
75, 98, 103, 104, 
111-113. (B) Taurine:α-ketoglutarate dioxygenase (TauD)86, 126. The orange arrows show 2 e- 
transfers and green arrows show 1 e
-
 transfers or radical recombinations. 
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(sMMOH), termed intermediate Q (Fig. 4A-(iv))
98, 103, 104
. This species is responsible for effecting 
the oxidation of methane to methanol in a variety of methanotrophic bacteria, thereby allowing 
these organisms to utilize methane as the sole source of carbon. The kinetics of the catalytic cycle 
of sMMOH have been extensively studied for nearly thirty years
109, 110
. The enzyme is proposed 
to pass through several intermediates prior to formation of Q, including a cis μ-1,2 peroxo 
complex termed P (Fig. 4A-(ii))
75, 79
. Although the conversion of P to Q was known to be proton-
dependent
101
, it was only recently that the details of the mechanism of the conversion have 
emerged, following determination of the long-sought vibrational spectrum of Q
98
. These studies 
indicate that formation of Q occurs by homolytic cleavage of the peroxo O-O bond, triggered by 
protonation of a first-sphere carboxylate ligand or metal-bound solvent molecule (Fig. 4A-(iii) to 
(iv)). The conversion of P to Q may proceed via a transient trans μ-1,2 peroxo which is depicted 
in Fig. 4A-(iii)
98
. Q is proposed to react with the methane substrate by hydrogen atom abstraction 
and subsequent radical recombination (Fig. 4A-(v) to (vii))
111-113
. Although Q is currently the only 
Fe
4+
/Fe
4+
 cluster that has been directly characterized, Q-like species are proposed be generated in 
the catalytic cycle of other diiron enzymes
58, 61
.  
Ribonucleotide reductase (RNR) is an (αβ)2 enzyme that catalyzes the reduction of 
ribonucleotides to the deoxyribonucleotides required for DNA synthesis. The R2 (β2) subunit of 
RNR (RNR-R2) binds a diiron cluster that is necessary for generation of a quasi-stable tyrosine 
radical cofactor (Y122 in the E. coli enzyme) that propagates to the R1 subunit where 
ribonucleotide reduction occurs
114-117
. RNR-R2 is technically an oxidase but is noteworthy 
because it uses a high-valent intermediate to generate the catalytic Tyr radical. Upon exposure of 
the apo RNR-R2 to O2 and free Fe
2+
, the Tyr radical cofactor is spontaneously assembled along 
with the diiron cluster. During assembly, a short-lived Fe
3+
/Fe
3+
-peroxo intermediate is formed 
which subsequently decays to a high-valent intermediate termed X following injection of one 
electron into the system
99, 118
. The peroxo intermediate has been characterized in wild-type (WT) 
enzyme and in first-sphere mutants of this enzyme and found to be a cis μ-1,2 Fe3+/Fe3+-peroxo119, 
120
. Compound X contains a high-valent Fe
3+
/Fe
4+
-oxo bridged cluster that is competent to 
perform the oxidation of Y122 to the catalytic radical with coincident decay of the cluster to the 
oxo-bridged diferric state
105, 121, 122
. However, in certain mutants of the enzyme, the reaction 
partitions between self-hydroxylation of the protein and radical generation, showing that the 
cluster is also competent to oxidize aromatic C-H bonds
99, 123
. 
Ferryl species are generated in many mononuclear iron enzymes. As noted above, these 
enzymes generate ferryl species at the cost of an organic cosubstrate that is oxidized by two e
-
 to 
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break the O-O bond
124, 125
. Commonly encountered organic cofactors include α-KG and 
tetrahydrobiopterin. During the catalytic cycle, α-KG- and pterin-dependent oxygenases oxidize 
these cosubstrates to succinate/CO2 and dihydrobiopterin, respectively
86, 93, 106, 124
. The consensus 
mechanism for the α-KG-dependent enzymes posits formation of a short-lived Fe4+-peroxo 
species (or an isoelectronic Fe
3+
-superoxo) as shown in Fig. 4B-(ii)
86
. The terminal oxygen atom 
of the metal-bound activated O2 species rapidly attacks the α-keto carbon of the organic cofactor 
leading to oxidative decarboxylation and heterolytic O-O bond cleavage (Fig. 4B-(iii)). This 
process generates a ferryl species (Fig. 4B-(iv)) that subsequently oxidizes the substrate using 
hydrogen atom abstraction (Fig. 4B-(iv) to (vi)). This results in a Fe
3+
-hydroxide and organic 
radical. Substrate is then hydroxylated via radical recombination, a process that also regenerates 
the Fe
2+
 cofactor (Fig. 4B-(vi))
126. Homologous α-KG-utilizing halogenases are also proposed to 
use this mechanism but with the key difference being rebound of a metal-bound halogen on the 
organic radical instead of the Fe
3+
-hydroxide
107
. The pterin-dependent aromatic amino acid 
hydroxylases also generate a reactive ferryl species but the steps leading to O2 activation and the 
mechanism of O-O bond scission are different
106, 124
. 
Rieske oxygenases contain a mononuclear iron cofactor where the O2 reaction takes place 
and also bind a Fe2S2 cofactor (the eponymous “Rieske” cluster)
29, 45, 127
. The Rieske cluster stores 
a single reducing equivalent and is located near the mononuclear iron in the protein. Based on 
work with the enzymes naphthalene dioxygenase and benzoate dioxygenase, the reaction with O2 
is proposed to proceed through a Fe
3+
-(hydro)peroxo intermediate
128
. This species is isoelectronic 
to an Fe
5+
-oxo hydroxo which is proposed to catalyze the dearomatization and cis-
dihydroxylation of the aromatic substrates
83, 127, 128
. The overall reaction oxidizes both the Rieske 
and mononuclear iron. Subsequent reduction of the latter cofactor is required for product 
release
128
. Recently, further studies with benzoate dioxygenase have suggested the possibility that 
a Fe
3+
-superoxo species may be responsible for catalyzing the initial attack on substrate instead of 
a high-valent species
70
. This assignment was based on the observation that the rate-determining 
step is substrate attack/oxidation, and that this event precedes Rieske cluster oxidation
70
. 
Formation of a reactive Fe
3+
-(hydro)peroxo or Fe
5+
 species before attack on the substrate requires 
a net donation of two e
-
 to the oxygen, one of which would necessarily derive from oxidation of 
the Rieske cluster before the attack on substrate. 
 
Regulatory strategies used by oxygenases to control O2 activation. One of the hallmarks of 
O2-activating enzymes is the regulatory mechanism used to prevent the adventitious formation of 
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potent oxidizing species in the absence of the cognate substrate. Almost invariably, enzymes that 
catalyze such reactions have been found to utilize some form of catalytic regulation that ensures 
O2 activation only proceeds rapidly in the presence of substrate(s). The need for such mechanisms 
is obvious: uncontrolled generation of reactive oxygen species is detrimental to the enzyme 
function and the cell itself, should the activated O2 species be released from the active site of the 
enzyme
129
. There are numerous examples of self-hydroxylation of enzymes or uncoupling of the 
reaction in mutated enzymes where the regulatory mechanism is abolished or where enzymes in 
the reduced Fe
2+
 state are incubated with O2 for extended periods in the absence of substrate
123, 
130-132
. Of positive note, self-hydroxylation has been proposed as a convenient probe for the 
formation of high-valent oxidizing intermediates
133
. This section will explore common 
mechanisms by which oxygenases control O2 reactivity, again using several enzyme families as 
examples. 
 (a) Regulation in mononuclear enzymes with a facial triad iron-binding motif (Fig. 5A) 
 This enzyme class, though incredibly diverse in terms of catalytic capabilities, utilizes the 
same iron-binding motif: the “facial triad” in which the metal is an octahedral coordination 
environment where three sites are coordinated by protein-derived ligands in a facial mode and the 
other three sites by solvent
96, 125, 134
. The most common ligand set contains two His and one 
carboxylate (Asp/Glu), though several enzymes with alternative sets have been characterized
135
. 
The regulatory logic for these enzymes can be reduced to a relatively simple paradigm: the Fe
2+
 
coordination sphere remains saturated, i.e., there are no open coordination sites on the metal for 
O2 to bind, until substrate has bound to the metal or in the active site but not on the metal. The 
facial coordination mode of the protein ligands facilitates this mechanism because it offers three 
available sites in a cis-arrangement on the metal. Most often, two are reserved for a substrate 
chelate, and O2 reacts in the remaining site. A common pathway is (i) direct chelation of 
cosubstrate (if required) and substrate to the metal (or in some cases in the active site but not 
directly to the metal), (ii) dissociation/displacement of the metal-bound solvent molecules to open 
a site on the metal cis to the substrate or cosubstrate and (iii) binding of O2 to the metal followed 
by electron transfer and O2 activation. This type of mechanism has been observed in the α-KG- 
and pterin-dependent oxygenases
86, 136, 137
, cysteine dioxygenase
84, 138
, extradiol dioxygenases
91, 
139
, Rieske oxygenases
29, 140
, aliphatic C-C bond-cleaving oxygenases
85, 141
, and oxidases
47, 48, 142, 
143
. It should be noted that in the Rieske enzyme naphthalene dioxygenase (NDO) and likely other 
members of the family, substrate must be bound in the active site and both the mononuclear iron 
and the Rieske Fe2S2 cluster must be in the reduced state, implicating a second layer of 
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regulation
29, 144
. In addition to controlling the timing of O2 activation, it is believed that direct 
coordination of the substrate to the metal has two more major  
effects on the fate of the reaction
66, 91, 138, 145-149
: (i) it properly aligns substrate for the reaction with 
O2, ensuring regio- and stereospecificity of the reaction product  and (ii) direct coordination or 
chelation of the substrate changes the electronic properties of the metal to make it more reactive 
towards O2. 
 (b) Regulation in diiron bacterial multicomponent hydroxylases (Fig. 5B) 
 The members of the BMM enzyme family catalyze some of the most potent oxygenase 
chemistries in nature. It is no surprise, then, that they have developed some of the most 
sophisticated regulatory mechanisms. The most extensively studied regulatory mechanism is that 
utilized by the sMMOH enzyme system from Methylosinus trichosporium OB3b and 
Methylococcus capsulatus (Bath)
109
. O2 activation in the hydroxylase component  is controlled by 
a small (16 kDa) regulatory protein named MMOB
150
. Although the hydroxylation reaction of a 
variety of unactivated C-H bonds still occurs in the absence of MMOB
28, 151, 152
, addition of 
MMOB to the system has dramatic effects on the reaction product distribution and maximal 
enzyme activity
150, 153
, the diiron cluster electronic properties
154-156
, and the rate constants of 
several discrete steps in the catalytic cycle
157, 158
. The primary roles of MMOB have been 
determined to be (i) to bind to MMOH, causing a structural change that  generates a molecular 
protein “sieve” that preferentially gates access for small hydrocarbon substrates to the active site 
and promotes quantum tunneling of the methane hydrogen atom during the reaction with Q
158-160
 
and (ii) to increase the reactivity of the active diferrous cluster of MMOH towards O2 1000-fold 
by inducing a structural rearrangement of the cluster ligands and lowering the iron redox 
potential
157, 161, 162
. Hence, the role of MMOB is multi-fold: to ensure entry of only the proper 
physiological substrate to the active site and permit rapid O2 reaction/activation only when the 
protein “gate” is in place. Similar regulatory mechanisms have been studied in other BMM 
enzymes including toluene-4-monooxygenase
53
, phenol hydroxylase
51
, and toluene/o-xylene 
monooxygenase
52
. 
 (c) Regulation by binding of a substrate-carrier protein (acyl-ACP desaturase) (Fig. 5C) 
The acyl-acyl carrier protein (acyl-ACP) desaturases are diiron enzymes with a protein fold and 
active-site cluster architecture similar to the BMMs but have a modified regulatory mechanism. 
The acyl-ACP desaturases oxidize ACP-tethered fatty acids to their corresponding desaturated 
analogues. The fatty acid substrates are tethered to an ACP via a covalent phosphopantetheine 
linker
163, 164
. These enzyme systems exemplify the third regulatory strategy: systems in which the  
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Fig. 5: Examples of strategies used by different oxygenase families to control O2 activation. 
(A) Taurine:α-ketoglutarate dioxygenase (TauD) and other α-KG utilizing oxygenases86. (B) 
Soluble methane monooxygenase hydroxylase (sMMOH)
150, 153-158, 160
. (C) Acyl-acyl carrier 
protein (ACP) desaturase
81, 166-168
. 
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substrate is tethered to another protein. The most studied desaturase is stearoyl-ACP Δ9-
desaturase from Ricinus communis (castor plant)
55, 165
. Binding of the acyl-ACP to the desaturase 
enzyme induces structural changes in the cluster that increase the reactivity of the cluster towards 
O2
81, 166, 167
, similar to the other mechanisms discussed above. The details of the structural changes 
induced in the desaturase upon acyl-ACP binding have not been definitely determined, but 
spectroscopic studies have suggested that the cluster ligands undergo a rearrangement causing a 
five-coordinate to four-coordinate transition of one of the metal ions
166
. X-ray crystallographic 
studies of Δ9-desaturase have shown that the protein-protein interaction is a critical component 
that controls O2 activation as well as the regiospecificity of the desaturation reaction
168
. Thus, the 
regulatory mechanism and the product specificity are controlled to a significant extent by the 
interaction with the protein carrier and structural changes induced at the protein-protein 
interface
168
. This regulatory theme will emerge again when discussing the non-ribosomal peptide 
synthetase-associated oxygenases in subsequent sections. 
 
Protocatechuate 3,4-dioxygenase 
 
Protocatechuate 3,4-dioxygenase belongs to the intradiol dioxygenase (IDO) family of aromatic 
ring-cleaving enzymes. It is a mononuclear non-heme iron-containing enzyme that uses a Fe
3+
 
cofactor to catalyze the ring-cleavage reaction, and a member of one of only two families of 
enzymes that utilize the oxidized form of the cofactor to initiate catalysis
25, 169
. IDOs function in 
the final step in the ortho-cleavage pathway of aromatic compounds in many species of soil 
bacteria and fungi, and allow the linearized products to be funneled into the organism’s central 
metabolism via the β-ketoadipate pathway (Fig. 6, bottom)32, 40, 170-172. The 3,4-PCD from the soil 
bacterium Pseudomonas putida is the most thoroughly characterized IDO. Its physiological role 
is to cleave protocatechuate (PCA, 3,4-dihydroxybenzoate) to the tricarboxylic ß-carboxy-cis,cis-
muconate product (Fig. 6)
19
. PCA is a common catabolite of an enormous variety of aromatic and 
polyaromatic monomers that are encountered by soil-dwelling organisms, including those formed 
during the depolymerization and breakdown of lignin (Fig. 6, green box) and the biosynthesis of 
aromatic amino acids (Fig. 6, red box)
173
. Because of their fundamental role in the metabolism of 
environmental aromatics including lignin catabolites and anthropogenic pollutants (Fig. 6 orange, 
black, and blue boxes)
171, 173-176
, dissection of the catalytic mechanism of these enzymes is a 
prerequisite to engineering the proteins (or entire host organisms) for environmental cleanup and  
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bio-based industrial applications
177, 178
. Studies of 3,4-PCD and its relatives have revealed a 
wealth of information, including the kinetic steps in substrate binding and product release
179-184
, 
the electronic properties of the iron cofactor in several states
185-189
, and insights into the oxygen 
activation mechanism
25, 32, 189-195
. 
 
 
 
Fig. 6: Metabolic funneling of aromatic compounds into the ortho-cleavage pathway initiated 
by 3,4-PCD. The β-ketoadipate pathway is shown at the bottom of the figure18, 19, 170. 
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IDO protein fold, substrate specificities, and active site architecture. IDOs are characterized 
by a core fold composed of two sets of mixed-type β-sheets. This fold has only been observed in 
members of the family
40, 196
. The structurally characterized members fall into three distinct 
categories based on their overall organization. The first class is typified by the catechol 1,2-
dioxygenases (1,2-CTDs) which preferentially cleave unsubstituted or methyl-substituted 
substrates
197-199
 as well as those members which preferentially cleave hydroxyquinol
200
 or halo-
substituted catechols
201, 202
. This class dimerizes via an α-helical N-terminal domain first 
identified in the Acinetobacter sp. ADP1 enzyme
197
; the iron cofactor is located in the C-terminal 
catalytic domain (Fig. 7A). The second class contains the protocatechuate dioxygenases
196, 203
, 
which are αβ heterodimers (Fig. 7B) and lack the explicit dimerization domain observed in the 
first class. Members of this group most often exist as large oligomeric (αβ)2-12 assemblies of the 
fundamental αβ-Fe3+ catalytic unit184, 193, 196, 204, 205. The 3,4-PCD from P. putida is a (αβ)12 
multimer (Fig. 7C)
196, 206. These α and β subunits are structurally homologous to one another. 
Interestingly, the 1,2-CTD from P. arvilla exists in three dimeric isoforms αα, αβ, ββ, 
highlighting a possible evolutionary linkage between 1,2-CTDs and 3,4-PCDs
198
. The final 
structural class of IDOs currently consists of only a single, recently characterized member that 
preferentially cleaves catecholic derivatives of lignin biosynthetic intermediates
176
. Unlike all 
other characterized IDOs, it is a monomer (Fig. 7D) and contains a C-terminal carbohydrate 
binding motif, which is implicated in targeting the enzyme to lignin surfaces. The active site of 
this enzyme is much more solvent exposed, lacking the tight substrate “pocket” observed in other 
IDOs. This is consistent with its apparent preference for large catecholic substrates. 
 All IDOs have a conserved metal-ligation sphere. The resting ferric cofactor is 
coordinated by a 2-His 2-Tyr motif and a solvent-derived hydroxide (Fig. 8-(i))
176, 196, 197
. This 
resting ligand set leads to a charge-neutral iron center, a property that has profound relevance to 
the catalytic cycle of the enzyme
179, 194
. The resting ferric ion is bound in a distorted 5-coordinate 
trigonal bipyramidal coordination environment. Y447 and H462 (residue numbering for 3,4-PCD 
from P. putida) are the axial ligands and Y408 and H460 along with solvent hydroxide are 
equatorial ligands. IDOs are characterized by a broad optical absorbance centered near 450 nm 
which confers a burgundy color to the enzyme. The chromophore derives from ligand-to-metal 
charge-transfer (LMCT) bands from both Tyr ligands to Fe
3+
 and provides a convenient probe for 
monitoring changes in the coordination sphere and binding of substrate
185, 186
. The presence of 
two Tyr ligands in the IDOs also dramatically lowers the redox potential of the metal (-0.5 to -1.1 
V)
207, 208
. As a final note, alongside IDOs, there are only a few characterized enzyme 
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families that have Tyr-metal ligands; these include the purple acid phosphatases and galactose 
oxidases
209, 210
. 
 
Proposed catalytic mechanism of 3,4-PCD. The reaction mechanism of 3,4-PCD is ordered 
sequential, with PCA binding before O2. Binding of PCA is proposed to occur in several steps, 
with PCA initially coordinating the Fe
3+
 as a 4OPCA monoanion, followed by a shift to a chelating 
mode that displaces Tyr447. This process results in coordination of the 4OPCA trans to H462 and 
3OPCA trans to Tyr408. In this enzyme-substrate (EPCA) complex (Fig. 8-(ii)), the plane of the 
aromatic ring of PCA is aligned with the axial direction of the iron coordination. The symmetry 
of the iron shifts to octahedral with one open site trans to H460, which is proposed as the site for 
eventual reaction with oxygen
181, 182, 203
. However, as O2 has no affinity for Fe
3+
, it is important to 
realize that there has never been any direct spectroscopic evidence for an Fe
3+
-O2 complex or 
 
 
Fig. 7: Crystal structures of various intradiol dioxygenases. (A) Homodimer of catechol 1,2-
dioxygenase from Acinetobacter sp. ADP1 (PDB structure 1DLM) . (B)  The catalytic αβ 
heterodimer unit of protocatechuate 3,4-dioxygenase from Pseudomonas putida (2PCD). (C) 
The (αβ)12 biological assembly of 3,4-PCD. (D) Dioxygenase domain of SACTE_2871 from 
Streptomyces sp. SirexAA-E (4ILV). In (B) and (C) the α-subunit is shown in white and β-
subunit in brown. The iron cofactor is shown as a brown sphere. 
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Fe
2+
-semiquinone radical character in the EPCA complex which might allow direct O2 binding to 
the iron
189, 191, 192
. This proposal is supported by several computational studies
25, 188, 211
. The EPCA 
complex is characterized as a Fe
3+
-catecholate complex with significant covalent bond 
character
188
, consistent with the spectroscopic properties observed for the complex
189, 212
. 
However, some dispute on this matter remains, as other calculations have suggested that EPCA 
does indeed have significant Fe
2+
 character
213, 214
. However, the extremely low redox potential of 
the metal, and the lack of any spectroscopic evidence for Fe
2+
 in the EPCA complex makes this 
assignment unlikely to be correct
25, 189, 192, 193, 207
. A key feature of the EPCA complex is an 
asymmetry in the binding mode of the catecholate: the Fe
3+
-O3PCA bond is considerably longer 
than the -O4PCA bond
181
. This apparent weakening of the Fe
3+
-O3PCA bond is proposed to facilitate 
later dissociation of the ketonized form of O3PCA from the metal during O2 activation.  
 Spectroscopic studies on 3,4-PCD have provided evidence that tyrosine coordination is a 
necessary feature in the O2 activation step
185, 186, 188
. Upon formation of the EPCA complex, 
additional low-energy charge transfer bands (at 500+ nm) arise from multiple catecholate-to-Fe
3+
 
LMCTs
212, 215
, with the lowest energy CT band proposed to provide a pathway for delivery of the 
β-spin electron from substrate to the iron during O2 activation, vide infra
188
. The reaction with O2 
is proposed to lead to a bridging Fe
3+
-alkylperoxo-PCA species (Fig. 8-(iii))
25, 181, 189, 216
. 
Formation of the alkylperoxo induces a shift of PCA back to the equatorial plane (Fig. 8-(iv))
25, 
213
. This shift is facilitated by a ketonization of 3OPCA and a lengthening of the bond to Fe
3+
 in a 
step that is essentially the reverse of the substrate binding process that initially resulted in the 
PCA chelate. This leads to the formation of a 5-coordinate complex with the axial site trans to 
His462 vacant (where Y447 coordinates Fe
3+
 in the resting state) and 4OPCA trans to Y408 (Fig. 
8-(iv)). Formation of the alkylperoxo intermediate is proposed to occur via a concerted two e
-
 
transfer process with the Fe
3+
 acting as an electron conduit and spin inverter leading to the 
simultaneous formation of both the Fe
3+
-OO2 (proximal) and C4PCA-OO2 (distal) bonds (Fig. 9)
25, 
188
. This net two-electron transfer process occurs through three simultaneous single-electron 
transfer processes: (i) transfer of a β-spin electron from the PCA πop-sym HOMO to the iron dxz 
orbital via the lowest energy PCA-Fe
3+
 LMCT bands (Fig. 9 red arrow), (ii) simultaneous 
delivery of an α-spin electron from the iron dz2 orbital to the HOMO of O2 (Fig. 9 green arrow), 
and (iii) transfer of an α-electron from the substrate to the O2 HOMO with the second unpaired β-
electron (Fig. 9 blue arrow). This electron transfer process leads to a net S = 3/2 spin system. This 
state is stabilized by ketonization and dissociation of O3PCA from the iron, resulting in a 
monodentate coordination mode of the substrate via O4PCA. The open sixth coordination site on  
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Fig. 8: Proposed catalytic mechanism for cleavage of PCA by 3,4-PCD
25, 179, 181, 189, 213
. The 
orange arrows show 2 e
-
 transfers and green arrows show 1 e
-
 transfers. The purple arrow 
illustrates the rearrangement of the alkylperoxo intermediate. 
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the iron is the  key to continuing the reaction. Protonation of the proximal oxygen in the 
alkylperoxo is proposed to lead to O-O bond scission. Either Y447 (Fig. 8-(v-a)) or solvent (Fig. 
8-(v-b)) have been proposed as possible proton donors 
25, 213, 217
. In either case, the proton donor is 
proposed to bind in the vacant sixth site on the metal. This return to a six-coordinate center favors 
intersystem spin crossing back to the S = 5/2 system, the spin state of the resting enzyme
189
. 
In 3,4-PCD, scission of the O-O bond has been theorized to result in the formation of an 
anhydride intermediate (Fig. 8-(vi)). Heterolytic O-O bond cleavage is facilitated by protonation 
of the proximal O atom of the peroxo moiety
213
. This heterolytic scission results in an Fe
3+
-bound 
OH while the distal O atom migrates into the ring via a Criegee-type mechanism (Fig. 8-(vi)) 
181, 
190, 194, 206
. This process incorporates the first O atom of O2 into the substrate ring. After anhydride 
formation, the iron-bound hydroxide attacks the ring to hydrolyze the anhydride, leading to 
 
 
Fig. 9: Proposed electron transfer mechanism for O2 activation in 3,4-PCD
25
. The Fe
3+
 
oxidation state is proposed to be maintained throughout. (A) Diagram showing the reactive 
orbitals involved in the electron transfer process. (B) Cartoon depicting the location and 
arrangement of the reactive orbitals. 
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cleavage and formation of the muconate product (Fig. 8-(vii)). Finally, either re-association of 
Y447 or binding of solvent (to regenerate the resting coordination sphere) could protonate the 
product leading to muconate dissociation and release
179
. Alternatively, a homolytic O-O cleavage 
mechanism has also been proposed based on evidence from reactions of a catechol 1,2-
dioxygenase with mechanistic probes
195, 218
. This path requires the formation of a ferryl 
intermediate and acyl radical which recombine and rearrange to generate the anhydride. 
 
Roles of specific active site residues during the catalytic cycle. Mutations of the axial Y447 
ligand to His greatly diminishes the rate of formation of the dianionic PCA chelate and reduces 
the turnover number of the enzyme 600-fold relative to WT
179
. The slowing of chelate formation 
is likely due to the mismatch in side-chain pKas between His (pKa ~ 6) and Tyr (pKa ~ 10.5). 
These results implicate the residue in assisting substrate binding by facilitating the deprotonation 
of the second substrate hydroxyl, thereby driving formation of the asymmetric chelate
179, 181
. 
Y447 was also assigned as having a role in facilitating product release by protonating one of the 
carboxylate functions on the muconate product
181
. This was based on the observation that product 
release in the H447 mutant was slowed relative to wild-type, providing further evidence for its 
role as an in situ acid/base. 
The function of the second Tyr ligand, Tyr408, has also been probed by mutagenesis. 
Various mutants of this residue result in O2 attack becoming rate-limiting because Y447 fails to 
dissociate from the iron, so that the substrate cannot progress rapidly from the monodentate to the 
chelate binding mode in the EPCA complex
194
. The overall turnover number in each of the mutants 
is reduced to less than 0.1% of WT
194
. These experiments suggest a role for Y408 in maintaining 
charge balance throughout the cycle and ensuring rapid ligand exchange during substrate binding 
and product release. trans-ligand effects from Y408 on the 3OPCA are also proposed to account for 
a weakening of the O3PCA-Fe
3+
 bond driving ketonization of O3PCA after O2 activation
181, 188,
 
 192
. 
The presence of one hydroxyl anion and two tyrosinate ligands in the resting coordination sphere 
also tunes the metal to strongly and preferentially bind the dianionic form of the substrate as two 
anionic ligands dissociate. 
Roles for several other residues have been suggested, but conclusive evidence for their 
role in the cycle has not been reported. The second-sphere residues R457 and Q477 are proposed 
to facilitate the shift of the alkylperoxo-PCA species into the equatorial plane by providing a 
stabilizing interaction with O4PCA and the ketonized O3PCA upon dissociation, respectively (Fig. 
8-(iv))
181, 206, 213
. R133 and Y324 are positioned near the entrance of the active site (near the 
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carboxylate function of metal-bound PCA), and have been proposed to help guide the PCA 
substrate into the active site and orient it properly for the reaction with O2
181
. 
 
Intradiol vs. extradiol dioxygenase cleavage specificity. IDOs represent one of the two major 
classes of catecholic ring-cleaving dioxygenases along with extradiol dioxygenases (EDOs). The 
most striking difference between these two families is the oxidation state of the iron. IDOs use an 
Fe
3+ 
cofactor to cleave between the vicinal hydroxyl groups of the catecholic substrate (ortho 
cleavage), whereas EDOs use an Fe
2+
 cofactor and cleave adjacent to the hydroxyl groups (meta 
cleavage). Intradiol and extradiol dioxygenases differ in their protein structure, active site 
architecture and the oxidation state of the cofactor, but the differences in their catalytic 
mechanisms are more subtle. Indeed, one of the primary goals of studying these enzyme families 
has been to understand the mechanism by which the site of ring-cleavage is controlled. The 
determining mechanism is more complex than simply the cofactor oxidation state (Fe
3+
 vs. Fe
2+
) 
or protein fold and ligand set, as a mutant enzyme of the EDO 2,3-HPCD can cleave certain 
substrates in an ortho mode
219
 and there have also been a few reports of IDOs performing meta 
cleavage on certain substrates
220-222
. Several mechanisms determining the site of ring cleavage 
have been proposed, including differences in the protonation site and timing of the intermediates 
formed during ring cleavage
219, 223-225
, the alignment of the alkylperoxo O-O bond relative to the 
substrate’s aromatic ring72, 226, the coordination mode (facial vs. meridional) of the iron 
cofactor
227, 228
, and differences in the O-O bond scission event controlled by the different iron 
oxidation states
195, 225, 229
. 
 
3,4-PCD: unanswered questions and current research directions. 3,4-PCD is a member of 
one of only two enzyme families that use the ferric state of the cofactor to activate O2
25
. 
Unfortunately, owing to the rapid chemistry of the WT enzyme (kcat ~ 70 s
-1
 at 25 °C), 
oxygenated intermediates have never been trapped for detailed characterization. Studies with 
various mutants of the enzyme have thus far not allowed characterization of the steps of the 
catalytic cycle in which O2 is activated
179, 194
. This has prevented the various mechanistic 
hypotheses from being directly tested
25, 195, 213
. In contrast, the ability to stabilize and trap reactive 
oxygenated intermediates in the Fe
2+
-utilizing EDO 2,3-HPCD has allowed us to assign specific 
roles to many of the active site residues and gain detailed insights into the myriad subtleties of the 
O2 activation mechanism
64, 71, 72, 230-233
. Similarly detailed information about the Fe
3+
-utilizing 
enzymes would provide fundamental lessons into how nature uses an otherwise inert cofactor to 
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catalyze O2 activation and facilitate comparisons to the Fe
2+
-utilizing enzymes. Thus, the first 
major challenge in 3,4-PCD is a detailed kinetic characterization of the O2 activation steps and a 
spectroscopic and structural interrogation of the oxygenated intermediates. 
Secondly, the roles of several of the second-sphere residues, including R457, Q477, 
Y324, and R133 are unknown. These residues are conserved in all 3,4-PCDs but diverge in more 
distant IDO relatives, such as the 1,2-CTDs
181, 206
. This implies that the residues may play a role 
in controlling substrate specificity
181, 200, 202
 and site-directed mutagenesis could provide a means 
to increase the enzyme’s reactivity toward alternative substrates. As 3,4-PCD and its relatives are 
positioned at a critical metabolic juncture in aromatic catabolism, these studies are a valuable 
precursor for engineering of the enzyme for various environmental applications
234, 235
. It also has a 
direct application to co-opting these enzymes for “green” biosynthesis of valuable chemical 
feedstocks
177, 236
. The factors that control intradiol vs. extradiol ring-cleavage specificity are still 
not well understood. A direct comparison of the structures of the intermediates in 3,4-PCD to 
those characterized in 2,3-HPCD
72, 231
 would be instrumental in understanding the role of the 
protein in controlling this site-specificity. This is of fundamental importance to understanding the 
mechanism of enzymatic catalysis, but also has applications in the design of new biomimetic 
model compounds or enzymes that catalyze desirable ring-cleavage reactions
228, 237, 238
. The recent 
characterization of an IDO involved in cleaving lignin precursors may also make these studies 
applicable to the field of renewable energy
174, 176
. 
 
CmlA 
 
The diiron enzyme CmlA catalyzes hydroxylation of the β-carbon of the non-canonical amino 
acid L-p-aminophenylalanine (L-PAPA). The enzyme is part of the non-ribosomal peptide 
synthetase (NRPS) pathway for chloramphenicol biosynthesis in Streptomyces venezuelae (Fig. 
10, red)
58
. Based on operon sequences, more than 40 homologs of CmlA exist in a variety of 
other natural product biosynthetic pathways, but these enzymes have yet to be cloned and 
biochemically characterized
239-242
. A variety of oxygenase enzymes are involved in NRPS-
mediated natural product biosynthesis
13
, most often cytochrome P450-type monooxygenases
243
, 
flavin-dependent oxygenases
244, and α-KG-dependent mononuclear iron enzymes245, 246. CmlA is 
the first characterized NRPS-associated oxygenase enzyme to utilize a diiron cluster cofactor. 
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Non-ribosomal peptide synthetase pathways and tailoring enzymes. NRPSs are complex, 
high-fidelity biosynthetic enzyme assemblies that catalyze the formation of many types of 
secondary metabolites in a variety of bacterial and fungal organisms
247, 248
. The enzymatic  
machinery of NRPSs relies on a modular biosynthetic logic in which the natural products are 
generated from amino acid monomers that are sequentially activated using ATP, covalently 
attached to the NRPS via an acyl-thioester linkage and condensed together to form and extend the 
polymer (Fig. 11A)
247-249
. NRPSs are composed of single or multiple modules that each contain 
several domains with distinct biosynthetic roles. Multi-domain NRPSs are commonly expressed 
as single polypeptides from a single gene resulting in immense sizes for some NRPSs
250
. In other 
pathways, multiple NRPSs expressed from different genes work in tandem to synthesize the final 
product. In each module, the amino acid monomers are selected and activated using ATP by 
action of a module’s adenylation domain (A domain) (Fig. 11B) 251, 252. The A domain selects and 
sequesters the substrates for each of the NRPS domains, ensuring that the correct amino acid 
monomer is activated for addition to the growing peptide. A second role of this domain is to  
 
 
Fig. 10: Non-ribosomal peptide synthetase (NRPS) biosynthetic pathway for 
chloramphenicol
58, 264
. The NRPS adenylation, peptidyl carrier protein, and reductase domains 
are shown as blue, yellow and orange spheres, respectively. 
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Fig. 11: Biosynthetic logic of NRPS machinery
247
. (A) Example of a four-module NRPS and 
the synthesis of a tetrapeptide. (B) Steps in the activation of amino acids to the AMP-
adenylates in the NRPS A domain. (C) Peptide condensation and extension catalyzed by the 
NRPS C domain. The various NRPS domains are colored as follows. Adenylation (blue), 
peptidyl carrier protein (yellow), condensation (green) and thioesterase/reductase (orange). 
29 
 
covalently attach the activated amino acyl-AMP adenylate to a second NRPS domain called the 
peptidyl carrier protein domain (PCP domain)
253
. The amino acid is attached as an acyl-thioester 
to a coenzyme A-derived phosphopantetheine group that is itself linked to a serine residue on the 
PCP domain
163, 254
. Condensation domains (C domains) catalyze condensation reactions between 
the monomers of sequential modules of the NRPS, forming a peptide bond to extend the nascent 
peptide (Fig. 11C). Reductase and thioesterase domains (R and TE domains) are found at the C-
terminus of NRPS systems and act to reductively or hydrolytically, respectively, release the 
peptide from the NRPS
255
. There are also trans-acting TE enzymes that work to release stalled 
NRPS assembly lines
256
. 
 The amino acid monomers that are utilized to synthesize the peptide are often themselves 
chemically modified either prior to or after covalent attachment to a NRPS PCP domain. These 
modifications are generated by so-called “tailoring enzymes,” which may either be part of the 
NRPS polypeptide, i.e., the same gene (cis enzymes), or free enzymes that are expressed in a 
separate gene (trans enzymes)
257
. Tailoring enzymes catalyze an enormous variety of 
modifications on the amino acid monomers including N- , C-, and O-methylation
258
, racemization 
and epimerization
259, 260
, hydroxylation 
13, 261
, cyclization
255
, and glycosylation
240, 262
. Such 
modifications are critical to the bioactivity of the final polypeptide produced by the NRPS. β-
carbon hydroxylated amino acids are common building-blocks of NRPS-synthesized 
polypeptides
261. These β-hydroxy moieties are sites for future modification including 
glycosylation, cyclization, and further oxidation or retro-aldol cleavage. 
Using the nomenclature just described, CmlA is a trans-acting hydroxylase-tailoring 
enzyme that β-hydroxylates the L-PAPA amino acid substrate while it is tethered to the PCP 
domain of the mono-modular NRPS CmlP
58
. CmlP consists of only a single three-domain module 
with A, PCP, and TE/R domains. The A domain is selective for L-PAPA which it activates and 
covalently tethers to the PCP domain
263
. The L-PAPA substrate itself is synthesized by the 
organism via a shunt from the shikimate pathway
264
. 
 
CmlA protein structure and active-site architecture. CmlA is the first discovered and 
characterized O2-activating enzyme to utilize a metallo-β-lactamase-like (MBL) fold, in contrast 
to the 4-helix bundle present in the BMMs, acyl-ACP desaturases, and RNR-R2. Related 
enzymes that reduce O2 in obligate anaerobes or catalyze nitric oxide reduction use the same fold, 
but they do not generate reactive oxygen species and have a different cluster ligand set
265-267
. The 
active site has been characterized by EPR, Mössbauer, EXAFS and resonance Raman (rRaman) 
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studies
58, 268
. The diiron cluster of CmlA exhibits some distinct properties, including a high 
exchange coupling constant (J > 90 cm
-1
) and an EPR silent S = 0 diferrous state
58
. In contrast, 
diferric MMOH has a lower exchange coupling (J ~ 14 cm
-1
) and a diferrous cluster with S = 4 
that arises from ferromagnetic coupling of two S = 2 ions
109
. The CmlA cluster is proposed to be  
coordinated by three His ligands and carboxylates (one glutamate and two aspartate) and bridged 
by an oxo ion. The absence of protons on the bridging moiety was determined using rRaman 
studies which showed that the oxygen-iron-linked vibrations are unaltered when the enzyme in 
incubated in H2O or 
2
H2O
268
. EXAFS measurements showed that both metals are six-coordinate 
in the resting form and the Fe-Fe distance is 3.3-3.4 Å. Currently, there is no structural 
information about the changes that occur upon reduction of the cluster or upon NRPS binding, but 
the exchange coupling of the diferrous cluster is reduced to 12 cm
-1 
suggesting a change in the 
bridging moiety
58
. This constant is much larger and has the opposite sign from that reported for 
diferrous MMOH (J ~ -0.7 cm
-1
)
49, 109
. 
 
CmlA catalytic mechanism and regulation. As this family of enzymes was only recently 
discovered, very little is known about the mechanism of O2 activation or its catalytic regulation. It 
is known that diferrous CmlA is only reactive with CmlP-tethered L-PAPA, implying a 
regulatory system that must be linked to the protein-protein interaction with the NRPS
58
. Thus, 
although CmlA uses a completely different fold than other hydroxylases, the cluster reactivity 
may also be gated by a structural rearrangement induced by interaction with another protein, like 
that of the MMOH-MMOB system
150, 157, 158, 269-271
 or the acyl-ACP desaturases
168
. Similar to the 
ACP in the latter group, CmlP is likely serving dual roles: (i) as a substrate carrier that targets the 
NRPS to the correct tailoring enzyme thereby ensuring overall product specificity of the 
synthetase and (ii) as a regulatory partner that controls the timing of O2 activation. No 
intermediates of the CmlA reaction have yet been trapped for characterization, and it remains to 
be determined if CmlA has a catalytic cycle analogous to that of the BMMs. Due to the strength 
of the Cβ-H bond (BDE ~ 85 kcal mol-1) a high-valent Q-like intermediate has been evoked as the 
oxidizing species
58
. 
 
CmlA: unanswered questions and current research directions. There are currently 
considerably more mysteries than answers regarding CmlA.  Some of the major areas of interest 
have already been alluded to in the above sections. Of primary interest is the determination of the 
structure of the enzyme. As noted, CmlA has a unique fold among all other characterized 
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oxygenase enzymes. Determination of the structure of the overall fold would permit insightful 
comparisons to other oxygenases that use different protein architectures to house and coordinate 
the cofactor. This could provide an explanation for the unique spectroscopic properties observed 
for the enzyme
58
. The elucidation of the as-of-yet uncharacterized N-terminal domain would also 
allow us to obtain the first structural clues as to the biological role of this novel fold in CmlA and 
in the homologs from other biosynthetic pathways. A structure is also a requisite for rational site-
directed mutagenesis of the enzyme’s cluster ligands.  
A second priority is the determination of the nature of the oxygenated intermediate that 
catalyzes the oxidation of the Cβ-H bond. Since CmlA belongs to an entirely new family of diiron 
hydroxylases, it is of interest to know whether it generates the same type of oxidizing 
intermediate as MMOH or if nature has devised an entirely different type that is exclusive to this 
protein fold and cluster architecture. Thus far, MMOH remains the only enzyme where a 
Fe
4+
/Fe
4+
 species has been directly characterized
272
. Having the structure of CmlA available could 
also be used to answer some basic questions about whether the cluster can support a Q-like 
intermediate and if it is likely to go through an analogous catalytic cycle to that of sMMOH. 
Finding evidence of a high-valent Fe
4+
/Fe
4+
 species in CmlA would show that other protein folds 
and cluster architectures can support the generation of such an intermediate. This is directly 
relevant to the design of new catalysts with industrial applications and of basic interest to 
understanding the nature of activated O2 species. 
 Finally, the mechanism of catalytic regulation in CmlA is of interest. As discussed in 
detail above, nature has devised a wide variety of elegant safeguards to control O2 activation. The 
regulatory mechanisms are as diverse as the reactions themselves. The unique protein fold of 
CmlA (amongst other oxygenases) and its role in an NRPS pathway suggests that it has a new 
type of regulatory mechanism. A detailed study would provide a new perspective on the methods 
nature uses to control O2 activation. The determination of the structure of CmlA would again go a 
long way towards answering some of these questions. A related topic is studying the mechanism 
by which CmlA is targeted to its cognate NRPS, which may be tied into the mysterious N-
terminal domain of the enzyme. Altering this targeting specificity and/or engineering the enzyme 
to react with alternative amino acids could one day be used to engineer and harness this system 
for the biosynthesis of new bioactive compounds such as antibiotics
273-275
.’ 
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CmlI 
 
CmlI is a diiron-cluster containing amine-oxidizing enzyme (N-oxygenase) that converts the 
aminoaryl group of the chloramphenicol precursor (D-threo-1-(4-aminophenyl)-2- 
dichloroacetylamino-1,3-propanediol, NH2-CAM) to the corresponding nitroarene, thereby 
generating chloramphenicol (CAM)
276, 277
. CmlI is in the same genetic operon as the CmlA β-
hydroxylase and is the last enzyme in the biosynthetic pathway for chloramphenicol in S. 
venezuelae (Fig. 10, blue)
57, 264
. Unlike CmlA, CmlI is not reactive toward NRPS-tethered amino 
acids. The primary structure of CmlI suggests that it coordinates the cluster in a 4-helix bundle
278, 
279
. 
 
Arylamine dioxygenases. The mechanism of N-oxygenation is of considerable interest due to the 
presence of the nitro function in several antibiotics and other medicinally important 
compounds
172, 280
. Although nitro groups have been recognized in several bacterial and fungal 
secondary metabolites, only a few biosynthetic N-oxygenases besides CmlI have been 
characterized in detail. One is AurF, a diiron arylamine oxygenase in the biosynthetic pathway for 
the antibiotic aureothin in Streptomyces thioluteus
281, 282
. Its structure and function are 
homologous to those of CmlI. The AurF substrate is p-aminobenzoate which the enzyme converts 
to p-nitrobenzoate. The second N-oxygenase that has been studied in detail is PrnD, a Rieske-type 
mononuclear iron enzyme involved in the biosynthesis of the antifungal antibiotic pyrrolnitrin
283
. 
 
CmlI catalytic mechanism. CmlI is a recent isolate and the details of the catalytic mechanism of 
the enzyme are relatively unknown. The mechanism is likely analogous to that catalyzed by 
AurF, a reaction that has been studied in more detail. However, many questions regarding the 
catalytic mechanism of CmlI and AurF are still under dispute, with various groups proposing 
different mechanisms for how the arylamine group is converted to the nitro
56, 282, 284
. The overall 
conversion of the arylamine group to the nitro is a six e
-
 oxidation and the general catalytic 
mechanism invokes three sequential two e
-
 oxidative steps for this conversion. The O2 
stoichiometry for this process is still under dispute. Some data suggests that three equivalents of 
O2 (along with six exogenous e
-
) are required per molecule of amino substrate for the full 
oxidation
57, 73
. Other data imply that only two O2 equivalents are necessary and that the third 
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oxidation step proceeds by oxidation of an intermediate by the diferric cluster
284
. One proposed 
mechanism for the first of the three oxidative cycles is shown in Figure 3B. 
Like all other diiron enzymes with the exception of MIOX, the diferrous state is reactive 
towards O2. Both CmlI and AurF, under certain conditions, generate long-lived Fe
3+
/Fe
3+
-peroxo 
species upon exposure of the diferrous cluster to O2
57, 73
. The peroxo species in CmlI has been 
characterized in more detail than the AurF peroxo. This study showed that the species has a novel 
geometry when compared to peroxo intermediates previously studied in other diiron systems
57, 73
. 
The kinetic data have supported a model in which the peroxo reacts directly with the substrate 
and the oxidation event occurs by nucleophilic attack of the amine (or hydroxylamine) group on 
the cluster-bound peroxo moiety
57, 73, 284
. How the unique geometry of the peroxo species relates 
to its ability to oxidize arylamine groups is still under investigation. In the arylamine oxygenases, 
the role of the diiron cluster is to activate O2 to a peroxo state, preparing the molecule for attack 
by the amino substrates. This mechanistic proposal also explains why the enzyme is unable to 
activate C-H bonds, which are unlikely to perform a nucleophilic attack on the peroxo moiety. 
 
CmlI: unanswered questions and current research directions. As with CmlA, the lack of a 
structure of the enzyme and knowledge of its active site architecture is one of the largest gaps in 
our current knowledge. A structure would facilitate a comparison to other diiron oxygenases and 
to the CmlI homologs in other natural product biosynthetic pathways. It would also provide the 
first insight into how the cluster may direct the formation of the biologically unique peroxo 
species. The recent spectroscopic characterization of the CmlI peroxo species also presents an 
opportunity for comparisons to other diiron peroxo modes and the correlation between geometry 
and reactivity
60, 74, 75, 81, 119
. Due to the long-lived nature of the intermediate, X-ray 
crystallographic characterization may be possible once crystallization conditions for CmlI are 
obtained
72, 76, 82
. The availability of a crystal structure would also provide an advantage in 
resolving some of the current disputes about the catalytic mechanism of the enzyme. Co-
crystallization with substrates is also key to determining the mechanism of substrate specificity of 
the enzyme. This, in turn, could open up the potential for site-directed mutagenesis of the enzyme 
to perform N-oxygenation reactions on alternative molecules. 
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Overview of the Chapters 
 
The first two chapters of this dissertation focus on the recent advances made in our understanding 
of the catalytic mechanism of 3,4-PCD. Chapter 1 presents the X-ray crystallographic trapping of 
the two most critical oxygenated intermediates in the 3,4-PCD catalytic cycle using an alternative 
substrate. Chapter 2 presents the kinetic characterization of the reaction of 3,4-PCD with various 
other alternative substrates and the discusses their relevance to the native reaction cycle. Chapters 
3 and 4 focus on the determination of the crystal structures of CmlA and CmlI, respectively. Their 
structures are compared to those of other diiron enzymes and the myriad insights into their 
catalytic mechanism and regulation are discussed. 
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CHAPTER 1 
 
Crystal structures of alkylperoxo and anhydride intermediates 
in an intradiol ring-cleaving dioxygenase 
 
 
Note: This chapter is reprinted (adapted) with permission from Knoot, C. J., Purpero, V. M., and 
Lipscomb, J. D. (2015) Crystal structures of alkylperoxo and anhydride intermediates in an 
intradiol ring-cleaving dioxygenase, Proc Natl Acad Sci U S A 112, 388-393. Copyright (2015) 
PNAS. 
 
 
Abbreviations: 
3,4-PCD: protocatechuate 3,4-dioxygenase 
4FC: 4-fluorocatechol 
PCA: protocatechuate (3,4-dihydroxybenzoate) 
IDO: intradiol dioxygenase 
E-4FC: the complex of 3,4-PCD with 4FC without O2 
E-PCA: the complex of 3,4-PCD with PCA without O2 
2,3-HPCD: homoprotocatechuate 2,3-dioxygenase 
RRT: reciprocal relaxation time 
LMCT: ligand-to-metal charge-transfer 
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Summary 
 
Intradiol aromatic ring-cleaving dioxygenases utilize an active site, nonheme Fe
3+
 cofactor to 
activate O2 and catecholic substrates for reaction. The inability of Fe
3+
 to directly bind O2 
presents a mechanistic conundrum. The reaction mechanism of protocatechuate 3,4-dioxygenase 
is investigated here using the alternative substrate 4-fluorocatechol (4FC). 4FC is found to slow 
the reaction at several steps throughout the mechanistic cycle, allowing the intermediates to be 
detected in solution studies. When the reaction was initiated in an enzyme crystal, it was found to 
halt at one of two intermediates depending on the pH of the surrounding solution.  The X-ray 
crystal structure of the intermediate at pH 6.5 revealed the key Fe
3+
-alkylperoxo species, while 
the Fe
3+
-anhydride intermediate was found for a crystal reacted at pH 8.5.  Intermediates of these 
types have not been structurally characterized for intradiol dioxygenases, and they validate four 
decades of spectroscopic, kinetic, and computational studies.  In contrast to our similar in 
crystallo crystallographic studies of a Fe
2+
-containing extradiol dioxygenase, no evidence for a 
superoxo or peroxo intermediate preceding the alkylperoxo was found. This observation and the 
lack of spectroscopic evidence for an Fe
2+
 intermediate that could bind O2 are consistent with 
concerted formation of the alkylperoxo followed by Criegee rearrangement to yield the anhydride 
and ultimately ring-opened product. Structural comparison of the alkylperoxo intermediates from 
the intra- and extradiol dioxygenases provides a rationale for site specificity of ring cleavage. 
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Introduction 
 
Most ring-cleaving dioxygenases belong to the non-heme mononuclear iron-containing enzyme 
family, many members of which play critical roles in the aerobic biodegradation of natural and 
synthetic aromatic compounds
32, 40, 175, 177, 285
. Ring-cleavage by these enzymes involves fission of 
the O-O bond of dioxygen and incorporation of both atoms into the product
17
. Two major classes 
of catechol ring-cleaving dioxygenases have been described. These differ in the mode of cleavage 
and the oxidation state of the iron cofactor: the Fe
2+
-utilizing extradiol dioxygenases (EDOs) 
cleave adjacent to the vicinal hydroxyl functions of catechols (meta-cleavage) while intradiol 
dioxygenases (IDOs) use a Fe
3+
 cofactor and cleave between the hydroxyl functions (ortho-
cleavage). The Fe
3+ 
in the active site of IDOs will not bind O2 and no direct spectroscopic 
evidence for redox cycling has been obtained
32
. This means that IDOs must activate O2 using a 
unique mechanism which differs from that of the much more common Fe
2+
-containing 
oxygenases that readily form an Fe-O2 complex after the substrate binds in the active site
64, 125, 286
. 
 The archetypal IDO is protocatechuate 3,4-dioxygenase (3,4-PCD), which catalyzes 
cleavage of its native substrate (3,4-dihydroxybenzoate, PCA) to yield β-carboxy-cis,cis-
muconate, thereby funneling aromatic substrates into the β-ketoadipate pathway170.  Much of our 
mechanistic knowledge of IDOs comes from kinetic, spectroscopic and crystallographic studies 
of 3,4-PCD, catechol 1,2-dioxygenase
25, 179, 184, 185, 194, 196
, and bio-inspired model compounds
237, 
238
. 3,4-PCD coordinates the Fe
3+
 in a 2-His, 2-Tyr ligand set which is conserved in IDOs
196
. The 
tyrosine ligands contribute several ligand-to-metal-charge transfer bands (LMCTs) in the visible 
which give IDOs a burgundy color that can be used to monitor the reaction
186
. In 3,4-PCD, the 
Fe
3+
 is coordinated by axial ligands Y447 and H462 and equatorial ligands H460, Y408 and 
solvent-derived hydroxide (Fig. 1)
196
. 
The proposed intermediates for the reaction of 3,4-PCD with PCA and O2 are shown in 
Fig. 12 and designated 1-8
25, 32, 179, 181, 185, 195, 213
. First, PCA binds to the metal of the resting 
enzyme 1 in a multi-step process leading to a complex 2 where both hydroxyls are ionized and 
the ring of PCA is axially oriented. Formation of 2 results in dissociation of Y447 from the metal, 
forming a 5-coordinate (5C) complex with a vacant site trans to H460. O2 reacts with 2 in a 
concerted process 3, generating a Fe
3+
-alkylperoxo species 4. Spectroscopic and computational 
studies suggest that catalysis requires a physical shift of a transient six-coordinate (6C) 
alkyperoxo 4 to a 5C species 5, opening the axial site trans to H462. Protonation of the peroxo 
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moiety 6 drives O-O bond scission and migration of one oxygen atom into the substrate ring to 
form an anhydride 7. Attack of the iron-bound hydroxide on the anhydride cleaves the substrate 
ring to form product complex 8, which, upon release, regenerates state 1. Transient kinetic studies 
have detected intermediates throughout the catalytic cycle, but the kinetics of their 
interconversion have not allowed any intermediate between the substrate and product complexes 
to be trapped for detailed characterization
179, 183, 184, 287
. 
 The use of alternative substrates has been a successful means to detect and trap 
intermediates in enzyme reaction cycles in which the native reaction proceeds too quickly or with 
unfavorable interconversion rate constants
126
. A powerful extension of this approach involves 
performing catalysis in enzyme crystals to trap reactive species for characterization using X-ray 
crystallography, which has been successfully applied to a few systems
72, 82, 231, 288, 289
. This 
approach was used by our laboratory to identify and characterize four distinct oxygenated 
intermediates in the catalytic cycle of the EDO homoprotocatechuate 2,3-dioxygenase (2,3-
HPCD)
72, 231
. Here, we have extended this in crystallo approach to the IDO 3,4-PCD as it turns 
over the alternative substrate 4-fluorocatechol (4FC), allowing determination of the structures of 
two intermediates following O2 addition. These intermediates provide a direct view of the key 
steps in the oxygen activation and reaction cycle of IDOs.  Insight is also gained into one of the 
longstanding questions in oxygenase research: the basis for cleavage site specificity in the ring 
cleaving dioxygenase family. 
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Materials and methods 
 
Protein expression and purification. 3,4-PCD was purified as previously described
194
. In 
addition, we generated an N-terminally 8x-His-tagged construct of the enzyme for rapid 
purification. The coding sequence for the pcaH and pcaG genes from Pseudomonas putida was 
amplified using polymerase chain-reaction (PCR) from a pCE120 expression template
194
,  with 
 
 
Fig. 12: Proposed intermediates in the reaction of 3,4-PCD with substrate and O2.  R 
represents either COOH (PCA) or F (4FC). 4FC is bound in the equatorial plane rather than 
the axial plane as shown in 2. It may rotate to the axial plane to react. The πop-sym HOMO of 
substrate is proposed to be the source of the reducing equivalents
25
. 
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the addition of 5’ PmeI and 3’ SgfI restriction sites encoded on the primer. The amplified PCR 
product was moved into a pCR-4 TOPO TA cloning vector (Invitrogen) and transformed into 
competent DH5α cells and plated on LB media supplemented with 100 µg/ml carbenicillin. 
Individual clones were transferred to fresh liquid media. The TOPO-Pme1-pcaHG-Sgf1 plasmid 
was purified and digested with the relevant restriction enzymes. This fragment was ligated into a 
similarly digested pVP91A vector (DNASU plasmid repository, Arizona State University), 
transformed, and clones selected on carbenicillin-supplemented media. Sequencing of the 
expression construct at UMN Biomedical Genomics Center confirmed that the coding sequence 
was error-free. 
 The His-tagged 3,4-PCD was expressed in BL21-DE3 E. coli. Standard LB growth media 
was supplemented with 10 mg/L ferrous ammonium sulfate during IPTG induction. The tagged 
enzyme was purified on a Ni-nitrilotriacetic acid (NTA) HisPur resin (Thermo Scientific) using 
the recommended procedures. 3,4-PCD was dialyzed into 20 mM HEPES pH 7.5, supplemented 
with 5% glycerol as cryoprotectant for the storage at -80 °C. The specific activity and electron 
paramagnetic resonance spectrum of the His-tagged resting enzyme were identical to those 
previously reported for untagged enzyme, suggesting there was no perturbation of the Fe
3+
 active 
site. 
 
Metal analysis. Total enzyme was quantitated using the calculated extinction coefficient at 280 
nm. The enzyme was digested in 4 M nitric acid while stirring at 90 °C for 3 hours. The digested 
sample was then centrifuged for 10 minutes, the supernatant quantitatively transferred to a 5 ml 
volumetric flask and diluted with nitric acid. The metal was quantitated using inductively-coupled 
plasma mass-spectrometry (ICP-MS) at the UMN Earth Sciences Department. Samples 
containing only buffer were run as controls. Purified 3,4-PCD was bound with roughly 0.75 mol 
iron per mol enzyme based on ICP-MS. 
 
Steady-state kinetic assays. 4-fluorocatechol (4FC) was purchased from TCI Chemicals and 
used without further purification. The extinction coefficient of 4FC at 282 nm was determined by 
nuclear magnetic resonance (NMR) spectroscopy using an aromatic proton inventory calibrated 
to an internal tryptophan standard
290
 and found to be 3400 ± 80 M
-1
cm
-1
 at pH 8.5. At pH 7.5, the 
extinction coefficient at 282 nm was calculated to be 3370 ± 50 M
-1
cm
-1
. For PCA, the extinction 
coefficient at 290 nm is 3870 M
-1
cm
-1
 at pH 8.5
179
 and determined here at pH 7.5 to be 3090 ± 40 
M
-1
cm
-1
. These values were used to quantify the concentration of 4FC or PCA used in the assays. 
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Extinction coefficients for the 4FC reaction product were determined by incubating a known 
concentration of 4FC with enzyme and 1.5-fold excess of dissolved O2. Once all spectral changes 
had completed, the UV absorbance at max along with the input substrate concentration was used 
to calculate the extinction coefficient . Kinetic parameters kcat and Km were determined using an 
oxygen electrode (Hansatech) to monitor the dissolved O2 consumption rate. The kcat values were 
determined in the presence of saturating 4FC (2 mM) and a 3-fold excess of dissolved O2 over the 
Km (750 µM). The high O2 concentrations were obtained by bubbling O2 gas through the assay 
buffers in a sealed vial. The buffers used for the steady-state assays contained 0.3 M Tris-HCl 
(pH 8.5), 0.3 M Hepes (pH 7.5), and 0.3 M MES (pH 6.5). All buffer solutions were brought to 
the same conductance using NaCl. 
 
Transient kinetics. Transient kinetic data were collected using an Applied Photophysics 
SX.18MV stopped-flow instrument in the single wavelength or spectra kinetic mode.  For 
anaerobic binding experiments, Ar-sparged 100 μM 3,4-PCD (Fe3+-loaded active sites) was 
rapidly mixed with anaerobic buffer (0.3 M HEPES pH 7.5) containing various concentrations of 
Ar-sparged 4FC substrate. For reactions with O2, the enzyme-4FC complex was pre-formed in an 
anaerobic bag, transferred to the stopped-flow and mixed with oxygenated HEPES buffer at 4 °C, 
pH 7.5. Due to the reversibility of the 4FC binding, a stoichiometric complex of enzyme and 4FC 
could not be formed with equal concentrations of 3,4-PCD and 4FC. The reaction was studied 
under two alternative conditions: (1) single turnover was done with excess enzyme and limiting 
4FC (900 μM 3,4-PCD, 250 μM 4FC, ~200 μM E-4FC) reacted with 1.9 mM O2 or (2) multiple 
turnover conditions (150 μM 3,4-PCD, 4 mM 4FC, ~150 μM E-4FC) to study the O2 dependence 
of the RRTs. Under the latter condition, only the first 6 s of the reaction were mathematically fit 
to avoid complications by multiple-turnover. RRTs were determined while monitoring in single-
wavelength mode at 540 nm for the aerobic reactions and separately at 325 nm, 425 nm and 660 
nm for the anaerobic binding. 
 
Mathematical fitting of the transient kinetic reactions and extraction of the optical spectra 
of the intermediates. Nonlinear regression fitting of the stopped-flow 4FC binding and O2 
reaction traces was performed using the Applied Photophysics Pro-Data Software Suite (version 
4.2.12). The equations used for the fits to the observed absorbance (At,obs) were sums of 
exponential functions having the form: 
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𝐴𝑡,𝑜𝑏𝑠 = ∑ 𝐴𝑖𝑒
(−
𝑡
𝜏𝑖)
𝑛
𝑖=1
+ 𝐴∞ 
where Ai is the observed amplitude of phase i (of n) in absorbance units, 1/τi is the reciprocal 
relaxation time of the phase (RRT, s
-1
), t is time (s) and A∞ is the absorbance at the end of the 
reaction. Each point and the corresponding error in the plots shown in Fig. 14 was based on three 
separate experiments using different batches of purified enzyme. 
 For the 4FC binding experiments, the hyperbolic dependence of the observed RRT on 
4FC concentration suggested the following kinetic model for binding: 
E+4FC
𝑘1
⇄
𝑘−1
E∙4FC
𝑘2
⇄
𝑘−2
E-4FC 
The plot was fit using a hyperbolic function with the form: 
1
𝜏𝑜𝑏𝑠
=
𝑘2[4FC]
(
𝑘−1
𝑘1
) + [4FC]
+  𝑘−2 
Extraction of the rate constants from the sum and product plots of the RRTs for the aerobic 
reaction was performed using previously described methods
230, 291, 292
. Three relaxations are 
observed in the transient reaction implying that there are at least 3 steps in the reaction. The first 
two phases have a clear dependence on O2 concentration (Fig. 13G and H). The nonlinear 
dependence on O2 concentration of the second relaxation is consistent with a sequential rather 
than parallel sequence of steps. Moreover, a nonlinear O2 dependence on one phase would only 
be observed if the first step in the reaction in which O2 binds is reversible. Based on the kinetic fit 
alone, it is possible that all three steps in the reaction are reversible. However, because the optical 
spectrum of the reaction following complete turnover of substrate is nearly indistinguishable from 
that of resting enzyme, the final step is unlikely to be reversible. This leads to the following initial 
model for the reaction with O2: 
E-4FC+O2 
𝑘3
⇄
𝑘−3
Int1
𝑘4
⇄
𝑘−4
Int2
𝑘5
→
 
E+P 
The rate constants for the individual steps cannot be determined directly from the exponential fits 
due to mixing of the relaxations through the reversible step(s). Under the assumption that the final 
irreversible step is slow, the analysis must be performed by solving a series of differential rate 
equations describing the first two steps of the reaction. This analysis shows that the first and 
second RRTs correspond to the negative roots of a quadratic equation 
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(𝟏)    𝜆2 + (𝑘3[O2] + 𝑘−3 + 𝑘4 + 𝑘−4)𝜆 + (𝑘3[O2](𝑘4 + 𝑘−4) + 𝑘−3𝑘−4) 
(𝟐)    
1
𝜏1
,
1
𝜏2
=
1
2
{(𝑘3[𝑂2] + 𝑘−3 + 𝑘4 + 𝑘−4) ± √[(𝑘3[O2] + 𝑘−3 + 𝑘4 + 𝑘−4)
2 − 4(𝑘3[O2](𝑘4 + 𝑘−4) +
𝑘−3𝑘−4)]} 
The rate constants may thus be extracted using the following relationships: 
(𝟑)    
1
𝜏1
+
1
𝜏2
= 𝑘3[O2] + 𝑘−3 + 𝑘4 + 𝑘−4 
(𝟒)    
1
𝜏1𝜏2
= 𝑘3(𝑘4 + 𝑘−4)[O2] + 𝑘−3𝑘−4 
The plot of the products of the RRTs vs. O2 concentration was revealed to have an intercept near 
zero (Fig. 14C), implying that the second step is also effectively irreversible (i.e. k-4 ~ 0 in the 
above equations).  This being the case, the assumption that the final step is slow is not required 
and k5 is given directly by the slowest RRT. 
Global kinetic analysis and extraction of the optical spectra of the intermediates shown in 
Fig. 14A was performed using the Applied Photophysics Pro-K Software Package (version 1). 
The data for the analysis was generated by monitoring the reaction at 13 discrete wavelengths 
between 340 nm and 700 nm. These data were analyzed using singular value decomposition in 
Pro-K using the kinetic model shown on page 51. The full experiment was repeated twice with 
similar results. 
 
Crystallization conditions and model nomenclature. Crystallography-grade reagents were 
purchased from Hampton Research. Untagged 3,4-PCD was crystallized using hanging-drop 
vapor diffusion in mother liquor containing 100 mM buffer (Tris-HCl for pH 8.5, HEPES for pH 
7.5, and MES for pH 6.5 soaks), 2.5 mM 2-mercaptoethanol and 1 to 1.4 M ammonium sulfate. 
The drops contained a 2:1 μl ratio of well solution to 40 mg/ml enzyme solution. Crystals 
typically formed over the course of two to three days. Nomenclature for the protein models is as 
follows: Chains A and B corresponds to the alpha and beta subunits of the protomer A, chains C 
and D to the alpha and beta subunits of the protomer B and chains E and F to the alpha and beta 
subunits of the protomer C. His-tagged 3,4-PCD could not be crystallized. 
 
Crystal soaking. To perform the in crystallo reactions, single crystals (0.3-0.5 mm measured 
along the longest axis) were removed from the crystallization drop and transferred to drops 
containing 100 mM 4FC in freshly prepared mother liquor at pH 6.5, 7.5 or 8.5. Crystals were 
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soaked for 30 min with 4FC in mother liquor containing 25% (v/v) glycerol as cryoprotectant and 
directly frozen in liquid nitrogen. For anaerobic soaks, crystals were grown anaerobically prior to 
soaking for 10 min with Ar-sparged 50 mM 4FC in mother liquor supplemented with 
cryoprotectant. 
 
Diffraction data collection. Data were collected at the Structural Biology Center at the 
Advanced Photon Source, Argonne National Labs on beamline 19-ID at 100 K. To test for 
possible photoreduction, an in-house data set was collected using a RigakuMSC Micromax 007 
X-ray generator with a rotating Cu-anode and a Saturn 944+ CCD detector. Diffraction data were 
indexed, integrated and scaled using the HKL2000 software package and phased using molecular 
replacement with a model of 3,4-PCD in space group C2. The final model was prepared using 
iterative cycles of modeling using Coot and refinement with Refmac5
293, 294
. All ligands were 
generated using JLigand 1.0.40. The final models were evaluated using Sfcheck and Rampage. 
All structure figures were produced using PyMOL Molecular Graphics System, Version 1.5.0.4, 
Schrödinger, LLC.  
 
Ligand refinement and modelling. In order to mitigate ligand bias of the calculated phases, the 
active site of 3,4-PCD was always the last site modeled, following refinement of the entire 
protein polypeptide, solvent molecules, mother liquor components, and 4FC molecules which 
were not bound in the active site. The occupancy of the intermediates was refined until the 
temperature factors were close to those of the surrounding protein residues and the iron and the 
residual |Fo|-|Fc| density following refinement with the ligand was minimized. The final percent 
occupancies were refined at 75% for the iron cofactor (based on temperature factors and ICP-MS 
analysis), 70% for 4FC (35% for each superimposed orientation), 65% for the alkylperoxo 
intermediates, and 65% for the anhydride and iron-bound hydroxide. Following refinement with 
the alkylperoxo intermediate at 65% occupancy, there was evidence for residual superposition of 
unreacted substrate in the |Fo|-|Fc| map. A superimposed model of equatorially-bound 4FC at 
10% occupancy satisfied the density, but 4FC alone failed to account for the all of the density. 
The observation of some residual unreacted substrate is unsurprising based on the slow O2 
reaction rate of the E-4FC complex. No evidence of residual E-4FC was observed in the 
anhydride maps. To generate the ligand-omit maps shown in the figures, the ligand was deleted 
from the final model and this model refined for an additional five cycles in Refmac5. The 
resulting structure factors were used to calculate the |Fo|-|Fc| difference map (“ligand-omit”), 
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which agreed well with the modeled orientation of the ligands. “Side-chain omit” maps were 
generated using the same approach. 
 
Refinement of the Y447 side-chain occupancies. In both the E-4FC and alkylperoxo structures, 
it was clear that some fraction of the active sites still had Y447 in the metal-bound orientation. In 
the E-4FC complex, the |Fo|-|Fc| density for the dissociated orientation of Y447 was found to be 
much stronger than for the metal-bound orientation. We have thus modeled this orientation at 
75% occupancy (equivalent to the metallated 4FC-bound fraction of active sites) and the 
substrate-free orientation at 25% occupancy (the metal-free fraction). This assignment is 
supported by the observation that, in metal-free crystals of 3,4-PCD (based on ICP-MS and 
UV/vis spectrometry), Y447 was not observed in the dissociated orientation. This suggests that in 
metal-free active sites, the Y447 side-chain still assumes the “metal-bound” orientation. The 
assignment of side-chain occupancies in the alkylperoxo complex was more difficult and we were 
unable to resolve differential occupancies with certainty. Based on the similar residual densities 
for the two occupancies, each orientation was modeled at 50% occupancy. In contrast, in the 
anhydride structure, the side-chain of Y447 was unambiguously found in the metal-bound 
orientation. No density for the dissociated orientation was observed. 
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Results 
 
Characterization of the reaction of 3,4-PCD, 4FC and O2 in solution. The kcat for turnover of 
4FC is reduced 100-fold relative to that of PCA at 22 °C, pH 7.5, and the Km values for the 
organic substrate and O2 are increased 8-fold and 5-fold, respectively (Table 1). The reaction of 
3,4-PCD with 4FC and O2 yielded a UV-absorbing product with a λmax of 256 nm, ε = 17 ± 0.8 
mM
-1
cm
-1
 as expected for the ortho cleavage product 3-fluoromuconate (Fig. 13A)
295
. 
Accordingly, acidification of the reaction product to pH 2 converted it to the characteristic 
lactonization product of 3-fluoromuconate (Fig. 13B)
296
. 
 A comparison of the optical features of 3,4-PCD and anaerobic E-4FC is shown in Fig. 
13C. IDO-catechol complexes exhibit additional catecholate-to-Fe
3+
 LMCT bands. Although 
binding of 4FC elicited changes in the LMCT bands (most notably at wavelengths >500 nm), the 
absorbance of the complex decreased relative to that of E-PCA (Fig. 13C). These results suggest 
that 4FC directly coordinates the metal, but this complex has different electronic properties than 
E-PCA. The structural basis for this change is described below. The anaerobic binding reaction of 
3,4-PCD and 4FC at pH 7.5 at 22 °C was studied using stopped-flow. The time courses at 660 nm 
over a range of 4FC concentrations could each be fit by a single exponential expression (Fig. 
13D), consistent with a one-step reaction.  However, the plot of reciprocal relaxation time (RRT) 
versus 4FC concentration is hyperbolic (Fig. 13E). This indicates that the binding process 
actually occurs in at least two steps where a fast, reversible initial complex is followed by a 
slower ligand rearrangement or conformational change that gives rise to the chromophoric 
change. The Kd of the initial complex (k-1/k1) is given by the apparent Kd (7.5 ± 0.4 mM) for the 
hyperbolic fit, while the forward (k2 = 34 ± 0.9 s
-1
) and reverse (k-2 ~ 0.4 s
-1
) rate constants for the 
second step are determined by analysis of the maximum and intercept values of the hyperbola 
(see Materials and methods)
292
. The overall Kd for substrate binding is thus predicted to be ~88 
μM, which compares favorably to the value of 75 μM determined by a direct optical titration (Fig. 
13F). The weak initial binding without a chromophoric change may indicate that 4FC first binds 
in the hydrophobic active site away from the iron. These experiments show that none of the steps 
in the 4FC binding process correspond to the rate-limiting step of the reaction (kcat = 0.71 s
-1 
at  
22 °C). 
To study the reaction with O2, anaerobic E-4FC was rapidly mixed with oxygenated 
buffer at 4 °C on the stopped-flow. When 100 µM E-4FC (see Materials and methods) was  
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Table 1. Steady-state kinetic parameters for the 3,4-PCD reaction with PCA and 4FC. 
 kcat, pH 7.5,  
22 °C (4 °C) 
(s
-1
)* 
kcat, pH 8.5, 
22 °C  
(s
-1
)* 
kcat, pH 6.5, 
22 °C   
(s
-1
)* 
Km,organic 
(μM) ‡ 
Km,O2  
(μM) ‡ 
kcat/Km,organic  
(M
-1
s
-1
) 
kcat/Km,O2  
(M
-1
s
-1
) 
 
PCA 81 ± 20   
(30
†
) 
106 ± 10 54 ± 9 29
†
 56
†
 2.8 x 10
6
 1.5 x 10
6
 
4FC 1.2 ± 0.09 
(0.18 ± 0.05) 
0.51 ± 0.02 0.70 ± 0.04 240 ± 20 270 ± 
100 
5.0 x 10
3
 4.4 x 10
3
 
All values were determined at 22 °C unless stated otherwise. Errors represent one standard  
deviation. All values normalized to the number of Fe
3+
-containing active sites. 
* The PCA assays contained 2 mM substrate and 750 µM dissolved O2. 4FC assays contained 2  
mM substrate. For 4FC, due to the high Km for O2, the kcat values and the corresponding 
error were extracted from the hyperbolic fit to the initial velocity vs. dissolved O2 
concentration plots. 
†
 value is from reference
179
. 
‡
 values for 4FC determined at pH 7.5. 
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reacted with 950 µM O2 at 4 °C, the time course of this pseudo first order reaction as monitored 
at 540 nm could be fit well by a sum of three exponential functions with RRTs of 0.92 s
-1
, 0.50 s
-1 
and 0.16 s
-1 
(Fig. 14B). Although the magnitudes of these RRTs are similar, they are resolvable 
because the phases have opposite amplitudes at 550 nm. Three phases imply that there are at least 
three steps in this portion of the reaction cycle. The slowest phase has a RRT very similar to kcat 
from steady-state experiments (0.18 s
-1 
at 4 °C). In all previous studies, we and others have found 
that product release is the rate-limiting step for IDOs, and the preceding ring-opening step is 
irreversible
180, 183, 184, 287
. This irreversible step allows the slowest RRT to be associated with the 
rate constant for a specific step in the reaction, presumably product release.  This assignment is 
supported by the observation that the spectrum of the resting enzyme is observed at the 
completion of the reaction. Only the fastest two phases show a dependence on O2 concentration, 
as expected if the slow product release is preceded by the irreversible ring-opening step (Fig. 
13G). Assuming that the fastest two phases arise from two sequential steps in which at least the 
first is reversible, the RRTs will be described by the two roots of a quadratic equation. 
Consequently, the plots of the sum and products of the RRTs vs. O2 will be linear and the all of 
Fig. 13 (previous page): Transient kinetics of the binding reaction of 4FC to 3,4-PCD and the 
reaction of E-4FC with O2. (A) Reaction product formation in the ultraviolet range. 5 μM 3,4-
PCD in oxygenated 0.3 M HEPES pH 7.5 was mixed with 4FC (final conc. 75 μM). Spectra 
are shown at 10 s intervals. (B) Acidification of the product shown in panel A to pH 2 with 
HCl resulted in conversion to the corresponding lactone product with λmax 277 nm
296
. (C) 
Optical spectra of resting 3,4-PCD (black), the anaerobic E-4FC complex (blue), and the 
anaerobic E-PCA complex (red) at 100 μM concentration. (D) Representative single 
wavelength data (black) for the reaction of 50 μM 3,4-PCD with 4 mM 4FC monitored at 660 
nm. The dotted orange trace is a 1-exponential fit with RRT 13 s
-1
 (residuals in the solid 
orange trace). (E) Substrate concentration dependence of the single observed RRT for the 
reaction of 50 μM 3,4-PCD with 4FC at 22 °C and pH 7.5. Error bars represent one standard 
deviation. The red trace shows a hyperbolic fit for the data with y-intercept 0.4 s
-1
 (k-2) and an 
extrapolated maximum of 34.4 s
-1
 (k2 + k-2). The Kd for the fit gives the Kd for the preceding 
unobserved binding step (Kd = 7.5 mM). The extracted kinetic model for 4FC binding is 
shown as an inset. (F) Adair plot for the anaerobic titration of 100 µM 3,4-PCD with 4FC at 
pH 7.5. The optical changes were monitored at 700 nm. The Kd for 4FC determined from the 
hyperbolic fit to the data (red trace) is 75 µM, close to that calculated from the transient 
kinetics (88 μM). (G) Plot of the dependence of 1/τ1 and 1/ τ2 in the reaction of 50 μM E-4FC 
with O2 on the dissolved O2 concentration. Error bars represent one standard deviation. The 
red trace is a linear fit to the 1/ τ1 data. The blue dashed trace illustrates the observed nonlinear 
dependence of 1/ τ2. This data is further analyzed in Figure 14C. (H) Speciation plot of the 
single-turnover reaction of 100 μM E-4FC with 950 μM O2 modeled using the kinetic 
parameters shown on page 51 (Tenua version 2.1). 
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the rate constants for the steps can be extracted (see Fig. 14C and Materials and methods). The 
second fastest step is effectively irreversible as expected.  The forward rate constant for the 
fastest step (8.7 x 10
2
 ± 0.8 M
-1
s
-1
) appears to be the bimolecular rate constant for O2 binding
184
. 
 
 
Fig. 14: Transient kinetics of the reaction of E-4FC with O2. (A) Optical spectra of resting 3,4-
PCD (black), the anaerobic E-4FC complex (red), and the extracted spectra of Int1 (blue) and 
Int2 (orange) shown at 100 μM concentration. (B) Representative single wavelength data 
(black) for the reaction of 100 μM E-4FC with 950 μM O2 monitored at 550 nm. The blue and 
orange dotted traces represent 2- and 3-exponential fits to the data, respectively. Residuals for 
the fits are shown in their respective colors. (C) Plots of the dependence of the sum (blue) and 
product (orange) of the two largest RRTs for the reaction of 50 μM E-4FC on the dissolved O2 
concentration. Error bars represent one standard deviation. 
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This value is 600-fold slower than that for O2 binding to E-PCA. The derived minimum kinetic 
model for the reaction is: 
E+4FC + O2 
𝑘3 = 8.7x10
2M-1s-1
⇄
𝑘−3 = 0.11 s
-1 
Int1
𝑘4 = 0.58 s
-1
→
 
Int2
𝑘5 =  0.16 s
-1
→
 
E+P 
Using global analysis of the single-turnover reaction monitored at 13 wavelengths, we 
extracted the pure component optical spectra of the intermediates formed during the reaction with 
O2 as shown in Fig. 14A. The intermediates have optical spectra with characteristics similar to 
those reported for transient oxygenated intermediates in related enzymes
183, 184
. The presence of 
relatively intense optical features for both of the observed intermediates shows that the metal 
remains in the +3 oxidation state, because reduction of the metal would bleach the optical 
spectrum almost entirely. The rate constants for the interconversions preclude trapping of the 
intermediates at high yield in solution (Fig. 13H). However, the slow rate of the reaction between 
E-4FC and O2 and of each subsequent step proved to be a great advantage in trapping O2-bound 
intermediates in crystallo. 
 
Crystal structure of 3,4-PCD with 4FC bound. 3,4-PCD was crystallized in a new space group 
I222 with three -protomers in the asymmetric unit, differentiated as protomers A, B and C in 
the model hereafter. No significant differences were noted in the resting active site structure of 
I222 crystals of 3,4-PCD and those of the monoclinic C2 crystals previously studied, but the I222 
crystals generally diffracted to higher resolution (1.3-1.5 Å limit). Data collection and refinement 
parameters for each of the structures solved for this study can be found in Table 2. The iron 
occupancy in all structures was refined at 75% based on ICP-MS analysis of the metal content of 
the enzyme batches used for the crystallizations. 
 Electron density maps from 3,4-PCD crystals soaked with 4FC at pH 8.5 under anaerobic 
conditions revealed direct binding of 4FC to the metal in all three protomers (Fig. 15A and B). In 
contrast to the axial binding mode observed in the PCA complex, 4FC bound in the equatorial 
plane, trans to H460 and Y408. This amounts to a roughly 100° rotation of the aromatic plane 
relative to the plane of PCA in the E-PCA complex (Fig. 15C). Two conformations of 4FC at 
roughly equal occupancy were observed, evidenced by the residual density apparent for two 
positions of the fluorine. The only difference in the binding mode is in the position of fluorine; 
the iron bond distances and position of the ring are essentially identical. The Fe-O4FC bond 
lengths are found to be 2.1 Å for both O14FC and O24FC
 
in all of the protomers. There is no 
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asymmetry in the Fe-hydroxyl bonds as observed for PCA
181
.  In each protomer, Y447 is 
dissociated from the metal and interacts with the phenol group of Y16; its orientation is 
superimposable with that in the E-PCA complex. The details of the ligand and Y447 refinement 
strategies and model occupancies are given in the Materials and methods section. 
 
In crystallo reaction of E-4FC with O2 at pH 6.5 and 7.5. Crystals of 3,4-PCD were transferred 
to drops supplemented with 100 mM 4FC and reacted under aerobic atmosphere at 22 °C for 15-
25 minutes before freezing. Following the incubation, 4FC ring-cleaved product was detectable in 
the drop. Electron density maps calculated from data sets at pH 7.5 suggested an averaging of 
multiple species bound to the metal in each protomer. No distinct species could be modeled into 
 
Fig. 15: Structure of the anaerobic complex of 3,4-PCD with 4FC (E-4FC) at pH 8.5. (A) 
Electron density maps of the active site of the E-4FC complex. The blue mesh is the 2|Fo|-|Fc| 
map contoured at 1.0 σ after refinement with 4FC. The green mesh is the |Fo|-|Fc| ligand-omit 
map contoured at +3.8 σ. (B) Bonding environment of 4FC. Only one orientation of 4FC is 
shown for clarity. Possible interactions are shown as red dashed lines and the distances are 
given in Å. (C) Comparison of E-4FC and E-PCA (PDB ID: 3PCA). The ring of 4FC is 
rotated 100° relative to that of PCA. Atoms are shown as spheres. Carbon atoms are gray 
(protein residues), yellow (4FC) or orange (PCA). Oxygen atoms and solvent atoms are 
colored red, nitrogen atoms blue and the iron atom brown. 
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these active sites. In contrast, when the experiment was repeated at pH 6.5, the resulting electron 
density maps had strong residual positive density for a metal-bound species clearly distinct from 
the 4FC present in the E-4FC complex. Interpretable electron density was only observed in active 
site A; solvent was modeled into active sites B and C to account for the missing density. The 
residual density in protomer A suggested the presence of an axially-oriented ring with connected 
density that “wrapped” around the metal in the equatorial plane to the coordination site trans to 
H460 (Fig. 16A). This site is where the peroxo has been proposed to form during the reaction of 
O2, and we accounted for this density by modelling an alkylperoxo species in active site A (Fig. 
16A and B). A 4FC-semiquinone-Fe-O2
-
 was also tested, but the refined models strongly 
supported the existence of a covalent bond between C24FC and O1O2. 
 The peroxo bridges between the metal and the substrate (Fe-O1O2 = 1.8 Å, Fe-O2O2 = 2.5 
Å, Fe-O-O angle = 100°). The refined peroxo O-O bond distance was 1.5 Å. The carbon of 4FC 
attacked by O2 is sp
3
-hybridized based on the observed bond angles and the ring is puckered, 
consistent with oxidation of 4FC. O24FC remains coordinated to the metal (1.9 Å), but it also 
interacts with the guanidinium group of R457 (2.8 Å) (Fig. 16B). In contrast, the O14FC ketone is 
dissociated from the metal (3.8 Å) and interacts with the Q477 side-chain. Y447 is found in both 
metal-bound and dissociated orientations at roughly equal occupancy. As noted, the ring of 4FC 
is axially oriented, indicating that 4FC rotates during (or prior to) the reaction with O2. The Fe-
ligand bond distances are considerably shorter than in the 2,3-HPCD alkylperoxo
72
, consistent 
with the expected higher metal oxidation state. 
 
In crystallo reaction of E-4FC with O2 at pH 8.5. The dramatic effect of pH on stabilization of 
the alkylperoxo intermediate prompted us to repeat the experiment at pH 8.5. The ligand-omit 
maps of the crystals reacted at pH 8.5 clearly indicated splitting of the peroxo moiety and 
formation of two separate metal-bound species. In the proposed mechanism, heterolytic O-O 
bond scission of the peroxo leads to formation of an anhydride intermediate via a Criegee-type 
rearrangement where one O atom of O2 migrates into the ring of substrate, while the second O 
atom of O2 remains metal-bound as hydroxide. Based on the clear evidence of O-O bond scission, 
a 4FC-derived anhydride and iron-hydroxide were modeled into the density (Fig. 16C and D). A 
lactone intermediate (present in the extradiol pathway) was also tested, but the anhydride 
provided a better fit. No intermediates could be modeled into sites B and C. The bond distance 
between the metal-bound hydroxide and the bridging O-atom of anhydride is 2.3 Å. The 
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anhydride remains metal-bound and interacts through the ketonized O24FC (2.0 Å) while the ring 
remains in the axial orientation. The position of the hydroxide is roughly the same as that of the 
proximal oxygen of the alkylperoxo moiety, but the Fe bond distance has increased to 2.1 Å. 
Critically, Y447 is found exclusively in the metal-bound orientation. 
 
Determination of whether the Fe
3+
 is photoreduced to Fe
2+
 during data collection. Two lines 
of evidence suggest that the Fe
3+
 active site was not photoreduced to Fe
+2
 during data collection 
on the synchrotron beamline. First, a model of the alkylperoxo derived from a data set  
 
 
Fig. 16: Structures of the intermediate species observed upon reacting 3,4-PCD crystals with 
4FC and O2 at pH 6.5 and 8.5. (A) Two views of the electron density observed at pH 6.5 and 
the 4FC-alkylperoxo model (yellow). (B) Bonding environment of the 4FC-alkylperoxo 
intermediate. (C) Two views of the electron density observed at pH 8.5 and the 4FC-
anhydride model (yellow) and hydroxide (red sphere). (D) Bonding environment of the 4FC-
anhydride intermediate. In panels A and C the blue mesh is the 2|Fo|-|Fc| map contoured at 1.0 
σ after refinement with the ligands and the green mesh is the |Fo|-|Fc| ligand-omit map 
contoured at +3.5 σ. In panels B and D the possible interactions are shown as dashed red lines 
and the distances are given in Å. Atom color code is as in Figure 15. 
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collected on an in-house diffractometer instrument resulted in nearly identical iron-ligand bond 
distances to those observed in the model produced from the synchrotron data (Fig. 17A). The 
crystal soaking conditions for this sample were the same as described above. Photoreduction to 
Fe
2+
 would have resulted in considerably longer bond distances in the synchrotron-derived model. 
Second, the crystals retained the characteristic burgundy color of the oxidized enzyme throughout 
data collection. Reduction of the cofactor to Fe
2+
 would have bleached the chromophore entirely, 
resulting in a colorless crystal. Optical spectra of single crystals obtained after diffraction data 
collection were also consistent with retention of the Fe
3+
 oxidation state (Fig. 17B). The optical 
spectra of the crystals with bound intermediates are generally consistent with those of the 
intermediates in solution. However, definitive assignments cannot be made at this time due to the 
high sensitivity of the spectra on the orientation of the crystal in the micro-spectrophotometer 
beam and the mixing of optical features from different intermediate species trapped in the active 
sites of the crystal. 
 
  
 
 
Fig. 17: The active site iron is not reduced by the synchrotron X-ray beam. (A) Comparison of 
the structure of the alkylperoxo intermediate solved using synchrotron data with that using 
data from a much lower X-ray intensity in-house generator.  The Fe-ligand bond lengths (in 
Å) are the same within error and are characteristic of Fe
3+
. (B) Optical spectra recorded of 
single enzyme crystals after data collection at the synchrotron.  The spectra are averages of 
spectra recorded at 6 crystal orientations. The intense chromophore shows that the metal 
center is Fe
3+
. The spectral line-shapes are consistent with Int1 and Int2 observed in solution 
but a direct assignment cannot be made because only one subunit in the crystal is fully 
occupied by the intermediate but all subunits contribute to the optical spectrum.  Also, the 
spectra are sensitive to the orientation of the crystal in the light path. The absorbance values 
on the y-axis are arbitrary.   
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Table 2. X-ray data collection and refinement statistics for the various 3,4-PCD-4FC crystal 
complexes 
 3,4-PCD resting 
pH 6.5 
3,4-PCD resting 
pH 8.5 
3,4-PCD + 4FC  
pH 8.5 
3,4-PCD + 4FC + 
O2  pH 6.5 
3,4-PCD + 4FC + 
O2  pH 8.5 
PDB ID 4WHP 4WHO 4WHS 4WHQ 4WHR 
Data collection      
   Space group I222 I222 I222 I222 I222 
Cell dimensions      
   a, b, c (Å) 127.92, 140.77, 
168.19 
128.09,140.64, 
168.66 
128.01, 140.66, 
168.14 
128.26, 140.72, 
167.82 
128.44, 140.64, 
168.29 
   α, β, γ (°) 90, 90, 90 90, 90, 90 90, 90, 90 90, 90, 90 90, 90, 90 
Wavelength (Å) 0.97918 0.97918 0.97918 0.97918 0.97918 
Resolution (Å) 50-1.54 50-1.83 50-1.35 50-1.78 50-1.58 
Total/Unique 
reflections 
1026896/ 
206314 
559978/ 
121908 
1617767/ 
309614 
689265/ 
140429 
756615/ 
188155 
Rmerge (%) *
,† 12.4 (47.5) 16.2 (45.3) 9.9 (50.6) 7.4 (52.8) 14.2 (35.1) 
I/σI* 30 (3.7) 25 (5.1) 34 (3.3) 30 (2.3) 24 (2.2) 
Completeness (%) * 93.0 (100) 89.3 (99.9) 94.6 (100) 97.5 (96.1) 91.3 (93.7) 
Redundancy* 5.0 (3.7) 4.6 (4.6) 5.2 (5.1) 4.8 (3.8) 4.0 (2.1) 
Model Refinement      
   Resolution (Å) 39.0-1.54 32.5-1.83 29.5-1.35 39.0-1.78 31.6-1.58 
   Rwork/Rfree (%)
‡ 0.140/0.172 0.180/0.216 0.136/0.167 0.164/0.195 0.148/0.192 
   Average B, all  
     atoms (Å2) 
21 22 19 27 25 
   ESU (Å) § 0.033 0.068 0.024 0.065 0.047 
RMSDs      
   Bond lengths (Å) 0.0072 0.012 0.008 0.011 0.0090 
   Bond angles (°) 1.3 1.5 1.4 1.5 1.4 
Ramachandran  
  analysis 
     
  Favored (%) 97.8 97.7 98.1 97.3 97.6 
  Allowed (%) 2.2 2.3 1.9 2.7 2.4 
All data collected on synchrotron beamline APS SBC-CAT 19ID-D 
* Highest resolution shell is shown in parentheses 
† Rsym = ΣhklΣi |Ihkl,i - <I>hkl|/ΣhklΣi|Ihkl,i|, where Ihkl is the intensity of a reflection and <I>hkl is the 
average of all observations of the reflection 
‡ Rfree, R-factor calculated from 5% of the data excluded from refinement 
§ Estimated overall coordinate error (ESU) based on maximum likelihood  
RMSD, root mean square deviation from ideal geometry 
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Discussion 
 
The current results show that 3,4-PCD catalyzes ring cleavage of 4FC to yield the expected 
intradiol product, but also that the reaction occurs at a greatly decreased rate relative to that with 
the native substrate, PCA.  Importantly, the rate decrease is seen throughout the reaction cycle, 
allowing intermediates in the key steps following O2 binding to be detected in solution and in 
crystallo. The visualization of the alkylperoxo and anhydride intermediates from the IDO reaction 
cycle provides direct insight into the reaction mechanism of this enzyme class at a level that has 
not previously been possible.  Moreover, it allows the results of four decades of kinetic, 
mutational, spectroscopic, and computational studies to be considered in a single framework.  
These aspects of the study are discussed here. 
 
Relationship to spectroscopic and computational studies of the IDO mechanism. The 
structural model of the alkylperoxo intermediate reported here is geometrically nearly identical to 
the 5C alkylperoxo species proposed from computational studies that were based on 
spectroscopic and structural studies of the E-PCA complex
25, 213
. This convergence suggests that 
the mechanistic insight into the ring cleavage mechanism for 4FC is relevant to that for PCA. 
Several important aspects of the predicted mechanism are confirmed by the structure.  First, the 
initial attack on the substrate by O2 is computed to be a concerted process (Fig. 12, 3) that directly 
forms the bridging peroxo moiety. This is the species we observe (Fig. 16A). In our in crystallo 
studies of 2,3-HPCD, a substrate radical-Fe
2+
-superoxo intermediate precedes the alkylperoxo 
species
72
. Similar discrete precursor complexes, such as a substrate radical-Fe
2+
 or substrate 
radical-Fe
3+
-superoxo species, have been proposed in previous studies of the IDOs and models
213, 
218, 226
. Although not definitive, we find no evidence for these species in the IDO crystal. More 
significantly, the failure to observe any fully bleached intermediates in the solution studies makes 
any Fe
2+
 species with a significant lifetime unlikely. These observations are consistent with the 
proposed concerted attack mechanism 3
25
. Second, while the initial concerted O2 attack results in 
a 6C iron species 4, a rapid rearrangement to a 5C iron species 5 is computationally predicted to 
be required for stability and reestablishment of the S = 5/2 spin state of the iron
25, 213
. The 
observed alkylperoxo species is in the predicted shifted position (Fig. 16A). Third, a subsequent 
shift in the position of the bridging peroxo moiety is predicted to increase the reactivity of the 
species and establish a geometry 6 that facilitates protonation of the proximal peroxo oxygen
25, 
58 
 
213
. This proton is proposed to drive O-O bond cleavage and insertion. It may derive from a metal-
bound solvent or deprotonation of Y447 as it returns to the iron as seen in 6. The shifts in the 
positions of the substrate and peroxo would open the exchangeable axial iron binding site for 
Y447 or solvent. In the structures reported here, the axial binding site is open in the alkylperoxo 
intermediate (Fig. 16A), but Y447 is bound following O-O bond cleavage in the anhydride 
intermediate (Fig. 16C). These observations strongly support both the computed mechanism and 
the role of Y447 as the source of the critical proton.  
The stopped flow studies described here reveal two intermediates following addition of 
O2 to the E-4FC complex.  While it is possible that these two intermediates are the species found 
in crystallo, we cannot make this correlation at present. 
   
Intradiol versus extradiol dioxygenase ring cleaving specificity. The IDO and EDO families 
have each been studied extensively with the goal of understanding their individual O2 activation 
mechanisms and the basis for their ring cleaving specificity.  It is now possible to directly 
compare representative structures of the alkylperoxo intermediates from these families. EDOs and 
IDOs mechanistically converge at an alkylperoxo intermediate, and both families have been 
proposed to utilize a concerted Criegee-like mechanism for oxygen insertion into substrate
32, 297
. 
While the current study does not address the detailed mechanism of oxygen insertion, it does 
provide insight into the key question: What determines the position of oxygen insertion when 
ostensibly the same alkylperoxo intermediate is formed in each enzyme class
195, 226-228, 298
? One 
possibility supported by computational studies is that the alignment of the O-O bond relative to 
the scissile bonds of the substrate determines whether acyl (intradiol) or alkenyl (extradiol) 
migration occurs during the rearrangement. Migration proceeds preferentially into the co-planar 
bond
213, 218, 299
. Comparison of the geometries of the EDO and IDO alkylperoxo intermediates 
shows that they differ substantially in the O-O and C-C bond alignments primarily because the 
substrate bonding to the iron is not the same. In the EDO, the peroxo and both substrate ring 
oxygen substituents coordinate to the iron, while only one hydroxyl coordinates the iron in the 
IDO (Fig. 18). In 3,4-PCD this coordination mode comes about as a result of the rearrangement 
described above and is stabilized by interaction with second sphere conserved residues Q477 and 
R457. As shown in Figure 18, the co-planar O-O and substrate C-C bond alignment favors 
formation of the anhydride in 3,4-PCD while alkenyl migration to form the lactone would be 
favored by the alternative alignment in 2,3-HPCD alkylperoxo. 
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Equatorial binding of 4FC and its effects on the reaction with O2. Axial binding of catecholic 
substrates is a characteristic of all classes of IDOs
180, 181, 197, 199
. The alternative equatorial 4FC 
binding mode provides insights into the driving force behind the substrate binding-mediated 
dissociation of Y447. Two possible origins for this rare endogenous ligand dissociation are direct 
displacement by a substrate hydroxyl function and/or a requirement to retain a constant charge at 
the metal center
179, 194
. In the current case, Y447 dissociates when 4FC is bound in the equatorial 
plane, and thus no direct competition for the iron coordination site is possible. On the other hand, 
coordination of 4FC in the equatorial plane as a dianion adds two negative charges while only 
displacing one negative hydroxide. The charge would be rebalanced by dissociating Y447 to its 
alternative site, supporting charge maintenance as the basis for ligand reorganization.  
 It is unknown whether 4FC can react with O2 while bound in the equatorial plane.  
Rotation to the axial plane clearly occurs at some point during the generation of the alkylperoxo 
intermediate.  Intriguingly, although 4FC is rotated ~100° relative to PCA in the substrate 
complex, the two substrates experience analogous metal environments, i.e. 4FC has a trans His 
ligand (H460) and cis phenolate ligand (Y408) like PCA (trans H462 and cis Y408). Thus, one 
 
Fig. 18: Comparison of the geometries of the alkylperoxo intermediates in 3,4-PCD and 2,3-
HPCD. The coordination mode of the intermediate may dictate acyl versus alkenyl migration 
and thereby cleavage specificity. The 2,3-HPCD and 3,4-PCD-PCA models are PDB 
structures 2IGA and 3PCA, respectively. 
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might expect the rates of O2 attack to be comparable. Two steric factors might prevent rapid 
reaction with O2 while 4FC in bound in the equatorial plane.  First, the equatorial binding mode 
of 4FC does not create a hydrophobic pocket for O2 to bind near the iron as we have noted for the 
axially-bound E-PCA complex
181, 203. Second, the “slot-like” active site is constructed to promote 
axial binding. As a result, equatorial substrate binding creates tight van der Waals contacts with 
walls of the active site. This would prevent the shift in substrate orientation required during the 
formation of the 5C alkylperoxo intermediate. No such restrictions are present for axial substrate 
binding. Given these restrictions, it seems likely that 4FC is actually bound as an equilibrium 
mixture of axial and equatorial orientations with only a small fraction bound in the axial 
orientation, making it undetectable in the electron density. If only the axial fraction is reactive 
towards O2, then the 600-fold reduction in the bimolecular reaction rate may be, in part, 
representative of the necessity of the substrate to reorient before it can react with O2. 
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Conclusions 
 
Together with comparable studies of the EDO reaction intermediates, the structures of the 
alkylperoxo and anhydride intermediates of the IDO reaction cycle make available a broad view 
of the factors that promote O2 activation and specificity in ring-cleaving dioxygenases. The 
formation of alkylperoxo intermediates is widely proposed, especially in the large 2-His-1-
carboxylate family of nonheme Fe
2+
 oxygenases. Although the mechanism of formation differs in 
the IDO case, the resulting complex is similar, and thus its structural parameters and the basis for 
its reactivity are significant. Finally, this study adds to a small but growing list that show enzyme 
intermediates can be trapped in high yields when the reactions are carried out in a crystal. This 
approach may provide an experimental inroad into a fundamental question in enzymology 
concerning the mechanism of efficient transit through multistep reaction cycles.  
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CHAPTER 2 
 
Kinetic characterization of the reaction of protocatechuate 3,4-
dioxygenase with alternative catecholic substrates 
 
Abbreviations: 
3,4-PCD: protocatechuate 3,4-dioxygenase 
PCA: protocatechuate (3,4-dihydroxybenzoate) 
CAT: catechol 
4FC: 4-fluorocatechol 
4CC: 4-chlorocatechol 
4MC: 4-methylcatechol 
ES complex: enzyme-substrate complex, used as a generic term for the complex of 3,4-PCD with 
one of the catecholic substrates 
IDO: intradiol dioxygenase 
RRT: reciprocal relaxation time 
LMCT: ligand-to-metal charge-transfer 
1,2-CTD: catechol 1,2-dioxygenase 
CCD: chlorocatechol dioxygenase 
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Summary 
 
Protocatechuate 3,4-dioxygenase (3,4-PCD) is an intradiol dioxygenase enzyme that catalyzes the 
oxygenolytic cleavage of catecholic substrates using a non-heme Fe
3+
-cofactor and O2 as a 
cosubstrate. The enzyme uses an ordered sequential mechanism in which the catecholic substrate 
binds to the iron ion first, then reacts with O2 to afford the ring-cleaved products. The native 
substrate protocatechuate (3,4-dihydroxbenzoate, PCA) is turned over too rapidly by the enzyme 
to study the transient kinetics of the reaction with O2 in detail. Alternative catecholic substrates 
provide a means to study these catalytic steps, provided the reaction is slowed sufficiently. Here, 
the steady-state and transient kinetic characterization of the reaction of 3,4-PCD with a series of 
alternative substrates is reported. The alternative substrates used include catechol, 4-
fluorocatechol, 4-chlorocatechol, and 4-methylcatechol. The kinetic study of these substrates 
facilitates comparisons among the alternative reactions and with the native substrate PCA. 
Insights into the rate-limiting steps and the effects of the catechol substituents on the catalytic 
reaction are gained. These results have implications for the mechanisms of substrate specificity of 
this family of enzymes and the role of the protein fold in orienting the catechol for the reaction 
with O2. 
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Introduction 
 
Intradiol ring-cleaving dioxygenases (IDOs) catalyze oxygen-dependent aromatic ring-cleavage 
reactions in a variety of soil-dwelling bacteria and fungi
32
. This class of enzymes uses a non-
heme Fe
3+
 cofactor to activate catecholic substrates and O2 for reaction, one of only two enzyme 
families to use the ferric form of the cofactor
25, 238
. The site of ring-cleavage catalyzed by IDOs is 
between the vicinal hydroxyl groups of the catechol and results in incorporation of both atoms of 
molecular O2 into the product (dioxygenases) to generate a substituted muconic acid product
19
. 
There are several families of IDO enzymes that are differentiated by their substrate preference 
and their overall protein fold. Prominent examples include the protocatechuate 3,4-dioxygenases 
(3,4-PCDs) that preferentially cleave 3,4-dihydroxybenzoate (protocatechuate, PCA)
196, 203
, 
methylcatechol and catechol 1,2-dioxygenases (1,2-CTDs)
197
, hydroxyquinol 1,2-dioxygenases 
(1,2-HQDs)
200
, chlorocatechol 1,2-dioxygenases (1,2-CCDs)
201, 202, 300
, and a single, recently 
discovered member that cleaves catecholic intermediates of lignin biosynthesis
176
. All members 
use the Fe
3+
 oxidation state of the cofactor and have a conserved 2-His 2-Tyr iron-coordination 
ligand set that is found only in this enzyme class. In the resting state, the iron also binds a 
hydroxide anion resulting in a five-coordinate trigonal bipyramidal complex. 
 The most-studied IDO is the 3,4-PCD from Pseudomonas putida (reclassified from 
Pseudomonas aeruginosa)
204
. The biological role of 3,4-PCD is to cleave the native substrate 
PCA to β-carboxy muconic acid with concomitant incorporation of both atoms of O2 into product. 
This acid is then converted to central metabolic intermediates via the β-ketoadipate pathway301. In 
the P. putida enzyme, the resting Fe
3+
 is coordinated by Y447 and H462 in the axial orientation 
and Y408 and H460 and hydroxide in the equatorial plane. The catalytic mechanism of ring-
cleavage has been studied since the 1960s
187, 189, 190, 204, 287
, but only recently have oxygenated 
intermediates been trapped for characterization (see Chapter 1). The proposed mechanism is 
shown in Figure 8 for PCA
25, 32, 179, 181, 184, 188, 192, 194
. The catecholic substrate binds directly to the 
metal as a dianionic chelate, leading to dissociation of the hydroxide ion and one of the 
endogenous Tyr ligands (Y447 in the P. putida enzyme). The electron transfer that leads to O2 
activation is proposed to occur after O2 binds in a hydrophobic pocket adjacent to the metal.  
Because the metal is in a
 
+3 oxidation state and has no affinity for O2, O2 is not proposed to bind 
directly to the metal before the electron transfer. This necessitates a unique O2 activation 
mechanism in which two electrons are transferred in a concerted step to O2 from catechol, one 
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directly and the other via the iron d orbital manifold
25
. This results in the formation a Fe
3+
-
alkylperoxo intermediate without a spin violation. After protonation of the peroxo moiety, the 
Fe
3+
-alkyl(hydro)peroxo intermediate decays to an anhydride species where one atom of O2 is 
incorporated into the substrate ring. The other O atom remains metal-bound as hydroxide. 
Nucleophilic attack by this hydroxide opens the anhydride ring, generating the ring-cleaved 
product. The resting active site is regenerated by influx of a water molecule and by the return of 
Y447 to the metal during O-O bond cleavage. 
 Although the most critical reactive intermediates have been trapped in this enzyme 
(Chapter 1, Fig. 16), several important questions about the enzyme’s catalytic cycle and the 
mechanism of substrate selectivity remain unanswered. In particular, it is uncertain how the 
protein architecture determines a preference for PCA over other catecholic substrates that are un-
substituted or have halo or methyl-substituents. Secondly, it is unclear what determines the 
reactivity of specific IDO enzyme-catechol complexes (ES complexes) towards O2. As discussed 
in Chapter 1, reactivity may be directly tied into the binding mode of the catechol substrate on the 
iron. However, it may also be that reactivity is related to the electronic characteristics of the 
substrate. Both factors may come into play, but it is unclear which one is more determinant in 
controlling the reaction rate with O2. 
In order to investigate these and other aspects of the catalytic cycle, we characterized the 
steady-state and transient kinetic reaction of 3,4-PCD with a series of alternative non-carboxylic 
substrates: catechol (CAT), 4-methylcatechol (4MC), and 4-chlorocatechol (4CC). The reaction 
with 4-fluorocatechol (4FC) has been characterized in detail in Chapter 1, but it will be discussed 
again in context of these other catecholic substrates. Our findings provide lessons into the role of 
the enzyme fold in producing a highly O2-reactive ES complex and into the mechanism of 
substrate specificity. We also find evidence for ways that the enzyme maximizes the capture 
efficiency and turnover number of substrate. This work has implications on the general 
mechanisms that enzymes use to stabilize (or de-stabilize) their substrate binding mode to induce 
catalysis and may be useful for engineering 3,4-PCD and its relatives to accommodate a wider 
substrate range. 
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Materials and methods 
 
Determination of catechol extinction coefficients and identification of reaction products. The 
catecholic substrates were purchased from either TCI America (4FC) or Sigma Aldrich. 4MC was 
purified by recrystallizing the solid in hexane and removing the solvent by evaporation. The other 
catechols were used without further purification. The extinction coefficients of the alternative 
substrates were determined by nuclear magnetic resonance (NMR) spectroscopy using an 
aromatic proton inventory calibrated to an internal tryptophan standard
290
. The values are reported 
at pH 8.5 and λmax for each molecule. CAT ε276 nm 2500 ± 660 M
-1 
cm
-1. 4CC ε287 nm 3200 ± 40 M
-1
 
cm
-1. 4MC ε281 nm 2400 ± 210 M
-1
 cm
-1
. The 4FC coefficient is reported in Chapter 1. Products 
were identified by first separating the molecule from the enzyme using an Amicon centrifugal 
filter (30 MWCO) and then comparing of their UV/vis spectra to those reported previously
295
 and 
by liquid-chromatography mass-spectrometry (LC-MS). Mass spectrometry was performed at the 
UMN Chemistry Department Mass Spectrometry Laboratory and analyzed using a Waters 
Acquity UPLC/TQD instrument. The parent peak of the products showed a mass increase of 32 
atomic mass units (amu) over substrate-only controls, consistent with incorporation of two 
oxygen atoms. The fragmentation pattern of the product also clearly evidenced successive losses 
of two carboxylate functions (Δ44 amu) as expected for the di-carboxylic muconic acid products. 
 
Steady-state kinetic characterization. Kinetic studies were performed at either pH 7.5 in 
HEPES buffer or pH 8.5 in Bicine buffer at 0.1 M concentration. Steady-state experiments were 
performed either using an oxygen polarimeter (Hansatech) or by monitoring of the reaction-
product formation using a UV/vis spectrometer. These methods produced comparable results. 
Extinction coefficients for the products were determined by incubating a known amount of 
substrate with enzyme and by assuming full conversion of substrate to product. Because the 
substrate and product UV spectra overlap, the product-formation rate was determined by using 
difference in extinction coefficients for the product and substrate at the same wavelength. For the 
organic Km, the dissolved O2 concentration was held nearly constant between 0.7 – 1.0 mM by 
performing the reaction in diluted O2-bubbled buffer while the catechol concentration was varied. 
For the O2 Km determination, catechol was maintained under saturating conditions, typically 2 
mM, while the O2 concentration was varied. Km values were determined by fitting the plots of 
initial velocity vs. catechol or O2 concentration using the Michaelis-Menten equation. Due to the 
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high Km for O2 for many of the substrates (Table 3), we were unable to attain truly saturating 
conditions (5-fold over Km) in some cases because of limited O2 solubility and technical 
limitations of the oxygen polarimeter. This meant we were not able to determine the initial 
velocity at some of the higher O2 concentrations that would be on the asymptotic portion of the 
hyperbolic plot. The kcat values could still be extracted from the fit, although the absence of data 
at higher concentrations resulted in significantly higher errors for the derived Km values. 
 
Crystal structure determination of E-CAT complex. 3,4-PCD was crystallized at pH 7.5 under 
anaerobic conditions as described in the Chapter 1 Materials and methods. Single crystals were 
soaked in mother liquor supplemented with 25% glycerol as cryoprotectant and 50 mM catechol. 
The crystal was soaked for roughly ten minutes before the crystal was flash-frozen directly in 
liquid N2. The structure was solved by direct Fourier phasing with a model of resting WT 3,4-
PCD followed by rigid body and restrained refinement. The final model was generated using 
Coot and refined in Refmac5
293, 294
. 
 
Transient kinetic characterization. An Applied Photophysics SX.18MV stopped-flow 
spectrophotometer was used to study the transient reactions. The enzyme-substrate complexes 
were pre-formed in an anaerobic glove bag (Coy) and reacted with O2-containing buffer at 4.5 °C. 
Since the high Km for the organic substrates precluded true single-turnover conditions, the 
experiments were performed under multiple-turnover conditions with excess catechol. Typical 
experiments contained 100-120 μM enzyme and 2 mM catechol in one syringe and anaerobic or 
oxygenated buffer in the other. Due to the occurrence of a very slow step near the end of the 
reaction cycle, multi-exponential fitting allowed two reciprocal relaxation times (RRTs) to be 
directly determined at early reaction time-points before the enzyme entered steady-state turnover. 
The RRT value for a third kinetic phase was determined by fitting the decay of the enzyme from 
steady-state turnover back to ES at long time-points when O2 was exhausted. This decay was 
well-fit by a single exponential function. Mathematical fitting of the reaction traces was 
performed using the Applied Photophysics Pro-Data Viewer software and is described in detail in 
the Chapter 1 Materials and methods. 
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Results 
 
Steady state characterization of the reaction of 3,4-PCD with the alternative substrates and 
comparison to PCA. Each of the alternative catecholic substrates tested are turned over to 
product at a significantly lower rate than the native substrate (>50-fold). All of the determined 
steady-state parameters are shown in Table 3. In order of highest to lowest kcat, the following 
trend was observed at 22 °C: CAT (1.5 s
-1
) > 4FC (1.2 s
-1
) > 4CC (0.35 s
-1
) > 4MC (0.05 s
-1
). Km 
values for the organic substrate are increased relative to PCA (29 μM). This is most noticeable 
with CAT, 4FC and, 4MC, where the values are increased to 100 μM, 190 μM and 240 μM, 
respectively. The Km for 4CC is only two-fold higher than that of PCA, 63 μM. Km values for O2 
for each of the alternative substrates are also considerably higher than for PCA (56 μM): CAT 
(130 μM), 4FC (270 μM), 4CC (440 μM), and 4MC (170 μM). Each of these catechols is 
converted into the expected intradiol ring-cleaved product (see Materials and methods). The 
decrease in both kcat/Km ratios relative to that of PCA is indicative of a greatly reduced catechol- 
and O2-capture efficiency by the resting enzyme and enzyme-catechol complex, respectively
302
. 
 
Optical spectra of the anaerobic enzyme-catechol substrate complexes. The enzyme-substrate 
(ES) complexes were prepared under anaerobic conditions with 100 μM enzyme and excess (2 
mM) catechols. The spectra for these complexes at pH 7.5 are shown in Figure 19 along with that 
of the resting enzyme (black trace) and the PCA complex (E-PCA, magenta). Each species 
exhibits the additional ligand-to-metal charge-transfer bands in the 500-750 nm range that are 
characteristic of the formation of a catechol-iron complex
185, 188, 205
. However, there are substantial 
differences in the λmax and overall intensities for the complexes. The 4CC complex (E-4CC, 
green) exhibits the greatest intensity in the 575-750 nm range while being considerably less 
intense than the other complexes at lower wavelengths. The E-4CC λmax is near 450 nm, but the 
peak is broader than that those of the other complexes. The 4FC (E-4FC, red) and CAT (E-CAT, 
blue) complexes are the most similar and differ only modestly at longer wavelengths whereas E-
4FC absorbs more intensely. Both complexes absorb maximally around 425 nm but have the 
lower intensities at longer wavelengths than E-4CC. The spectrum with 4MC (E-4MC) is shown 
in orange and has a λmax of 500 nm and lower overall intensity at lower wavelengths than E-4FC 
and E-CAT. Compared to E-PCA (magenta), all of the other ES complexes are considerably less  
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Table 3. Steady-state kinetic parameters for the reaction of 3,4-PCD with PCA, catechol, 4-
methyl, 4-fluoro, and 4-chlorocatechol and O2. 
 
 kcat* 
(s
-1
) 
Km,organic 
(μM) 
Km,O2  
(μM) 
kcat/Km,organic 
(M
-1
s
-1
) 
kcat/Km,O2  
(M
-1
s
-1
) 
PCA
†
 81 ± 20 29
§
 56
§
 2.8 x 10
6
 1.5 x 10
6
 
CAT
†
 1.5 ± 0.31 100 ± 10 130 ± 72 1.5 x 10
4
 1.2 x 10
4
 
4MC
‡
 0.05 ± 0.002 190 ± 10 170 ± 73 2.6 x 10
2
 2.9 x 10
2
 
4FC
†
 1.2 ± 0.09 240 ± 24 270 ± 110 5.0 x 10
3
 4.4 x 10
3
 
4CC
†
 0.35 ± 0.03 63 ± 5.8 440 ± 160 5.6 x 10
3
 8.0 x 10
2
 
Errors represent one standard deviation. All values normalized to the number of Fe
3+
-containing 
active sites.  
* due to the high Km for O2 for these substrates, the reported kcat values and the corresponding 
error were extracted from the hyperbolic fits to the initial velocity vs. dissolved O2 
concentration plots 
† values determined at 22 °C in 0.1 M Hepes buffer at pH 7.5. 
‡ values determined at 22 °C in 0.1 M Bicine buffer at pH 8.5. 
§ values are from reference
179
. 
 
 
 
intense at all wavelengths. These spectra may indicate that CAT, 4CC, and 4MC, like 4FC, bind 
to the metal in an altered manner relative to PCA (Fig. 15 shows the binding mode of 4FC). 
 
Crystal structure of the E-CAT complex. Crystals of 3,4-PCD were soaked anaerobically with 
CAT substrate in order to generate the E-CAT complex for structural characterization. The 
structure of the complex was solved at 1.67 Å resolution with a model Rwork and Rfree of 16.5% 
and 18.9%, respectively. The data collection and modelling statistics are given in Table 4. The 
electron density at the active site evidenced clear binding of a catechol molecule directly to the 
iron cofactor (Fig. 20A). CAT binds to the metal in a rotated orientation and its position is 
superimposable with the 4FC substrate in the E-4FC crystal structure (Fig. 15). This binding 
mode amounts to a rotation of roughly 100° of the CAT aromatic ring into the equatorial plane 
relative to PCA in the E-PCA complex. The two hydroxyl/alkoxide groups of CAT coordinate to 
the metal trans to H460 and Y408 with Fe-OCAT bond distances of 2.1 Å and 2.3 Å, respectively 
(Fig. 20B). Y447, which fully dissociates from the metal in E-PCA
181
, is modeled at a 50/50 
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metal-bound and dissociated occupancy. The ability of CAT to cause dissociation of Y447 even 
though it does not physically displace the residue’s side-chain was also observed in E-4FC and is 
consistent with the propensity of the metal center to maintain charge-balance during the catalytic 
cycle (see Chapter 1)
179, 194
. The iron is in a distorted octahedral or square pyramidal environment 
when Y447 is metal-bound or dissociated, respectively.  
 
Transient kinetic characterization of the reaction of the enzyme-substrate complexes with 
O2. In order to characterize the reactivity of the ES complexes with O2, we used stopped-flow 
spectroscopy to monitor the reaction optically and extract the rate constants for the reaction. Due 
to the relatively high organic Km for each of these substrates the transient kinetic analysis was 
performed under multi-turnover conditions containing saturating catechol concentrations. Under 
these conditions, the initial portion of the reaction time course of E-CAT, E-4MC, or E-4CC with 
O2 could each be fit by a sum of two exponentials. Exponential fitting was appropriate in these 
cases because a very slow step occurs near the end of the reaction cycle thereby kinetically 
isolating the initial steps of the reaction from the steady state turnover. Longer time-courses 
 
 
Fig. 19: Optical spectra of the anaerobic ES complexes. Samples contained 100 μM 3,4-PCD 
and 2 mM catechol substrate at pH 7.5. The figure shows the resting enzyme (black), E-PCA 
(magenta), E-CAT (blue), E-4FC (red), E-4MC (orange), and E-4CC (green). The spectra 
were obtained anaerobically in 0.1 M HEPES pH 7.5. 
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evidenced the existence of a third process that logically corresponds to the decay of a steady-state 
intermediate back to ES. An example of such a long time-course is shown for a 4MC reaction in 
Figure 21. Overall, this kinetic behavior suggested a kinetic model with at least three steps and 
two intermediates where decay of the second intermediate was rate-limiting under  
 
 
Fig. 20: Crystal structure of the E-CAT complex at pH 7.5. (A) Electron density for one of the 
active sites in the asymmetric unit of the complex. The mesh represents the 2|Fo|-|Fc| map 
contoured at 1σ. (B) The interactions of CAT with the iron and nearby residues with bond 
distances given in Å. In both panels, CAT is shown in yellow (carbon) and protein residues in 
gray (carbon). Oxygen atoms are red and nitrogen atoms blue. Iron is shown as a brown 
sphere. 
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Table 4. E-CAT X-ray diffraction data collection and model statistics. 
 
 3,4-PCD catechol complex 
 
PDB ID 
 
3T67 
Data collection  
   Space group I222 
Cell dimensions  
   a, b, c (Å) 128.01, 140.78, 168.19 
   α, β, γ (°) 90, 90, 90 
Wavelength (Å) 0.979 
Resolution (Å) 50-1.67 
Total/Unique reflections 163821/ 
28740 
Rmerge (%) *
,†
 5.5 (57.5) 
Completeness (%) * 99.3 (99.0) 
Redundancy* 5.7 (5.7) 
Model Refinement  
   Resolution (Å) 30.68-1.67 
   Rwork/Rfree (%)
‡
 16.5/18.9 
   Average B, all  
     atoms (Å
2
) 
21 
   ESU (Å)
 §
 0.053 
RMSDs  
   Bond lengths (Å) 0.013 
   Bond angles (°) 1.42 
Ramachandran  
  analysis 
 
  Allowed (%) 99.9 
  Outlier (%) 0.1 
All data collected on synchrotron beamline APS SBC-CAT 19-BM-D 
* Highest resolution shell is shown in parentheses 
† Rsym = ΣhklΣi |Ihkl,i - <I>hkl|/ΣhklΣi|Ihkl,i|, where Ihkl is the intensity of a reflection and <I>hkl is the 
average of all observations of the reflection 
‡ Rfree, R-factor calculated from 5% of the data excluded from refinement 
§ Estimated overall coordinate error (ESU) based on maximum likelihood  
RMSD, root mean square deviation from ideal geometry 
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steady-state conditions. This same behavior was observed for the reaction of E-4FC with O2 and 
is discussed in Chapter 1. 
The pre-steady state region of the reaction time-courses of E-CAT, E-4MC or E-4CC 
with O2 was fit by a sum of two exponentials in order to extract the RRTs (Fig. 22). This same 
analysis was performed for 4FC (Fig. 14B and C) and discussed in Chapter 1. The sum and 
product plots of the RRTs and their dependence on the dissolved O2 concentration are shown for 
E-CAT in Figure 22A, E-4MC in Figure 22B and E-4CC in Figure 22C. Analysis of the slope and 
intercepts of these plots yielded the rate constants for the steps which are shown in Table 5 (see 
the Materials and methods section of Chapter 1 for the details of the methodology). This analysis 
indicated that the reaction of all three ES complexes with O2 is consistent with a model with three 
steps where the first step is reversible whereas the second and third are irreversible (k-2 and k-3 ~ 
0): 
ES + O2 
𝑘1
⇄
𝑘−1
Int1
𝑘2
→
 
Int2
𝑘3
→
 
E + P 
 
 
Fig. 21: Single-wavelength trace (430 nm) of the reaction of E-4MC with 950 μM O2 as 
monitored using stopped-flow spectroscopy. The inset shows the same data but zoomed on the 
first 10 seconds of the reaction. The reaction was performed at 4.5 °C in 0.1 M Bicine buffer 
at pH 8.5. 
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The same type of kinetic model was derived for 4FC as shown in Chapter 1. The magnitude of k3 
is comparable to the turnover number for the substrates, once the value is corrected for the 
temperature difference. This is consistent with decay of Int2 being rate-limiting under steady-
state conditions. The relative magnitude of the bimolecular rate constant (k1) for the reaction with 
O2 was found to follow the trend E-4MC (6.3 x 10
3
 M
-1 
s
-1
) > E-CAT (8.9 x 10
2
 M
-1 
s
-1
) ~ E-4FC 
(8.7 x 10
2
 M
-1 
s
-1
) > E-4CC (7.8 x 10
2 
M
-1 
s
-1
). The equivalent rate constant for E-PCA is 5.0 x 10
5 
M
-1 
s
-1
, nearly two orders of magnitude greater than that for E-4MC, the most reactive alternative 
complex. In order to determine whether the observed bimolecular rate constant correlated with 
the electronic nature of the substituent, we plotted log k vs. the Hammett substituent coefficient 
for the meta (σm) and para (σp) position, as shown in Figure. 23. As evidenced by the plots, there 
is no clear correlation between the observed rate constant and the electron-withdrawing or 
donating characteristics of the substituent. Factors other than electronics appear to be determinant 
of O2 reactivity. 
 
 
 
Table 5. Transient kinetic parameters for the reaction of 3,4-PCD with PCA, catechol, 4-
methyl, 4-fluoro, and 4-chlorocatechol and O2. 
 
 k1 
(M
-1
s
-1
) 
k-1 
(s
-1
) 
k2 
(s
-1
) 
k3 
(s
-1
) 
 
PCA* 5.0 x 10
5
  450 36 
CAT
†
 8.9 x 10
2
 0.68 0.51 0.38 
4MC
‡
 6.3 x 10
3
 0.45 1.6 0.01 
4FC
†
 8.7 x 10
2
 0.11 0.58 0.16 
4CC
†
 7.8 x 10
2
 0.13 0.06 0.09 
All listed values were determined at 4.5 °C. 
*
 
values for PCA are from reference
184
. 
† values determined at 22 °C in HEPES buffer at pH 7.5. 
‡ values determined at 25 °C in Bicine buffer at pH 8.5. 
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Fig. 22: Sum and product plots of the observed RRT plotted vs. dissolved O2 concentration. In 
all panels, the sum plot is shown in black and the product plot in red. Error bars represent on 
standard deviation. (A) E-CAT vs. O2. (B) E-4MC vs. O2. (C) E-4CC vs O2. Details of the 
experimental setup and conditions are discussed in the Materials and methods. 
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Discussion 
 
It is shown here that the reactions of 3,4-PCD with the alternative substrates makes possible the 
observation of the catalytic step(s) in which the reaction with O2 takes place. The kinetic analysis 
allows us to investigate the effects of substrate electronics and steric bulk on the O2 reactivity of 
the ES complexes. Here, we discuss the implications that these findings have on the mechanism 
of substrate selectivity in IDOs and the factors that determine O2 reactivity in this enzyme family. 
We also propose a mechanism by which the enzyme modulates the binding mode of substrate to 
effect an increase in the substrate-capture efficiency and product-release rate. 
 
Comparison of the reaction of the ES complexes with O2. All of the reactions of the various 
ES complexes with O2 exhibit a similar kinetic pathway. The concentration dependence of the 
reaction kinetics is consistent with O2 binding in the first observable step.  In this step, the 
reaction with O2 is reversible and the forward bimolecular rate constant varies considerably 
between the substrates. The other steps are essentially irreversible for all substrates and k3 is 
always the smallest and rate-limiting. In the O2 reaction of E-PCA and the 1,2-CTD-substrate 
complex, two intermediates have also been observed, in which the decay of the second species is 
rate-limiting
180, 183, 184
. In 1,2-CTD, the first species could be a peroxo intermediate but is too 
 
 
Fig. 23: Plots of the observed forward bimolecular rate constant (log scale) for the reaction 
with O2 for the ES complexes vs. the Hammett coefficient for the aromatic substituent. (A) 
Hammett meta coefficient (σm). (B) Hammett para coefficient (σp). 
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short-lived to characterize in detail
183
. The second species is very likely a product complex (EP), 
suggesting that product release is rate-limiting with the substrates tested
205, 287
. Indeed, product-
release from 3,4-PCD has been determined to be rate-limiting for nearly all substrates previously 
studied
179, 180, 184, 287
. The assignment of Int2 as a product complex in the reactions studied here is 
supported by the optical similarity of Int2 to that for the previously characterized EPs (see Figure 
14A, orange trace, for the spectrum of Int2 in the 4FC reaction)
179, 183, 205
. This may indicate that 
product release (k3) is also rate-limiting with CAT, 4MC, 4FC and 4CC. 
 It is interesting to note that while the E-4MC complex is the most reactive towards O2, it 
has the smallest kcat of all the alternative substrates. The increased O2 reactivity may be due to the 
electron-donating character of the methyl substituent which is expected to increase the electron 
density on the ring and accelerate the reaction with O2
25, 183, 190
. Although there is no clear linear 
trend in the Hammett plots for the non-PCA substrates, there is a correlation between the 
electron-donating/withdrawing character of the substituent and the observed bimolecular rate 
constant, namely 4MC > CAT ~ 4FC > 4CC. This order correlates with the substituents donating 
to withdrawing character: methyl > proton > fluoro > chloro (although the carboxylate substituent 
of PCA does not fit in this series). However, the kcat shows no such trend. Decay of Int2 is rate-
limiting for all substrates and the rate constant for this process for 4MC is an order of magnitude 
lower than that with the most electron-withdrawing substrate, 4CC. If this species corresponds to 
an enzyme-product complex, it is possible that the presence of a methyl group somehow sterically 
impedes product release to such an extent that it becomes slower than for all of the other 
substrates. The absence of a polarizable substituent may also slow egress if the enzyme uses 
electrostatic interactions to drive the product out of the active site. The methyl group is the largest 
substituent in terms of van der Waals radius of those tested in this series. However, the 
carboxylate of the native substrate PCA is larger than a methyl group, but product release is 
9,000-times faster (36 s
-1
 vs. 0.004 s
-1
 at 4° C). An explanation would be that the anionic 
carboxylate could form interactions with some of the conserved second-sphere residues in 3,4-
PCDs. The candidate residues Y324 and R133 were previously identified to be conserved only in 
3,4-PCDs
181, 206
 but diverge in the 1,2-CTDs, which preferentially cleave unsubstituted and 
methyl-substituted catechols. Non-covalent interactions of the PCA carboxylate may orient the 
catecholic substrate (Fig. 24), oxygenated intermediates and product in a way that facilitates rapid 
chemical interconversion and release from the active site. 
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Possible explanation for the dramatically increased reaction rate of E-PCA towards O2 vs. 
the other ES complexes. The bimolecular rate constant for E-PCA reaction with O2 is orders of 
magnitude faster than those with all of the other substrates. Substrate electronics are simply 
unable to account for this dramatic difference as indicated by the Hammett plots of Fig. 23. The 
crystal structure of E-4FC (Fig. 15) shows that 4FC binds in a dramatically altered orientation 
relative to PCA: a 100° rotation into the equatorial plane of the metal coordination sphere. This 
same binding mode is observed in E-CAT (Fig. 20). This provides a possible explanation for the 
comparable O2 reactivity of E-4FC and E-CAT and the optical similarity of these two ES 
complexes. 4MC and 4CC may also bind in an altered mode relative to PCA that may be similar 
to that of 4FC and CAT. In Chapter 1, the equatorial orientation of 4FC was hypothesized to be 
responsible for the reduced O2 reactivity of the ES complex because the active site architecture is 
not optimized to drive the interconversion of equatorially-oriented substrates and oxygenated 
intermediates. Because of the similarity of the optical spectra of all the ES complexes (lower 
intensity and different shape than E-PCA) and the overall low O2 reactivity, it is plausible that the 
same mechanism(s) is responsible for slowing the reaction with all of these alternative substrates. 
A more speculative interpretation of the data is that the substrates are bound to the metal as a 
mixture of equatorially- and axially-oriented modes and only the axial mode is reactive. The axial 
 
 
Fig. 24: Non-covalent interactions of the protein with the PCA carboxylate that are proposed 
to stabilize this substrate in the more reactive axial orientation. Bond distances are given in Å. 
PCA is in orange and the protein in gray. The image was generated from PDB structure 
3PCA. 
 
79 
 
mode would need to be present at a very low occupancy, based on our inability to observe this 
mode in the crystals. The divergence of the observed bimolecular rate constants from a linear 
Hammett trend could then be representative of the different relative ratios of the axial/equatorial 
orientation of the alternative substrates. 
As discussed in Chapter 1, the reaction of E-PCA with O2 is rapid because the substrate is 
already bound in the reactive axial orientation and there is a clear site for O2 to bind near the iron. 
Thus, the binding mode of PCA is apparently more important in determining the reaction rate 
with O2 than the substrate electronics. Other IDOs which preferentially cleave un-substituted and 
methyl- or halo-substituted catechols stabilize these molecules in an axial metal-bound 
orientation in ES
197, 202
. The reactivity of these ES complexes towards O2 is comparable to that of 
3,4-PCD-PCA with O2
183
. We propose that the preferential stabilization of this binding mode has 
two major effects on catalysis in IDOs: (i) it increases the O2 capture efficiency (kcat/Km,O2) and 
the reactivity of ES towards O2 and (ii) it may increase rate-limiting product release step, thereby 
increasing kcat. Both effects are expected to greatly enhance the flux through this ring-cleavage 
pathway in vivo. 
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Conclusion 
 
3,4-PCD retains intradiol-cleavage specificity even with the alternative methyl- and halo-
substituted catechols. It is likely that the product-release step is rate-limiting for all substrates. 
The steps in the catalytic cycle where the reaction with O2 occurs are slowed more than 100-fold 
with the alternative substrates relative to PCA. Based on the trends in O2 reactivity and the 
previous observation of an alternative binding mode for the 4FC substrate, we conclude that the 
reactivity of the ES complex may be primarily controlled by the binding mode of the substrate to 
the iron. The evidence suggests that 3,4-PCD has evolved to selectively bind PCA in a more 
reactive orientation than other substrates, conferring a preference for the carboxylated catechol 
over the other substrates. It may do this by interacting with the carboxylate function of substrate 
using a set of second-sphere residues that are only conserved in 3,4-PCDs but not in relatives that 
preferentially cleave methyl or chloro-substituted substrates. Such interactions may also help 
orient the PCA oxygenated intermediates and cleaved product for rapid progression through the 
catalytic cycle. 
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CHAPTER 3 
 
Structure of a dinuclear iron cluster-containing β-hydroxylase 
active in antibiotic biosynthesis 
 
 
Note: Parts of this chapter are reprinted (adapted) with permission from Makris, T. M., Knoot, C. 
J., Wilmot, C. M., and Lipscomb, J. D. (2013) Structure of a dinuclear iron cluster-containing 
beta hydroxylase active in antibiotic biosynthesis, Biochemistry, 52 (38), 6662-6671. Copyright 
(2013) American Chemical Society. 
 
Note: Parts of this chapter are reprinted (adapted) with permission from Knoot, C. J., Makris, T. 
M., and Lipscomb, J.D. Dinuclear iron cluster-containing oxygenase CmlA, Encyclopedia of 
Inorganic and Bioinorganic Chemistry, Online © 2011–2015 John Wiley & Sons, Ltd. This 
article is © 2015 John Wiley & Sons, Ltd. This article was published in the Encyclopedia of 
Inorganic and Bioinorganic Chemistry in 2015 by John Wiley & Sons, Ltd. 
 
Abbreviations: 
NRPS: non-ribosomal peptide synthetase 
CmlA: β-hydroxylase of the chloramphenicol biosynthetic pathway 
CmlP: NRPS of the chloramphenicol biosynthetic pathway 
sMMO: soluble form of methane monooxygenase 
MMOB: regulatory component B of the sMMO system 
L-PAPA: L-p-aminophenylalanine 
PPant: 4’-phosphopantetheine cofactor 
PCP: peptidyl-carrier protein. This CmlP domain contains the serine attachment site for PPant 
and the amino-acid substrates that are subsequently covalently linked to PPant. PCP is 
alternatively termed the thiolation (T) domain. 
CmlPAT: truncated version of full-length CmlP lacking the C-terminal reductase domain 
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Summary 
 
A family of dinuclear iron cluster-containing oxygenases was recently described that catalyze β-
hydroxylation tailoring reactions in natural product biosynthesis by nonribosomal peptide 
synthetase (NRPS) systems. Here, the 2.17 Å X-ray crystal structure of the archetypal enzyme 
from the family, CmlA, is reported. CmlA catalyzes β-hydroxylation of L-p-aminophenylalanine 
during chloramphenicol biosynthesis. The fold of the N-terminal domain of CmlA is unlike any 
previously reported, but the C-terminal domain has the αββα-fold of the metallo-β-lactamase 
(MBL) superfamily. The diiron cluster bound in the C-terminal domain is coordinated by an 
acetate, three His, two Asp, one Glu and a bridging oxo moiety. One of the Asp ligands forms an 
unusual monodentate bridge. No other oxygen-activating diiron enzyme utilizes this ligation or 
the MBL protein fold.  The N-terminal domain facilitates dimerization, but using computational 
docking and a sequence-based structural comparison to homologs, we hypothesize that it likely 
serves additional roles in NRPS recognition and the regulation of O2 activation. 
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Introduction 
 
Biosynthesis of many complex secondary metabolites by bacteria and fungi is effected by 
nonribosomal peptide synthetases (NRPS). These large, modular enzymes act as ‘assembly lines’ 
in which each module plays a role in extending or modifying the growing natural product
247
. 
Generally, a parent amino acid or adduct is covalently tethered to the 4'-phosphopantetheine 
(PPant) moiety of a modified serine residue on a peptidyl-carrier protein (PCP) domain of the 
first module of the NRPS by the action of a preceding adenylation (A) domain.  The resulting S-
acyl amino acid intermediates are either chemically modified by following NRPS domains or 
transferred to the S-acyl-linked amino acid adduct on the PCP domain of the next module by the 
action of a condensation (C) (or similar) domain, forming a new peptide bond. When the 
synthesis is complete, the natural product is released by the action of a thioesterase (TE) or a 
reductase (R) domain.   
In some cases, the chemical modifications of the developing natural product are catalyzed 
by “tailoring” enzymes that are not modules of the NRPS but are rather encoded elsewhere, often 
in the same genetic operon
247, 257
. A common modification for tethered amino acids is β-
hydroxylation, which is crucial for the function of many natural products including the 
vancomycin and coumarin antibiotic families as well as the antitumor compounds of the 
bleomycin family
239-241, 261, 303, 304
. The newly introduced hydroxyl function can serve as a site for 
glycosylation or act as a nucleophile during release of the natural product from the NRPS to form 
large macrocyclic molecules. Study of the structural and regulatory mechanisms that control the 
specificity and spatiotemporal activity of these accessory enzymes is necessary in order to 
understand the biosynthetic origins of complex natural products.  Learning how to harness these 
capabilities may enable the production of new antibiotics and pharmaceuticals
274, 275, 305
.  
 Sequencing of the chloramphenicol biosynthetic operon
264
 led to the discovery of a 
tailoring enzyme (CmlA) that catalyzes β-hydroxylation of the precursor molecule L-p-
aminophenylalanine (L-PAPA) to form L-p-aminophenylserine
58
. This is a key step in 
chloramphenicol synthesis as illustrated in Figure 25
306
. The amino acid sequence of CmlA 
suggests that it has two domains.  The N-terminal domain has no known homologs, but the C-
terminal domain contains the signature sequence of the αββα-type metallo-β-lactamase (MBL) 
superfamily
58, 307
. The vast majority of MBLs catalyze hydrolysis reactions utilizing a dizinc 
cluster coordinated by the signature His-X-His-X-Asp-His scaffold, although MBLs with both 
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mono- and di-metal clusters containing other metals are known
265
.  In contrast, spectroscopic 
characterization of CmlA showed that it contains a diiron cluster
58, 268
.  
Prior to the characterization of CmlA, no MBL-like enzymes catalyzing O2 activation and 
hydroxylation reactions were known to exist,  although a branch of the MBL family that utilizes a 
diiron cluster to reduce O2 or NO in obligate anaerobes has been described
265, 266. Typically, β-
hydroxylation reactions in NRPS pathways are catalyzed by α-ketoglutarate-dependent 
oxygenases or cytochrome P450s
245, 261, 303
. CmlA represents a third class, and it is the only known 
diiron enzyme to catalyze β-hydroxylation of an amino acid-like substrate. Oxygen activation and 
hydroxylation reactions involving diiron clusters are generally carried out by members of the 
bacterial multicomponent monooxygenase (BMM) family
308
, which includes enzymes such as the 
soluble methane monooxygenase (sMMO)
109
. In contrast to CmlA, BMMs coordinate the diiron 
cluster in a 4-helix bundle.  The typical cluster coordination consists of four carboxylate 
(Asp/Glu) and two histidine ligands
309
. Numerous kinetic, spectroscopic, and structural studies 
have shown that both the diiron cluster and the protein scaffold play important roles in 
orchestrating and regulating the oxygenation chemistry
109, 110, 310
. 
Genome database searching based on the CmlA gene sequence has now shown that there 
are many enzymes serving similar roles in natural product biosynthesis that are homologous to 
both the N- and C-terminal regions of CmlA
58
.  To date, no enzyme from this group of 
homologous enzymes has been structurally characterized, and no role for the N-terminal domain 
has been forthcoming. 
 Here, we present the crystal structure of CmlA at 2.17 Å resolution. The structure 
confirms the predicted MBL C-terminal fold and reveals the structure of the N-terminal domain.  
 
 
Fig. 25: Steps in the biosynthesis of chloramphenicol. The β-hydroxyl shown in red is derived 
from O2 and is incorporated through the catalytic activity of CmlA. 
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The detailed structure of the dinuclear iron cluster differs from those of previously characterized 
oxidoreductases from the MBL family, as well as those from the O2-activating BMM family.  The 
overall organization of the enzyme suggests different roles for the N- and C-terminal regions as 
well as the basis for regulation of O2 activation through interaction with the NRPS from the 
chloramphenicol biosynthetic pathway, CmlP. 
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Materials and methods 
 
Crystallization of CmlA. CmlA and CmlP were expressed, purified and quantified as previously 
described
58
. Crystals of resting CmlA were acquired by the hanging drop vapor diffusion method 
at 277 K by addition of 3 μl of a 15 mg/ml solution of CmlA in 50 mM HEPES pH 7.5 to an 
equal volume of mother liquor containing 100 mM HEPES pH 7.5, 10-15 % polyethylene glycol 
(F.W. 20,000), 100 mM potassium acetate, and 10 % glycerol. Square-bipyramidal CmlA crystals 
typically grew to 0.2 – 0.6 mm over the course of several days. Selenomethionine-labeled CmlA 
was generated by feedback inhibition during expression
311
. Crystals were soaked in mother liquor 
supplemented with 25 % glycerol prior to looping and flash-freezing in liquid nitrogen. For the 
amino acid co-crystallization, crystallization and freezing conditions were identical to the non-co-
crystallized samples except the mother liquor and cryoprotectant contained L-phenylalanine, L-
tyrosine or L-PAPA at final concentrations of 10-20 mM. 
 
Data collection and modeling. Data were collected at the Structural Biology Center at the 
Advanced Photon Source, Argonne National Labs on beamline 19-ID at 100 K. Diffraction data 
were indexed, integrated and scaled using the HKL2000 software package
312
 and phased using 
single-wavelength anomalous dispersion of SeMet-labeled enzyme with Phenix
313
. The initial 
model was prepared with Phenix followed by manual rebuilding. The preliminary model was then 
used in direct Fourier phasing of a higher-resolution native data set using Refmac5
294
 from the 
CCP4 suite
314
. The final model was prepared using iterative cycles of modeling using Coot
293
 and 
refinement with Refmac5. Iron-ligand bond distances were not restrained during any of the 
refinement cycles. Model geometries were evaluated using SFCHECK and PROCHECK
314
. X-
ray data processing and refinement statistics are summarized in Table 6. All structure figures 
were produced using PyMOL Molecular Graphics System, Version 1.5, Schrödinger, LLC. 
 
Computational docking of the CmlP PCP domain and PPant amino acid substrate.  
Homology modeling of the CmlP PCP domain was performed using Swiss-Model
315
 and docked 
to CmlA using the HADDOCK online server
316
. In order to guide the docking of the PCP domain, 
we defined several residues to be part of the interface based on studies of our CmlA model and 
prior sequence information. For CmlA we input W438, D496, and H501. These surface residues 
were chosen based on their proximity to the active site channel. For the CmlP T domain 
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homology model, we input only the serine identified as the putative PPant attachment from 
sequence comparisons to other structurally characterized PCP domains, with the rationale that 
this residue must be poised above the channel upon binding of the NRPS to CmlA. 
Docking of L-PAPA-PPant to CmlA was performed using the Sybyl-X 2.0 Surflex-Dock 
Suite [Sybyl-X 2.0 Tripos International, 1699 South Hanley Rd., St. Louis, Missouri, 63144, 
USA]. The final CmlA model was prepared by deleting all water molecules and non-protein 
ligands, except the Fe atoms, followed by addition of hydrogen to residues. The structure was 
then minimized using the Amber7 FF99 package in the docking suite, but Fe atoms and ligand 
positions were unaltered. The substrate was modeled manually in Sybyl-X and atomic partial 
charges for both the protein and substrate were automatically calculated and assigned, with the 
exception of Fe atoms which were manually assigned as +3 and +2 for Fe1 and Fe2, respectively. 
The parameters for defining the active site were as follows: threshold 0.65, bloat 0. The active 
site was automatically identified by the program. The protein was not allowed to flex during 
docking. 
 
Approaches to determine whether CmlA is partially photoreduced during data collection. In 
order to determine the effects of radiation dosage on the resulting models, we compared models 
of the active site that were produced from data collected on comparable crystals with the 
synchrotron beam attenuation set to 5, 50 and 100, corresponding roughly to a total radiation dose 
of 33 MGy, 3.3 MGy and 1.7 MGy, respectively. Dosage was calculated for the exposed region 
of the crystal using RADDOSE-3D
317
. The resulting models had identical cluster geometries and 
bond distances within coordinate error, and there were no significant shifts in the orientation of 
side-chains or the position of the oxo atom following refinement. However, crystals exposed at 
high X-ray dosages showed increases up to 10 Å
2
 in the B factor in the resulting models, making 
direct comparisons between these data and those from crystals exposed at lower X-ray doses 
difficult. The final deposited structure was collected with the beam attenuation set to 50. Data 
processed in slices and merged also showed no significant changes in the bond distances or 
coordinates of the ligands. Additionally, soaking of crystals in cryoprotectant supplemented with 
10-20 mM sodium ascorbate as an electron scavenger prior to freezing also showed no significant 
changes in the iron-oxo bond distances or iron ligand orientations. Microspectrophotometer UV-
vis absorbance data on single CmlA crystals collected pre- and post-exposure were inconclusive 
due to the low extinction coefficient (3.5 mM
-1
 cm
-1 
at 340 nm per diiron cluster) of the charge-
transfer chromophore and detection limitations of the instrument.  CmlA crystals are square-
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bipyramidal in shape and samples used for the microspectrophotometer experiments were 
typically 0.3-0.5 mm long (all dimensions). In all X-ray diffraction datasets, the Fe2-oxo distance 
consistently appeared longer than that of Fe1-oxo. Based on these experiments, we could not 
definitively identify the redox state of the cluster. 
 
Cloning and mutagenesis. The expression construct for the E430A mutant of CmlA was 
produced using an Agilent Quickchange II Site Directed Mutagenesis kit. The following primer 
pair was used to introduce the mutation into a pET28a expression plasmid for wild-type (WT) 
CmlA:  
 
CGTCTTCATCGGCATGGAGCTCATCGGCGCGG (forward) 
CCGCGCCGATGAGCTCCATGCCGATGAAGACG (reverse)  
 
Mutated plasmid was transformed into chemically competent XL1-Blue E. coli and plated onto 
media containing 50 µg/ml kanamycin. Individual colonies were screened via colony PCR and 
sequenced to confirm the presence of the mutation. E430A enzyme was expressed and purified as 
described above. Mass spectrometry of CmlA was done with a QSTAR XL Quadrupole TOF MS 
from AB Sciex at the University of Minnesota Center for Mass Spectrometry and Proteomics and 
used to confirm the presence of the desired mutation in purified enzyme. The deconvoluted mass 
spectrum showed a major peak at 62,204 Da and 62,146 Da for the WT and E430A, respectively, 
the difference corresponding to the expected loss of a carboxylate and CH2 group in the mutant. 
 
Stopped flow kinetics. All stopped-flow experiments were performed with an Applied 
Photophysics model SX.18MV stopped flow device at 4 °C. Stopped-flow experiments and CmlP 
amino acid loading were performed as previously described
58
, with the exception that reduced 
CmlA was pre-mixed with L-PAPA loaded CmlPAT in an anaerobic chamber and rapidly mixed 
with O2 saturated buffer on the instrument. Excess CmlA reducing reagents and CmlP loading 
reagents were removed prior to the experiment using a PD10 desalting column. 
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Results and discussion 
 
Overall structure of CmlA. The structure of CmlA was determined by single-wavelength 
anomalous dispersion of selenomethionine-enriched enzyme. The enzyme crystallized in 
spacegroup P43 21 2 with a single monomer in the asymmetric unit. The CmlA model was refined 
to 2.17 Å resolution with a Rwork of 20.3% and Rfree of 23.0% with 99.6% of residues in the 
allowed regions of the Ramachandran plot (Table 6). Overall, 522 residues and 151 solvent 
molecules were modeled into the electron density map. The polypeptide can be roughly divided 
into two structural domains of equal length. As expected from the primary structure, the N-
terminal half (residues 1-235, Fig. 26, gray surface) has a previously unclassified architecture. 
The second half (residues 249-532), however, belongs to the metallo β-lactamase (MBL) 
superfamily (Fig. 26, blue surface)
307
. The two domains are connected by a linker region (residues 
236-248) that is unobserved in the electron density. Overall, the secondary structure of the 
enzyme is 34% α-helical and 21% β-sheet and contains a total of 20 α-helices (α1-20) and 23 β-
strands (β1-23) (Fig. 26). The active site is housed entirely within the MBL catalytic domain. 
Members of the MBL family have a distinct αββα-motif which is also observed in CmlA. Prior to 
the discovery of CmlA, nearly all characterized diiron hydroxylases bound the active site cluster 
within a 4-helix bundle motif. 
The N-terminal domain of CmlA is relatively flat and roughly triangular in shape and 
contains a mixture of α-helices and β-sheets (Fig. 27, left). One face of the triangle packs against 
the MBL-like catalytic domain. Interactions between secondary structural elements is limited to 
packing of several pairs of α-helices and three sets of antiparallel β-sheets each composed of 2-4 
individual strands. A long, kinked helical region (residues 68-107, α5) runs the nearly the length 
of one of the sides of the triangle. One of the vertices of the domain contains a winding three-turn 
motif (residues 108-142) which is stabilized by packing of α5 and α6 and a pair of antiparallel β-
strands (β4, β5). The surface residues of the vertex engage in electrostatic and hydrophobic 
interactions with a 2-fold symmetry-related CmlA protomer in the unit cell. The interface area 
buried between the protomers is 2700 Å
2
 – 13% of the total accessible monomer surface area - 
and probably corresponds to the interface of the biological dimeric assembly. This feature is here 
termed the dimerization arm, as it mediates most of the inter-residue contacts with the second 
CmlA protomer (Fig. 28 and Fig. 27, left). The dimeric quaternary structure of CmlA was 
confirmed using native-PAGE gel chromatography. The second vertex of the N-terminal domain  
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Table 6. CmlA X-ray diffraction data collection and refinement statistics. 
 
 Native Se 
Data collection   
   Space group P43 21 2 P43 21 2 
Cell dimensions   
   a, b, c (Å) 153.2, 153.2, 93.4 153.3, 153.3, 92.7 
   α, β, γ (°) 90, 90, 90 90, 90, 90 
Wavelength (Å) 0.97857 0.97926 
Resolution (Å)* 38.7-2.17 (2.21-2.17) 20.9-2.60 (2.64-2.60) 
Unique reflections 56972 35553 
Rmerge (%) *
,†
 6.3 (43.5) 10.8 (45.0) 
I/σI* 28 (3.1) 27 (4.5) 
Completeness (%) * 96.4 (81.6) 99.9 (100) 
Redundancy* 7.3 (7.1) 7.2 (7.4) 
Overall figure of merit       0.405 
Cruickshank’s Diffraction 
   Precision Index (DPI) 
0.154  
Model refinement   
   Resolution, Å 38.7-2.17  
   Number of reflections 54097  
   Rwork/Rfree (%)
‡
 20.3/23.0  
   Averaged B factor (Å
2
) 35.1  
RMSDs   
   Bond lengths (Å) 0.0151  
   Bond angles (°) 1.78  
Ramachandran analysis   
   Favored regions (%) 95.6  
   Allowed regions (%) 4.0  
   Disallowed regions (%) 0.4  
All data collected on synchrotron beamline APS SBC-CAT 19ID-D 
* Highest resolution shell is shown in parentheses 
† Rsym = ΣhklΣi |Ihkl,i - <I>hkl|/ΣhklΣi|Ihkl,i|, where Ihkl is the intensity of a reflection and <I>hkl is the 
average of all observations of the reflection 
‡ Rfree, R-factor calculated from 5% of the data excluded from refinement. 
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contains an L-shaped α-helical extension (Fig. 27, α2- α4). This feature, along with a protrusion 
from the catalytic domain of CmlA, forms a groove which runs along the surface of CmlA, see  
below. The channel to the active site is positioned at the base of this groove. The final vertex of 
the domain contains the N-terminus of the enzyme and is stabilized by a pair of packed helices 
(α10, α11) and two antiparallel β-strands (β1, β8).  
The C-terminal MBL-like catalytic domain houses the diiron active site. The fold is 
characterized by a central β-sandwich motif surrounded by two α-helical faces. One of these faces 
packs against the N-terminal domain of the same protomer and the other against the dimerization 
arm of the symmetry-related protomer. The core is composed of a β-sandwich with each half 
containing seven β-strands, each in a mixed antiparallel-parallel sheet (Fig. 26 and 27, right). The 
α-helices which surround the core are in the loop regions between these sheets, most often in αβα-
motifs. The loop between β12 and β13 contains the conserved MBL metal coordination motif 
His-X-His-X-Asp-His which sits above the strands of the β-sandwich. This motif contributes four 
ligands to the diiron cluster; and the other first-sphere ligands are furnished by loops extending 
between the other β-strands. A final notable feature of this domain is the presence of an extended, 
partially helical loop between β19 and β20 which contains α16-α18. This protrusion points away 
from the core of the domain and, along with the L-shaped arm from the N-terminal domain, forms  
 
 
Fig. 26: Crystal structure of the CmlA monomer shown from two views. The surface of the N-
terminal domain is shown in gray and that of the C-terminal metallo-β-lactamase-like domain 
in blue. The dashed line represents a stretch of disordered residues that connects the two 
domains for which no electron density was observed. α-helices are colored blue and β-strands 
orange. 
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Fig. 28: The dimer interface of CmlA. One monomer is shown in blue and the other in 
maroon. Notable α-helices are labeled and the shape of the interface is demarcated by the 
dashed black line. The location of the channel to the active site in each protomer is indicated 
by the red arrows. 
 
 
the other side of the groove that runs along the surface of CmlA. It is stabilized in this extended 
orientation by packing against the dimerization arm of the second CmlA monomer (Fig. 28). 
 
Structure of the CmlA diiron cluster. The active site of CmlA is situated above the β-sheets of 
the αββα-core of the catalytic domain. Structural alignments of this domain show that the active 
sites of other members of the MBL-superfamily are found in similar spatial positions relative to 
the rest of the fold. The iron atoms are ligated in part by four ligands derived from a loop 
containing the conserved metal binding motif, which extends upward between the fourth β-strand 
and second α-helix of the catalytic domain. The only apparent access to the active site is from the 
channel above, although some solvent-occupied caverns can be seen extending from the substrate 
binding pocket.  
The two iron atoms in the enzyme active site are in distorted octahedral environments 
with six ligands each (Fig. 29A). Herein, iron atoms are referred to as Fe1 and Fe2 for Fe600 and 
Fe601 in the model, respectively. Iron atom occupancies refined to 1.0 for Fe1 and 0.75 for Fe2 
based on an analysis of the model B-factors after refinement. The iron-iron distance was  
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Fig. 29: Structure of the CmlA active site and nearby residues. (A) Cluster geometry and bond 
distances in Å, with iron ligands in grey, second-sphere conserved residues in yellow and the 
bridging oxo atom as a red sphere. Blue dashes indicate hydrogen bonds. The exogenous 
acetate ligand (Act) is shown in cyan. When not directly indicated, distances are given in 
parenthesis. (B) Positive Fo-Fc difference electron density (green) following removal of the 
oxo bridge atom and trimming of D403 back to Ala, followed by 5 cycles of refinement. Fo-Fc 
difference electron density contoured at + 4σ for the oxo and at + 7σ for D403. The map was 
calculated using a resolution range of 38.7-2.17 Å. (C)  One possible rotameric conformation 
of the disordered E430 side chain (green) places the carboxylate within 3 Å of Fe2, 
overlapping partially with the acetate (cyan) binding site. 
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determined to be 3.39 Å, in close agreement with EXAFS studies
268
. Strong density for a bridging 
atom is also apparent in the difference map following refinement of the cluster (Figure 29B) and, 
based on previous spectroscopic studies of the diferric state of CmlA
58, 268
, we have modeled this 
density with an oxo atom (O602).  The iron-oxo bond distances refined to 1.77 Å and 2.15 Å for 
Fe1 and Fe2, respectively. EXAFS studies 
268
 suggested the average iron-oxo distance is ~1.8 Å, 
raising the possibility that Fe2 may have been reduced to the ferrous state during data collection, 
forming a mixed-valent Fe
3+
Fe
2+
 cluster. Consistent with this, the overall average ligand distances 
refined to 2.0 Å for Fe1 and 2.3 Å for Fe2. We investigated the possibility of reduction during 
data collection by several standard approaches as detailed in the Materials and methods. 
However, none of these methods provided definitive evidence for a mixed-valence cluster.  
The cluster in CmlA is coordinated by one less endogenous amino acid carboxylate and 
one more histidine ligand than found for most other diiron hydroxylases. All nitrogen ligands 
derive from the conserved MBL metal-binding scaffold. The N-terminal domain contributes no 
cluster ligands. Fe2 is coordinated by D309, H310, a monatomic bridging D403, an acetate 
molecule (ACT603) derived from the crystallization buffer, and the bridging O atom. Fe1 is 
coordinated by a chelating E377, bridging D403, H305, H307 and the bridging O atom. It is 
likely that in solution the coordinating acetate is replaced by solvent because no acetate is added 
to the purification buffer.  Exposure of CmlA to 100 mM potassium acetate in buffered solution 
results in no detectable changes in the chromophore. 
 
Monodentate diiron cluster bridging structure. The monodentate μ-2 binding mode of D403 
in CmlA was unexpected, because in most oxygen-activating diiron enzymes and model 
complexes the carboxylate forms a μ-1,3 bridge.  The monodentate bridging mode has been 
observed in purple acid phosphatase, the reduced form of the D84E mutant of E. coli 
ribonucleotide reductase β subunit, and reduced sMMO hydroxylase component209, 318-321. 
However, in the latter two cases, the bridging mode is μ-(1,2) where the second oxygen of the 
carboxylate coordinates to one of the irons.  Also, in both cases, a traditional μ-1,3 bridging 
carboxylate is also present.  It is unlikely that D403 in CmlA can assume a μ-1,3 orientation 
without significant rearrangements of the backbone due to several constraints: (i) D403 is 
sterically restrained and essentially limited to rotation around the Cβ-Cγ bond, (ii) D403 needs to 
rotate towards Fe1 to bring the second oxygen close enough to coordinate Fe2; not only would 
this introduce severe strain on the sp
3
 hybridization of the D403 Cα, but it would result in steric 
clashes with E377 and a too-short iron-oxygen bond to Fe1. Finally, (iii) if the backbone 
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rearranges, it would be required to undergo a nearly 90° rotation to bring the carboxylate into an 
allowed conformation close enough to coordinate both metals. Indeed, rubredoxin:oxygen 
oxidoreductase has a bidentate Asp bridge and the backbone runs perpendicular to the iron-iron 
axis
265
, whereas in CmlA and purple acid phosphatase the backbone runs more parallel
209
. Thus, 
the bridge in CmlA is essentially “locked” into a single orientation during the catalytic cycle in 
the absence of significant structural rearrangement.  
 
Structure of the substrate binding pocket. The diiron cluster is located 10 Å from the surface 
of the enzyme. An opening (~6 Å in diameter) and a short channel are located above the cluster. 
This entrance is positioned at the base of the surface groove that is formed by the protrusions 
from the catalytic and N-terminal domains of the enzyme (Fig. 30A). The active site cavity is 
elongated and extends partially into the interior of the protein toward residue Q308 (Fig. 30B). 
The diiron cluster sits at the end of the pocket that is closer to the entrance. The sides of this 
pocket are lined by hydrophobic residues W20, F37, W438, I439, L458, V492, and M493. 
In all models, additional areas of residual positive |Fo|-|Fc| density were observed in the 
part of the pocket above the cluster. We attempted to model this density with solvent molecules, 
but this resulted in significant residual positive density after refinement. Co-crystals of CmlA 
with 10-20 mM amino acids L-tyrosine, L-phenylalanine or L-PAPA resulted in isomorphous 
crystals, but insufficient density to model any amino acid substrates in the binding pocket. This 
density appeared nearly identical to that observed in crystals that were not co-crystallized with 
amino acids and does not correspond well with components of the crystal mother liquor, thus its 
source remains unknown. The absence of significant electron density for any amino acids in these 
co-crystallized samples demonstrates that free amino acids have little affinity for binding in the 
CmlA active site. This behavior was also observed in a cytochrome P450 tailoring system where 
no amino acid binding was detected even with a 500-fold excess over protein. In contrast, the 
NRPS-tethered substrate had a binding affinity in the low micromolar range
322
. The possible 
binding mode of the NRPS-bound substrate in CmlA is modeled and discussed in context below. 
 The monooxygenase chemistry catalyzed by CmlA requires delivery of two protons and 
two electrons to the reactive center during turnover, leading to release of a water molecule. We 
searched for possible endogenous proton donors in CmlA. One candidate is H258 which is 
positioned only 3 Å from Fe2 in the same plane as the cluster (Fig. 29A). Ramachandran analysis 
shows H258 to be in a strained orientation, likely because the residue engages in a hydrogen bond 
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with D309. On the opposite side, another His residue H378 is positioned 5 Å from Fe1 but points 
away from the cluster. Alternatively, the surface-exposed E430 could act as a proton shuttle from 
bulk solvent.  
 
Conserved structural features of CmlA and its homologs. The structure of CmlA permits the 
sequence-based structural comparison of its family members. CmlA homologs are encoded in 
the genomes of a wide variety of mostly soil-dwelling bacteria and some cyanobacteria but the 
biosynthetic roles of most of these enzymes have not been determined. The biosynthetic operons 
for the glycopeptide antibiotics teicoplanin (from A. teichomyceticus)
240, 323
, A47934 (from 
Streptomyces toyocaensis strain NRRL 15009)
239
, and A40926 (from Nonomurea sp.)
241
 contain 
homologs that accept L-Tyr as the NRPS-tethered amino acid substrate. A L-His-accepting 
homolog may also be involved in bleomycin biosynthesis in Streptomyces verticillus
304
. The 
biosynthetic pathway for lysobactin from Lysobacter sp. ATCC 53042 contains three β-
hydroxylated amino acids (Phe , Leu, and Asn), but only one hydroxylase is in the operon, 
suggesting that a broader substrate specificity may be accommodated
324
. Some 
 
 
Fig. 30: Structure of substrate-binding cavity of CmlA. (A) The channel to the active site 
(dark gray) is located at the base of a groove formed by protrusions from both domains of 
CmlA. The helices α4 and α17 are important in forming the sides of this groove and are 
indicated in the panel. (B) The substrate-binding cavity extends into the interior of CmlA 
(dark gray). The side-chains of residues which form the cavity are shown and labeled, along 
with the diiron cluster. The white dashed arrows illustrate a possible path for the tethered 
substrate as it is delivered by CmlP. 
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other notable species that encode a homolog and are known to produce antibiotics or other 
bioactive compounds using NRPS systems include Teredinibacter turnerae
325
, Nodularia 
spumigena
326
, and Streptomyces tsukubaensis
242
. 
In general, CmlA homologs are of similar length (500-540 residues) and typically have 
30-45% sequence identity. In some cases, a C-terminal thioester-reductase domain is present; this 
may functionally replace the reductase domain of the NRPS that releases the hydroxylated 
product. Conserved residues in the N-terminal domain are primarily found to stabilize the tertiary 
structural elements, particularly the dimerization arm and the kinked, L-shaped arm on vertex 2 of 
the domain (Fig. 31). The characteristic His-X-His-X-Asp-His motif is present in all of the 
homologs. The first-sphere iron ligands are conserved in all homologs, along with several second-
sphere residues including Y440, H258, H378, and E430 whereas Q308 is replaced by His in 
many cases. Most of the hydrophobic residues that line the substrate binding cavity (F37, I439, 
L458, V492, M493) are not conserved but are often substituted by residues with a similar 
chemical character. In contrast, W20 and W438 are entirely conserved. 
 Putative electron delivery routes have been identified in other diiron enzymes
327
, and we 
attempted to find such a route in CmlA, as well as identify a possible ferredoxin (Fd) or flavo- 
 
 
Fig. 31: Surface diagram showing locations of conserved residues based on the alignment of 
CmlA with 13 homologs. Colors indicate conservation of chemical character (yellow) or 
absolute (red) conservation. Residues which are not conserved but are at the interface between 
CmlA and the docked CmlP PCP domain are shown in blue (see Fig. 33A). One side of the N-
terminal domain of CmlA is outlined in orange for clarity. Most of the surface of CmlA is 
highly variable, including the protruding arms that form the surface groove. 
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iron-sulfur reductase interaction site. From the sequence alignments, we noted a partially 
conserved buried aromatic network starting at the solvent-exposed Y479 that runs to underneath 
the cluster through the interior of the catalytic domain terminating at Y255, which is hydrogen 
bonded to the carbonyl group of H258 (Figure 32A). In more distant homologs, some positions 
are substituted by other aromatic residues. CmlA surface electrostatics reveal a strongly acidic 
patch (residues D423, E474, D476 and E477) at the base of the catalytic domain (Fig. 32B) that 
might form a binding site for an electron transfer partner. Y479 is next to this patch and engages 
in a hydrogen bond with the carboxylate of E477. The acidic nature of this region would be more 
compatible with direct electron transfer from a flavo-iron-sulfur reductase
30
 than a Fd
31
, which is 
likely to carry a strong negative charge. Unfortunately, a specific reductase protein for CmlA has 
 
 
Fig. 32: Proposed electron delivery network and reductase binding site in CmlA. (A) 
Conserved aromatic network that extends from solvent-exposed Y479 to the diiron cluster. (B) 
Surface electrostatics map of CmlA showing a possible acidic binding site at the base of 
catalytic domain. Y479 is drawn in stick colored by atom (carbon, green). The map was 
generated using APBS [http://www.poissonboltzmann.org/] and contoured at 5 kT/e. 
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not been identified, and the Cml operon appears not to encode such a protein
264
. Thus, a definitive 
test of this hypothesis through mutagenesis is not currently possible. 
  
Interaction of CmlA with the NRPS.  CmlA hydroxylates only L-PAPA tethered to the carrier 
PCP domain of CmlP via a thioester bond to a PPant linker, minimally necessitating a specific 
interaction between the holo-PCP domain and CmlA. In order to identify the binding site of the 
PCP domain of CmlP and elucidate possible features conferring NRPS specificity, we docked a 
homology model of the highly conserved CmlP PCP domain
253, 328
 to the crystal structure of 
CmlA (Fig. 33A).  In this model, the carrier protein binds directly above the channel to the active 
site, as observed in similar systems
329
 and the serine residue where the PPant cofactor attaches is 
poised above the channel to the active site. The PCP domain interacts primarily with the loop 
between α16 and α17 that extends from the catalytic domain of CmlA and the residues around the 
channel to the active site. The binding site is minimally conserved (Fig. 31) consistent with the 
high specificity of the hydroxylation reaction.  
 
 
Fig. 33: Structures of the CmlP PCP domain and the amino acid substrate computationally 
docked to CmlA. (A) Docked structure of a homology model of the CmlP PCP domain (gold) 
to the surface of CmlA (gray). The conserved serine residue on the PCP domain that is the site 
of PPant attachment is shown as sticks and is located above the substrate channel. Nearby α-
helices on CmlA are labeled. The location of the CmlA residue Glu430 is shown as gray 
sticks. (B) L-PAPA-PPant docked (gold) in the active site CmlA. The β-carbon of L-PAPA is 
positioned roughly 4.3 Å from the cluster. Bond distances are given in Å. 
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Sequence-based structural comparisons of CmlA and homologs show that the surface 
composition of the N-terminal domain is highly variable. Nevertheless, there are 12 conserved 
residues, and these appear to be required to maintain the overall folded structure of each of the 
protruding arms on CmlA.  This suggests that each arm is functionally relevant, but the small size 
of the CmlP carrier domain would limit its interaction to a portion of the arms identified in the 
docked model. Analysis of CmlA surface electrostatics reveal that the tips of the arms, which 
form the groove between domains, have a net positive charge relative to the rest of the surface 
suggesting that it may be used as a mechanism to electrostatically target the correct NRPS. One 
interpretation is that NRPS specificity of the trans-acting tailoring enzymes from the CmlA 
family is conferred by interactions with the entire NRPS module and not just the CmlP carrier 
domain. Resolution of this possibility awaits further study. 
 
NRPS-loaded substrate binding in the active site of CmlA. In the P450biol-ACP crystal 
complex, PPant-tethered substrate is funneled into a long U-shaped cavity that positions the 
hydroxylation site above the heme for oxidation
329
. We propose that a similar mechanism 
functions in CmlA, and that substrate positioning is primarily directed by the shape of the pocket 
and the length restraints of the linker, resulting in the positioning of the β-carbon of L-PAPA 
above the cluster. The shape of the pocket suggests an orientation where the tethered amino acid 
substrate is pushed past the cluster, towards Q308 and between the side chains of M493 and I439 
(Fig. 30B). The length of the linker requires that the substrate be pushed farther down towards 
Q308, with the aromatic portion extending beyond the cluster. The Q308 side-chain stabilize L-
PAPA in a specific orientation through hydrogen bonding to the p-NH2 group of L-PAPA. In 
CmlA homologs, Q308 is substituted with other residues capable of H-bonding to substrate. In 
Tyr-accepting homologs (from A. teichomyceticus, Nonomurea sp., and S. toyocaensis) involved 
in synthesis of teicoplanins and other glycopeptides, Q308 is substituted with Ser. In a putative 
His-accepting homolog from S. verticillus involved in bleomycin synthesis, Q308 is replaced by 
His. The β-carbon of L-PAPA is the site of hydroxylation, and must be positioned near the cluster 
after binding of substrate. In our docked CmlA-PCP domain model, the distance between the 
PPant attachment site and the cluster is 13 Å, which matches well with observations from other 
systems
329, 330
. Upon binding, this would position the L-PAPA amide somewhere above the 
cluster and β-carbon slightly beyond it, near the site occupied by the oxo bridge in the resting 
state structure.  
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In order to test this possibility, we docked a model of the PPant-L-PAPA substrate to our 
structure of CmlA (Fig. 33B). In this model, the aromatic group of L-PAPA is positioned in the 
pocket identified in Figure 29, and p-NH2 group interacts with nearby carbonyl groups from 
V492 and the side-chain of Q308. The β-carbon is positioned above the cluster, with the correct 
pro-chiral hydrogen placed within 3.4 Å of both Fe atoms. These results support our proposed 
binding orientation and are consistent with a role for Q308 in orienting substrate in the pocket. 
 
Regulation of O2 activation. Intermediates formed during O2 activation are potentially 
dangerous oxidants to living systems
129, 133
. BMMs have evolved sophisticated regulatory 
mechanisms to only generate these oxidizing species in the presence of substrate and/or 
regulatory protein binding partners in order to mitigate undesired side-reactions (see Figure 5 in 
the Introduction)
53, 74, 109, 166, 270
. The triggering of O2 activation by CmlA only upon binding to 
substrate-loaded CmlP is a salient example, and it implies a regulatory role for the NRPS
58
. The 
mechanism of regulation of O2 activation in the BMM family often involves structural changes.  
For example, the binding of the regulatory protein MMOB to the hydroxylase component of 
sMMO causes structural changes near the diiron cluster
162, 271
, and similar perturbations may also 
occur in CmlA.  Comparison of the predicted and observed cluster ligand structures of CmlA 
suggests a possible regulatory mechanism. 
In our earlier study, the cluster ligands reported here were correctly predicted based on 
sequence comparisons to other members of the MBL superfamily and alignments to CmlA 
homologs
58
. However, E430 was also identified as a likely fourth carboxylate ligand to the diiron 
cluster.  Analysis of the electron density maps shows that this residue is positioned nearby on a 
loop (430-437) that runs along the base of the groove between the domains above the acetate 
binding site of Fe2. It does not coordinate the cluster and the side chain of E430 appears 
disordered. One possible rotameric conformation of E430 places the carboxylate group within ~3 
Å of Fe2 (green in Figure 29C), an orientation that partially overlaps with the acetate ligand (and 
the solvent(s) that presumably replaces the acetate when the enzyme is in solution). The residue is 
far enough away that it cannot coordinate to the cluster without a concomitant shift in the 
backbone. Coordination of E430 to Fe2 would build the carboxylate rich diiron cluster that 
differentiates O2 carrier proteins from O2-activating enzymes
58, 268, 331
. Consequently, a 
conformational change that allows E430 to coordinate might serve as the switch to promote O2 
activation. E430 is located on a loop directly below the tentative binding site of the CmlP PCP 
domain identified in the docked structure (Fig. 33A), so that the docking of CmlP may shift E430 
103 
 
close enough to coordinate to Fe2. Conservation of the nearby G433 residue could indicate it is 
required in order to maintain the backbone flexibility required for this change.  
An initial examination of the hypothesized role of E430 was made using the E430A 
variant.  A single turnover of fully reduced E430A in complex with L-PAPA-loaded CmlPAT 
resulted in a 25-fold decrease in the maximal rate constant for reaction with O2 as shown in 
Figure 34. In contrast, the autooxidation rate in the absence of L-PAPA-loaded CmlPAT was 
unchanged from that observed for wild type CmlA. Total iron loading of the active site of the 
E430A variant was comparable to that of wild type CmlA, but exhibited a blue-shifted optical 
absorption spectrum. This demonstrates that E430 interacts strongly with the diiron cluster 
despite its remote position from Fe2.  As expected, the optical spectra of diferrous CmlA and 
E430, with or without L-PAPA loaded CmlPAT bound, were bleached and featureless in the 
visible region
58
. These results support the hypothesis that E430 has a role in establishing a diiron 
cluster structure that is capable of rapidly activating O2. However, the fact that E430A still 
accelerates the rate of O2 reaction over autooxidation suggests that the complex with the loaded 
NRPS has additional structural and/or electronic effects on this reaction.  Initial attempts to 
crystallize E430A were successful, but the resulting crystal forms did not diffract to high 
resolution. 
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Fig. 34: Stopped flow reaction between 100 µM chemically reduced wild type or E430A 
CmlA in complex with 2.5-fold excess L-PAPA-loaded CmlPAT rapidly mixed with O2 
saturated buffer at 4 °C at pH 7.5. The reaction of wild type CmlA (blue trace) is complete 
within 1 s (1/τ1 = 17 s
-1
 and 1/τ2 = 5.2 s
-1
). The E430A reaction (black trace) can be fit by a 
sum of three exponentials (red dashed line) with 1/τ1 = 0.68 ± 0.09 s
-1
, 1/τ2 = 0.18 ± 0.04 s
-1
 
and 1/τ3 = 0.020 ± 0.006 s
-1
. The basis for the multiple exponential time course is unknown.  
Auto-oxidation of the cluster upon exposure of reduced E430A to O2 in the absence of CmlP 
(green trace) can be fit (red dashed line) to a single exponential with 1/τ1 =  0.014 ± 0.007 s
-1
, 
the same as that observed for wild type CmlA autooxidation. The reaction of wild type CmlA 
(blue trace) is from reference
58
.  
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Conclusion 
 
Tailoring of natural products during biosynthesis in NRPS-based systems is highly specific.  The 
X-ray crystal structure of the archetypal diiron cluster-containing β-hydroxylase from an NRPS 
system described here provides insight into the basis for this specificity.  It is likely to involve 
interactions directly with the substrate, L-PAPA, in the CmlA active site and also with the NRPS 
to which L-PAPA is covalently attached. The two structural domains identified in CmlA may 
serve different roles in establishing specificity. The structure demonstrates directly that the C-
terminal domain houses the active site in which the diiron cluster responsible for oxygen 
activation is bound.  The full role of the N-terminal domain with its previously uncharacterized 
structural motif remains open to speculation. While the structure shows that this domain 
facilitates dimerization in this family of enzymes, its proximity to the channel into the active site 
and the structural conservation of CmlA homologs also imply a role in establishing the NRPS 
complex. Finally, the NRPS may also act as a regulator of O2 activation, delivering substrate and 
engendering conformational changes in CmlA that ensure that the oxidative chemistry only 
occurs in the presence of the tethered amino acid. 
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CHAPTER 4 
 
Crystal structure of CmlI, the arylamine oxygenase from the 
chloramphenicol biosynthetic pathway 
 
 
Abbreviations: 
CmlI: full length wild-type CmlI enzyme 
CmlIΔ33: 33 amino acid N-terminally truncated variant of CmlI used for crystallization 
CAM: chloramphenicol 
NH2-CAM: D-threo-1-(4-aminophenyl)-2- dichloroacetylamino-1,3-propanediol, the arylamine  
precursor of CAM, native CmlI substrate 
Fe-AurF: the functional diiron variant of the aureothin arylamine oxygenase, AurF   
Mn-AurF: the catalytically inactive dimanganese variant of AurF 
RNR-R2: the R2 subunit of ribonucleotide reductase which houses the diiron cluster 
sMMO: soluble form of methane monooxygenase  
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Summary 
 
Nitroaromatic compounds are found in a variety of important industrial, medical, and agricultural 
chemicals. Natural biosynthetic pathways for nitro compounds are thus of considerable interest 
due to their potential importance in devising green synthetic routes for these chemicals. Only a 
few enzymes involved in the biological formation of nitro compounds have been studied. The 
chloramphenicol biosynthetic operon in Streptomyces venezuelae encodes an arylamine 
oxygenase enzyme that catalyzes the final step in the pathway. This enzyme, CmlI, converts the 
arylamine group of the chloramphenicol precursor to the equivalent nitro, thereby generating the 
final bioactive antibiotic. CmlI uses a diiron cluster cofactor to activate molecular oxygen (O2) 
for the reaction with organic substrate. In this chapter, we report the X-ray crystal structure of an 
N-terminally-truncated variant of CmlI in the as-isolated Fe
3+
/Fe
3+
 and chemically-reduced 
Fe
2+
/Fe
2+
 cluster states. The structures allow us to compare CmlI to other arylamine oxygenases 
and more distantly related diiron enzymes. We also find evidence for geometric flexibility at the 
cluster in the form of a carboxylate shift of one of the cluster ligands. This flexibility may 
represent an as-of-yet uncharacterized regulatory mechanism.  
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Introduction 
 
Nitro-substituted aromatic compounds (nitroaromatics) are used as synthetic building blocks for 
various chemicals including explosives, pesticides, and pharmaceuticals. Although relatively rare 
in nature, several natural pathways for the biosynthesis of nitroaromatics have been discovered 
and characterized
172, 280
. Many of these compounds are produced by soil bacteria of the 
Pseudomonas and Streptomyces genera and have antibiotic and medicinal properties
264, 332, 333
. 
The primary route to the generation of biological nitroaromatics is by direct enzymatic nitration 
of substrates
280, 334
. An alternative pathway involves oxygenase enzymes which catalyze the direct 
incorporation of the O atoms of molecular dioxygen (O2) into the substrate to form the nitro 
group
56, 277, 283
. One of the most well-known and widely used natural nitroaromatic compounds is 
the antibiotic chloramphenicol (CAM) which is synthesized by Streptomyces venezuelae
58, 264, 277, 
306
. The biosynthesis of CAM uses a non-ribosomal peptide synthetase (NRPS) pathway and 
several tailoring enzymes to chemically modify an aromatic amino acid precursor to the final 
product
58, 247, 257, 263, 277, 335
. The final step in CAM biosynthesis is oxidation of the arylamine 
function of the CAM precursor D-threo-1-(4-aminophenyl)-2- dichloroacetylamino-1,3-
propanediol (NH2-CAM) by the N-oxygenase CmlI (Fig. 10, blue)
277
. 
 CmlI is part of a diverse family of enzymes that use a carboxylate-bridged diiron cluster 
cofactor to activate O2 for oxidation reactions or the hydroxylation of organic substrates
109
. Some 
of the enzymes found in this broad family include: the hydroxylase component of the soluble 
methane monooxygenase (sMMOH) 
28, 309
, the R2 subunit of class I ribonucleotide reductase 
(RNR-R2)
54
, plant fatty-acid desaturases
165, 336
, aldehyde-deformylating oxygenase
337
 and many 
more. All of the aforementioned enzymes coordinate the diiron cluster in a highly conserved 4-
helix bundle fold and are part of the “ferritin-like” superfamily331. The as-isolated CmlI cluster is 
diferric and only reacts with O2 upon reduction of the cluster to the diferrous state
57
. The 
proposed catalytic cycle of CmlI is shown in Figure 3B. Upon exposure of the cluster to O2, it 
generates a diferric peroxo species which reacts directly with NH2-CAM (Fig. 3B-(ii)). Most of 
the peroxo species that have been characterized in enzymes have a cis μ-1,2 geometry in which 
each O atom of the peroxo coordinates a different iron
60, 75, 81, 120
. In contrast, the CmlI peroxo 
species is proposed to have a μ-η1:η2 geometry in which one O atom coordinates to both metals 
but the other to only one. Prior to CmlI, such a species had not been observed or studied in an O2-
activating enzyme. At pH 9.0, the CmlI peroxo intermediate was found to be highly stable, 
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having a t1/2 of nearly 3 hours at 4 °C. The exceptional longevity of the species makes it amenable 
to various structural techniques, possibly including X-ray crystallography. It is of interest to 
determine how the unique geometry of the CmlI peroxo relates to its ability to perform N-
oxygenations. 
A homolog of CmlI called AurF has been characterized biochemically and structurally
56, 
278, 279, 284
. This enzyme was isolated from Streptomyces thioluteus and catalyzes the conversion of 
p-aminobenzoate to p-nitrobenzoate in the biosynthesis of aureothin
333
. Crystal structures of this 
enzyme have been reported in the diiron (Fe-AurF)
279
 and dimanganese form (Mn-AurF)
278
. The 
dimanganese form is catalytically inactive, but its structure was solved because of early disputes 
over the identity of the functional metal
338
. AurF is composed of a core 4-helix bundle motif, 
which is used to house a μ-oxo- and carboxylate-bridged diiron cluster278. The structure of Fe-
AurF with the reaction product  showed that the substrate binds in a cavity above the cluster but 
not directly to the metals
279
. The crystal structure of CmlI has not yet been solved, but it is of 
considerable interest as it catalyzes the final step in the synthesis of one of the most widely-used 
antibiotics. Its structure would also facilitate comparisons to AurF, which has a different substrate 
specificity. The structure could also be compared to other diiron enzymes in this diverse family 
which would generate insights into how the architecture of the fold and active site directs the 
chemistry that takes place. 
Here we report the crystal structure of an N-terminally truncated variant of CmlI in the 
as-isolated state at 1.97 Å resolution and the chemically reduced state at 1.96 Å resolution. This 
truncated form of the enzyme exhibits the same reactivity as the full-length enzyme and can 
generate CAM product. Although the crystal structures reveal that CmlIΔ33 has an overall fold 
that is similar to that of AurF, there are marked differences in some of the secondary structure 
elements, the diiron cluster architecture, and substrate channel between these two enzymes. The 
differences in the clusters provide insights into the geometric variability of diiron cofactors and 
permits structural comparisons to other family members like sMMOH, RNR-R2 and the fatty acid 
desaturases. The structural malleability of the CmlIΔ33 cluster may represent a type of catalytic 
regulation found in the arylamine N-oxygenases.  
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Materials and methods 
 
Mutagenesis, overexpression, and purification. Polymerase chain-reaction (PCR) was used to 
generate the 33 amino acid N-terminally truncated version of CmlI (CmlIΔ33) in a pVP91A 
expression plasmid (Arizona State University plasmid repository). The primers used to generate 
the truncated coding sequence from the full-length pVP template were as follows (gene coding 
sequence underlined and restriction sites bolded) 
 
5’ AAAAGCGATCGCGGAGAACGCGGTCATC 3’ (forward) 
 
5’ AAAAGTTTAAACTCATCGGGTCACCGTC 3’ (reverse) 
 
This amplicon was cloned into a pCR4-TOPO vector (Thermo Fisher Scientific) and transformed 
into XL1 Blue cells. The CmlIΔ33-TOPO vector was isolated and digested with SgfI and PmeI 
restriction enzymes (New England Biolabs) and ligated into a similarly-digested pVP91A vector 
before transforming into XL1 Blue cells for plasmid propagation. Sequence confirmation of this 
plasmid was performed at the University of Minnesota Biomedical Genomics Center. 
Overexpression and purification of the truncated enzyme were accomplished using the same 
methods as previously described for the full-length enzyme
57
. 
 
Kinetic characterization of CmlIΔ33 and CAM product detection. NH2-CAM was purchased 
from Toronto Research Chemicals and stored as a concentrated stock in methanol at -20 °C prior 
to use. All assays were performed in 50 mM Bicine buffer at pH 9.0 in order to facilitate 
comparisons to the full-length enzyme. The CmlI peroxo was generated using the methods 
described previously
57
. Transient kinetic experiments were performed using an Applied 
Photophysics SX.18MV stopped-flow spectrophotometer at 4.5 °C. For these experiments, the 
CmlIΔ33 diferric-peroxo species was generated beforehand, loaded into the instrument and 
reacted with NH2-CAM in aerobic Bicine buffer. These reactions were monitored at 500 nm to 
follow the decay of the peroxo species. Product analysis was performed by incubating pre-formed 
CmlI peroxo (200 μM) with 0.5 equivalents of NH2-CAM substrate on ice for 30 minutes. The 
reaction product was separated from the enzyme using an Amicon centrifugal filter (3 kDa 
MWCO). The flow-through was acidified by addition of trifluoroacetic acid to 1% (vol/vol) and 
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residual precipitant pelleted by centrifugation. High-performance liquid chromatography (HPLC) 
was performed using a Waters 1525 model binary HPLC pump and elution monitored using a 
Waters 2487 detector. The acidified samples were injected into a Phenomenex Luna hexyl-phenyl 
column (5 μm particle size, 150 x 4.6 mm) and eluted using a gradient of 5% to 95% acetonitrile 
in 0.1% formic acid at a flow-rate of 2 ml/min. Under these conditions NH2-CAM had a retention 
time (tR) of 1.14 min and CAM a tR of 5.81 minutes. The elution was monitored at 280 nm. 
 
Crystallization of CmlIΔ33 and molecular replacement. We screened for initial crystallization 
condition hits of CmlIΔ33 at the UMN Nanoliter Crystallization Facility. Initial hits were 
obtained from conditions containing 10-20% polyethylene glycol (PEG) 1,500 and 0.2 M 
ammonium tartrate, which produced small (5-10 µm) barrel-shaped crystals. The conditions were 
optimized for hanging-drop crystallization and modified to contain 10-20% PEG 1,500, 0.15 M 
ammonium tartrate, and 0-2% glycerol. Typical drop ratios contained 1-1.5 µl mother liquor and 
1 µl CmlIΔ33 at 15-20 mg/ml concentration with a well reservoir volume of 0.5-1.0 ml. The pH 
of these drops was near 6.5. Crystals were obtained at 20-22 °C and at 4 °C. The space group 
obtained at the different temperatures was the same, but the morphology of the actual crystals was 
different. Those grown at room-temperature were triangular with longest dimensions of up to 200 
µm whereas the 4 °C conditions yielded hexagonal plate-like crystals that were 50-100 µm. The  
4 °C crystals required a longer time to grow—between three to seven days—as compared to 
overnight for those grown at room temperature. Crystals of CmlIΔ33 were chemically reduced by 
placing single crystals in a drop containing Ar-sparged anaerobic mother liquor with 25% 
glycerol, 40 mM sodium dithionite and a catalytic amount of methyl viologen. The crystals were 
incubated for 10 minutes before flash-freezing in liquid N2. 
 Initial diffraction data of the crystals were collected in-house at the University of 
Minnesota Kahlert Structural Biology Laboratory at 100 K. Crystals were soaked in mother liquor 
supplemented with 25% glycerol as cryoprotectant and flash-frozen in liquid N2. Data reduction 
of the initial data sets indicated that the crystals belonged to a trigonal P3 2 1 space group. This is 
an enantiomorphic space group which could possess either a P32 or P31 screw-axis symmetry. As 
such, we processed the diffraction data separately in both space groups. The  
P32 2 1 enantiomorph determined to be the correct space group during the molecular replacement 
process. Analysis of the solvent content and Matthews coefficient for the crystals suggested the 
most likely scenario contained a single CmlI monomer in the asymmetric unit (solvent content 
38% and Matthews coefficient 1.98 Å
3
/ Da). The structure was solved by molecular replacement 
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with the Phaser MR software
339
 using a trimmed model of an AurF monomer
279
. For the 
molecular replacement, most of the loops near the AurF surface were removed prior to inputting 
the search model. Following the initial solution, CmlI was iteratively modeled using Coot
293
 and 
the model refined using Refmac5
294
. Synchrotron-derived diffraction data for the reported 
structures were collected at the Structural Biology Center at Argonne National Laboratories, 
Beamline 19-ID at 100K. All structure figures were produced using PyMOL Molecular Graphics 
System, Version 1.5, Schrödinger, LLC.  
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Results 
 
Rationale for generation of the N-terminal CmlI truncation variant. Attempts to crystallize 
the full-length wild-type (WT) CmlI with or without the N-terminal 8x-His purification tag were 
unsuccessful. In order to identify the possible reasons for our inability to crystallize this form of 
the enzyme, we generated a sequence alignment of CmlI with its closest structurally-
characterized homolog, AurF. AurF has 37% sequence identity with CmlI and has been 
crystallized in two different space groups
278, 279
. The two enzymes are of similar overall length 
(Fig. 35), but we noted that CmlI contained a stretch of ten amino acids near the N-terminus that 
are not present in AurF. Analysis of the available crystal structures of AurF shows that the N-
terminus is positioned near a protomer packing interface in the unit cell (PDB structures 3CHU 
and 3CHI)
279
. We theorized that the additional ten amino acid stretch of residues in CmlI could be 
interfering with the crystal packing and nucleation. To test this possibility, we generated a 
truncated variant of the enzyme where the first 33 amino acids were removed (CmlIΔ33, Fig. 35). 
This site was chosen based on the observation that in two of the three AurF crystal structures the 
first 23 amino acids are not visible presumably because of conformation flexibility, and this was 
interpreted as meaning that the region was not critical to the AurF crystallization
279
.  
 
Biochemical characterization of CmlIΔ33. The reaction of CmlIΔ33 was studied with the 
native substrate NH2-CAM and the results compared to that reported for the full-length enzyme
57
. 
CmlI is able to generate a long-lived diferric-peroxo species (t1/2 ~ 3 hours, 4 °C) at pH 9.0 after 
exposure of the chemically reduced enzyme to O2
57
. This species is characterized by a weak 
optical band centered at 500 nm (ε ~ 0.5 mM-1 cm-1). We were able to generate this species in 
CmlIΔ33 using the same methods and conditions as for full-length enzyme (Fig. 36A, black 
trace). Titration of this peroxo with NH2-CAM indicated that roughly 3.3 equivalents 
peroxo/substrate were sufficient to fully consume the species (Fig. 36B). A similar 3:1 
stoichiometry was observed for full-length CmlI
57. CmlIΔ33 was also able to generate the CAM 
product in the expected yield (three peroxos consumed/CAM molecule produced) as determined 
using high-performance liquid chromatography and comparison to a CAM standard (Fig. 36C). 
Substrates have been shown to react with the CmlI peroxo in what appears kinetically to be a 
second order reaction
57
. We used stopped-flow spectroscopy to determine whether the CmlIΔ33 
peroxo exhibited similar kinetic behavior. Reaction of pre-formed CmlIΔ33 peroxo with different 
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concentrations of NH2-CAM substrate in buffer suggested that the truncated variant also reacts 
directly with substrate, as evidenced by the linearity of the peroxo decay rate constant vs. NH2-
CAM concentration plot (Fig. 36D). The zero-intercept and linearity of the plot means that the 
slope of the fit gives the apparent bimolecular rate constant for the reaction of peroxo with 
substrate
57. This value was comparable between CmlIΔ33 and the full-length enzyme: 12 mM-1 s-
1
 vs. 7.1 mM
-1
 s
-1
, respectively. In both cases, the zero intercept of the plot shows that the reaction 
is irreversible.  The experiments performed here demonstrate that CmlIΔ33 is functionally 
identical to the full-length enzyme and that the N-terminal truncation does not alter the reactivity 
of the enzyme significantly. Thus, the findings derived from a structure of the truncated mutant 
are likely to be applicable to the natural form of CmlI.  
 
Crystallization of CmlIΔ33 and its overall structure. Crystals of CmlIΔ33 were obtained in 
conditions containing 10-20 % PEG 1,500, 0.15 M ammonium tartrate and 0-2 % glycerol. The 
enzyme only crystallized near pH 6.5; attempts to generate crystals at higher pH values 7.5 - 9.0 
 
 
Fig. 35: Alignment of the CmlI amino acid sequence from S. venezuelae (Genbank 
CCA54211.1) and AurF from S. thioluteus (Genbank CAE02601.1). The alignment was 
generated using the ClustalW server. The red arrow shows the start of the truncated CmlI 
variant (ENAV…) and starred residues are the diiron cluster ligands, as based on the AurF 
crystal structures. 
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were unsuccessful even at 50 % higher precipitant concentrations. Data collection and model 
refinement statistics for the as-isolated and chemically reduced structures are given in Table 7. 
The enzyme crystallized in a trigonal P32 2 1 space group with one CmlI monomer in the 
asymmetric unit (Fig. 37A). In all, 283 residues were modeled in the as-isolated structure and 290 
residues in the reduced structure. The two structures are nearly superimposable (atomic  
 
 
Fig. 36: Results of the biochemical characterization of CmlIΔ33. (A) Optical spectra of 200 
μM CmlIΔ33 in the chemically reduced state (red), the diferric peroxo state (black) and upon 
titration with 0.1 molar equivalents of NH2-CAM substrate (blue traces). The green trace is the 
final spectrum of diferric CmlI after the peroxo is consumed. (B) Consumption of the 
CmlIΔ33 peroxo when titrated with NH2-CAM based on the observed intensity at 500 nm. (C) 
HPLC analysis of the CmlIΔ33 reaction products. Extracted CmlIΔ33 reaction product from 
reaction of 200 μM diferric peroxo with 100 μM NH2-CAM (black), buffer-only negative 
control (red), 60 μM NH2-CAM substrate standard (green), 60 μM CAM standard (blue). (D) 
Transient kinetic analysis of the dependence of peroxo decay on NH2-CAM concentration as 
monitored at 500 nm. The red line shows a linear fit to the data. All of the reactions in this 
figure were performed at pH 9.0 in 50 mM Bicine buffer. The transient kinetic reactions in 
panel D were completed at 4.5 °C. 
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Table 7. CmlI X-ray diffraction data collection and model statistics. 
 
 CmlIΔ33 
as-isolated 
CmlIΔ33 
chemically reduced 
Data collection   
   Space group P32 2 1 P32 2 1 
Cell dimensions   
   a, b, c (Å) 56.73, 56.73, 150.28 56.96, 56.96, 151.10 
   α, β, γ (°) 90, 90, 120 90, 90, 120 
Wavelength (Å) 0.97926 0.97933 
Resolution (Å) 50-1.97 50-1.95 
Total/Unique reflections 71031/ 
17711 
145686/ 
21534 
Rmerge (%) *
,†
 8.2 (50.5) 8.1 (55.3) 
I/σI* 33 (2.9) 33 (3.1) 
Completeness (%) * 85.7 (91.8) 99.6 (99.5) 
Redundancy* 4.0 (4.2) 6.8 (6.9) 
 
Model Refinement 
  
   Resolution (Å) 26.54-1.97 35.24-1.95 
   Rwork/Rfree (%)
‡
 0.205/0.264 0.191/0.240 
   Average B, all  
     atoms (Å
2
) 
41 37 
   ESU (Å)
 §
 0.140 0.112 
RMSDs   
   Bond lengths (Å) 0.0108 0.0118 
   Bond angles (°) 1.43 1.47 
Ramachandran  
  analysis 
  
  Allowed (%) 100 100 
  Outlier (%) 0 0 
All data collected on synchrotron beamline APS SBC-CAT 19ID-D 
* Highest resolution shell is shown in parentheses 
† Rsym = ΣhklΣi |Ihkl,i - <I>hkl|/ΣhklΣi|Ihkl,i|, where Ihkl is the intensity of a reflection and <I>hkl is the  
average of all observations of the reflection 
‡ Rfree, R-factor calculated from 5% of the data excluded from refinement 
§ Estimated overall coordinate error (ESU) based on maximum likelihood  
RMSD, root mean square deviation from ideal geometry 
  
117 
 
coordinate RMSDs 0.14 Å). Density for the N-terminal purification tag and a portion of the C-
terminal section of the protein was missing and not able to be modeled in either structure. In both 
structures, a disordered stretch of residues between K52 and L61 could also not be modeled 
(dotted line in Figure 37A). CmlI is entirely composed of α-helices and the intervening loop 
regions. In total, the protein contains ten α-helices (α1-α10) which are labeled in Figure 37A. 
Like many other diiron-cluster containing enzymes, it coordinates the diiron cluster in a 4-helix 
bundle. His and Glu residues in helices α2, α3, α5, and α6 are ligands for the cluster. A structural 
search of the CmlI protein using the DALI server shows that the closest structural hit is Mn-AurF 
(RMSD 1.5 Å)
278
 followed by Fe-AurF (RMSD 2.1 Å)
279
. The next closest hits are the R2-
subunits of class I ribonucleotide reductases and the hydroxylase component of sMMO (9-12% 
sequence identity, RMSD 3.0-3.4 Å)
54, 309
. These enzymes also use a core 4-helix bundle fold to 
house the diiron cluster. The biological unit of CmlI is a dimer and the dimer interface lies along 
one of the crystallographic symmetry axes in the unit cell (Fig. 37B). The CmlI dimer interface 
buries a surface area of 1090 Å
2
 and the interaction is mediated by residues in helices α2 and α3. 
This results in a 22 Å separation of the two diiron clusters, the same as in AurF. 
 In the proposed catalytic model for CmlI, the arylamine substrate binds near the diiron 
cluster for reaction with activated O2
57
. The crystal structures of Fe-AurF revealed a clear channel 
for substrate ingress to the interior of the protein and to the buried cluster
279
. In contrast, in Mn-
AurF this channel is collapsed with no clear open path for substrate to access the active site
278
. A 
putative substrate channel was also identified in CmlI (Fig. 38A). The entrance is located between 
helices α2, α5, α7, and α9 (Fig. 38B and orange arrow in 38A). This channel is lined by primarily 
hydrophobic amino acid side-chains: F69, P75, M73, Y101, I108, I208, Y211, F273, F278 and 
W281. These residues also encompass a relatively large cavity that is just inside the entrance to 
the substrate channel (starred in Fig. 38A). Above the diiron cluster, this channel contracts to a 
diameter that is too small to accommodate the relatively bulky NH2-CAM. 
 
Comparison of the overall structure to Fe-AurF and Mn-AurF. An alignment of the overall 
structure of CmlI with Fe-AurF shows that there are differences in the arrangements of some of 
the α-helices. The most notable of these is a break in the secondary structure of one of the four 
core helices (equivalent to α5 in CmlI). In AurF, there is a stretch of residues numbered 197 to 
201 that are not α-helical and are pushed out away from the substrate channel and the cluster (Fig. 
39A, purple cartoon). In contrast, in CmlI, this region remains α-helical (Fig. 39A, gray cartoon)  
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and is pushed in closer toward the putative substrate channel and the cluster. This has the effect of 
collapsing the channel above the cluster in CmlIΔ33 whereas it remains open in AurF (Fig. 39B 
and C). In particular, the side-chain of residue I208 (I199 in AurF) occludes the space above the 
CmlI cluster but not in AurF, where the side-chain is pulled away from the cluster. Interestingly, 
the structures of CmlIΔ33 and Mn-AurF are nearly identical in this respect. Namely, in both 
structures the region shown in Figure 39A remains α-helical and I208/I199 is pushed toward the 
channel and presumably occludes access to the active site. It will be shown in the next section 
that the position of I208 also has an important effect on one of the diiron cluster ligands.  
 In an attempt to crystallize an alternate form of CmlI where the channel was open as in 
Fe-AurF, we tried to co-crystallize CmlIΔ33 with various substrates including NH2-CAM. 
Unfortunately, this did not yield any alternate crystal forms, nor was there any evidence for 
substrate binding in crystals prepared under these conditions. The substrate channel was still 
collapsed similar to those prepared without any substrate present in the mother liquor. Attempts 
to incubate the enzyme with substrate prior to adding it to the mother liquor also did not result in 
any detectable differences. Chemical reduction of the cluster had no observable effect on the 
 
 
 
Fig. 38: A putative substrate channel and entrance found in the CmlIΔ33 crystal structure. (A) 
A channel in the interior of CmlIΔ33 that leads to the diiron cluster (orange spheres). The 
orange arrow shows the entrance to this channel that is on the surface of the protein. Above 
the cluster, the channel is collapsed and too small to accommodate the NH2-CAM substrate. 
(B) Surface-view of CmlIΔ33 showing the entrance to the channel with the surrounding 
helices labeled. The α-helices of CmlIΔ33 are shown in blue and intervening loop regions in 
white. 
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size of the substrate channel or the orientation of the residues that line the channel. Due to the 
similarity of the CmlIΔ33 structure to Mn-AurF, we checked to ensure that the active site was not 
loaded with other transition metals such as manganese. Inductively-coupled plasma mass 
spectrometry (ICP-MS) of the acid-digested enzyme used for the crystallization revealed that that 
 
 
Fig. 39: Comparison of the substrate channels in CmlI and Fe-AurF and the structural 
difference observed in helix α5. (A) Alignment of the structure of CmlIΔ33 (gray) and Fe-
AurF (purple, PDB ID 3CHH) showing the region of helix α5 which differs between the 
structures. In CmlI this region remains helical but in Fe-AurF there is a break in the loop as 
some of the residues lose their secondary structure (yellow star). The side-chains of residue 
I201 (CmlIΔ33, gray) and I199 (Fe-AurF, purple) are shown as sticks and the atomic radii as 
transparent spheres. I199 points away from the channel and cluster in Fe-AurF. (B) The 
collapsed substrate channel in CmlIΔ33. Important residues are shown as sticks and labeled. 
(C) The open substrate channel in Fe-AurF with important residues shown as sticks and 
labeled. Iron ions are shown as brown spheres. The channel in CmlIΔ33 appears different 
from that in Figure 37A because a slightly larger solvent-probe radius was used to calculate 
the cavity volume. This made it easier to compare to the Fe-AurF channel.  
 
121 
 
iron was present in roughly stoichiometric ratio (1.9:1) relative to the amount of protein, as 
expected. Iron was also present at nearly 20-fold higher concentration than any of the other 
metals, making it unlikely that these other metals were present in the active site above a trace 
level. It should also be noted that if CmlIΔ33 were loaded with non-cognate metals it would not 
be expected to exhibit the reactivity or be able to generate product at the yield that we observe. 
 
Structure of the as-isolated CmlIΔ33 diiron cluster. The diiron cluster is coordinated by four 
Glu and three His ligands (Fig 40A). All cluster ligands are derived from the core 4-helix bundle: 
E109 (from helix α2), E144 and H147 (α3), E205 (α5), and H232, E236, and H239 (α6). One 
metal ion (Fe1) is in a six-coordinate environment with five protein-derived ligands: E109, H232 
(Nε mode), H147 (Nδ mode) and E144 and E236 which both bridge between the iron ions in a μ-
1,3 mode. The other metal (Fe2) is five coordinate with four protein-derived ligands: the two 
bridging carboxylates E144 and E236, H239 (Nδ mode) and monodentate E205. A weakly-
coordinated solvent molecule (2.4-2.5 Å bond distance) is found in the putative substrate binding 
cavity and interacts with both metals. The Fe-Fe distance is 3.3 Å which is similar to that seen in 
several other diiron enzymes in the oxidized diferric state
54, 336, 337
 but is shorter than in the Fe-
AurF homolog (3.45 Å)
279
. No evidence for a μ-oxo ligand is observable even though the 
spectroscopic characterization of the enzyme suggested the presence of such a moiety in the as-
isolated state
57
. Assuming that this structure represents the diferric form of the enzyme, the 
absence of a dianionic μ-oxo bridge also implies that the cluster is not charge-neutral, as there are 
only four anionic ligands to neutralize the six positive charges. 
The cluster overlays well with that of AurF with one important exception: the carboxylate 
of E236 is rotated in CmlIΔ33 and occupies the site where the μ-oxo bridge is found in the Fe-
AurF structure (Fig. 41A)
279
. As noted, this residue bridges between the metals in a μ-1,3 mode 
and the carboxylate function lies in the same plane as the Fe-Fe vector. This same coordination 
mode of the Glu residue is observed in Mn-AurF, for which there was also no evidence of a μ-oxo 
bridge in the crystal structure
278
. In AurF, the equivalent residue to CmlI’s E236 is E227, which is 
instead found in a monodentate mode, coordinated only to Fe2. The difference in orientation 
between the proteins stems from a projection of the side-chain of I201 towards the cluster (Fig. 
39A, sticks and spheres), which was discussed in a previous section. This positioning of I201 
forces the carboxylate and Cγ of E236 into nearly the same plane as the Fe-Fe vector of the 
cluster. In AurF, E227 is presumably able to assume the monodentate orientation because the  
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Fig. 40: Structure of the CmlIΔ33 diiron cluster. (A) As-isolated structure. (B) Chemically 
reduced structure. (C) Overlay of the as-isolated cluster (gray) and reduced cluster (blue). 
Bond distances are given in Å. Oxygen atoms are red and nitrogen atoms blue. Iron atoms in 
panels A and B are colored brown. 
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side-chain of the equivalent I199 residue is pointing away from the cluster (Fig. 39A, purple 
spheres). The bidentate bridging mode of E236 means that CmlI has two μ-1,3 carboxylate 
bridges (E144 and E236) whereas Fe-AurF only has one. Clusters with this type of ligand 
arrangement are also present in the diferrous RNR-R2 subunit and diferrous plant desaturases
165, 
340
. A structural alignment of the CmlIΔ33 cluster with that of Fe-AurF and Mn-AurF is shown in 
Figure 41A and B, respectively. 
 Inadvertent photo-reduction of oxidized diiron clusters by the high-intensity X-ray beams 
generated on synchrotron beamlines is a commonly encountered phenomenon when studying this 
class of enzymes
341, 342
. One could argue that the absence of a μ-oxo bridge evidences reduction of 
the cluster. We used several approaches to test for and mitigate reduction of the CmlIΔ33 cluster 
during data collection and crystallization. First, the initial data sets were collected on a low 
photon-flux in-house diffractometer which generates X-rays orders of magnitude less intense than 
synchrotron radiation. Structures from these data sets did not indicate any notable differences 
from the structures solved at the synchrotron and were also lacking a μ-oxo bridge. For some data 
sets, we co-crystallized or soaked crystals with a low-millimolar concentration of the oxidizing 
agent potassium hexachloroiridate(IV), in order to absorb the solvent-derived electrons generated 
during data collection. This also did not have a detectable effect on the cluster architecture. 
Although we cannot rule out reduction of the cluster during data collection or crystallization, 
explicit chemical reduction of the crystals did result in some observable differences from the as-
isolated cluster. 
 
Structure of the chemically reduced diiron cluster. Crystals of CmlIΔ33 were chemically 
reduced under anaerobic conditions using methyl viologen as mediator dye and sodium dithionite 
as a source of reducing equivalents. No significant changes in the space group or unit cell 
parameters were noted compared to the as-isolated crystals. Only relatively subtle changes occur 
upon reduction of the cluster (Fig. 40B). Both of the metals are five-coordinate in a square planar 
geometry. There is no evidence of the weakly-coordinated solvent molecule and there is an open 
site on each iron that is pointing towards the putative substrate channel/ binding cavity. The 
coordination mode of all of the ligands remains the same but the overall Fe-ligand bond distances 
are increased relative to the as-isolated cluster (Fig. 40C). One more notable change is a 
movement of the carboxylate of E236 closer to Fe2 which results in an alteration of its bridging 
orientation closer to a μ-1,1(1,2) mode. In this orientation, one of the oxygen atoms coordinates 
to both irons and the other only to Fe2. This type of ligand coordination is also present in 
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diferrous sMMOH
319
 and the RNR-R2 D84E variant
318
. Perhaps the most noticeable change is an 
increase in the Fe-Fe distance from 3.3 to 3.5 Å upon reduction. The side-chain of I201 remains 
in the same location, which locks the carboxylate of E236 into the same plane as in the as-isolated 
state. 
 
  
 
 
Fig. 41: Structural alignment of the CmlI and AurF clusters. (A) CmlIΔ33 (gray carbon atoms) 
and Fe-AurF (green, PDB ID 3CHH, 2.0 Å maximal resolution). The green spheres are the 
iron ions in the Fe-AurF structure and the red sphere is the μ-oxo ligand. (B) CmlIΔ33 (gray) 
and Mn-AurF (magenta, PDB ID 2JCD, 2.1 Å maximal resolution). The purple spheres are the 
Mn ions. Other coloring is the same as in Figure 40.  
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Discussion 
 
A large variety of different diiron cluster ligand architectures have been described, and the crystal 
structure of CmlI permits another opportunity to compare and contrast the diverse structural 
motifs that can be found in this class of enzymes. Although the overall structure of the protein 
and active site is similar to that of the AurF homolog, there were some surprising differences that 
evidence the conformational flexibility inherent in the protein scaffold and the cofactor ligands. 
These observations provide an explanation for some of the spectroscopic properties observed for 
this enzyme in previous studies. Discussed here are the relationship of the CmlI cluster to those of 
other diiron enzymes as well as the implications that the structure have on the catalytic cycle of 
the enzyme.  
 
Explanations for the differences in the CmlIΔ33 diiron cluster crystal structure and that of 
Fe-AurF. There are subtle differences in the secondary structure of CmlIΔ33 and AurF that have 
a dramatic effect on the cluster geometry and the size of the substrate channel (Fig. 39B and C 
and Fig. 41A). We considered several possible causes for these differences. One is that the pH of 
the crystallization buffer may have an effect on the cluster and/or the secondary structure of the 
protein. Prior spectroscopic studies of CmlI indicated that the diferric enzyme contained a 
mixture of several different cluster species which were sensitive to the pH at which the enzyme 
sample was prepared
57
. Diferrous CmlI was only studied at pH 9.0, but the experiments suggested 
the presence of a single major cluster species. The changes in the diferric cluster observed upon 
alteration of the pH were noted to be more complex than a simple binary conversion of one 
species to another. The molecular cause of these differences was not ascertained but could be 
caused by protonation of the bridging μ-oxo/hydroxo moiety and/or a shift of a cluster ligand. The 
structure of CmlIΔ33 was solved at pH 6.5, considerably lower than the pH 9.0 used for most of 
the spectroscopic characterizations. One possible explanation is that the complex pH-dependent 
behavior of the cluster is caused by loss of the bridging moiety at lower pH and a shift of E236, 
possibly to the bidentate μ-1,3 mode seen in the crystal. The shift of the Glu to this orientation 
may drive the rearrangement of α-helix identified in Fig. 39A and also result in a collapse of the 
substrate channel (Fig. 39B). As a comparison, Fe-AurF crystallized at pH 8.5
279
 and Mn-AurF at 
pH 7.8
278
. The corresponding proton concentrations are 100-fold and 20-fold lower, respectively, 
than at the pH where CmlI was crystallized. If pH is the sole explanation for the differences, it 
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would imply that a cluster transition takes place at some point between pH 6.5 and 7.8, as Mn-
AurF also lacks the μ-oxo bridge. 
 An alternative explanation could be that crystal-packing forces are responsible for 
inducing a rearrangement of helix α5 in CmlIΔ33. This, in turn, forces the side-chain of I201 into 
the active site and induces a rearrangement of E236. Indeed, we find that the tip of helix α7 from 
one of the crystal symmetry-related protomers in the CmlIΔ33 lattice packs against this region of 
the protein. If this packing is the cause of the structural difference, it would mean that the 
transition takes place upon nucleation and, due to the high symmetry of the crystal, is propagated 
to other CmlI molecules as they become incorporated into the lattice. In orthorhombic Fe-AurF 
crystals (PDB structure 3CHH) and the monoclinic form (3CHI) there is no nearby packing 
interface and the residues in this region may be able to relax to the non-helical state, thereby 
allowing E227 to assume the monodentate binding mode. However, in Mn-AurF (2JCD) there is 
also no packing interface nearby, but the helix remains intact. Thus, the cause is very likely more 
complex than simply pH or crystal packing and is probably some combination of these or 
additional as-of-yet unknown forces. These observations do, however, highlight the important 
effects that the crystallization conditions can have on the derived enzyme crystal structures.  
 
Comparisons of the CmlI cluster architecture to other diiron enzymes. The as-isolated form 
of CmlIΔ33 has two μ-1,3 carboxylate bridges which has, to our knowledge, not been observed in 
other diferric clusters. Clusters with one μ-1,3 bridge are present in a variety of diiron enzymes 
including sMMOH and its relatives
52, 53, 309, 343
, RNR-R2
54
, aldehyde deformylating oxygenase
337
, 
and O2 and nitric oxide reductases
265, 266
. Those with two μ-1,3 bridges have so far only been seen 
in diferrous clusters as in dithionite-reduced RNR-R2 crystals
340
 and diferrous desaturases
165
. 
However, the Fe-Fe distance in the reduced RNR-R2 and desaturase clusters is considerably 
longer: 3.9 Å in RNR-R2 and 4.2 Å in the desaturases vs. 3.3 Å in CmlI. Chemical reduction 
increases the CmlI Fe-Fe distance but also subtly changes the orientation of E236 closer to a μ-
1,1(1,2)  mode which makes direct comparisons more difficult. A possible explanation for the 
longer Fe-Fe distance in RNR-R2 is that one of the terminal Glu ligands - equivalent to CmlI’s 
E109 - is replaced by a shorter Asp residue. Mutation of this residue in RNR-R2 (D84E) 
decreases the Fe-Fe separation of the mutant diferrous cluster to 3.4 Å
318
. Thus, the differences in 
Fe-Fe separation are likely due to a compression of the cluster by the terminal ligands. In the 
desaturases, the terminal ligands are both Glu, but they chelate the metals and are in a very 
different orientation than in CmlI, which may allow the metals to relax apart upon reduction. 
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There are some other differences in the cluster architectures that are worth pointing out. 
Compared to the clusters of RNR-R2, sMMOH, and the castor bean desaturase, the CmlI cluster 
has an additional His ligand to Fe1 (H232). Secondly, the orientation of the terminal Fe2 ligand 
E205 is rotated so that the carboxylate is nearly chelating the metal. In RNR-R2 and sMMOH this 
carboxylate points away from the cluster. In the castor bean desaturase, the terminal ligands are 
both Glu but chelate the metals in an orientation rotated roughly 90° relative to that in CmlI
165, 336
. 
A third difference in RNR-R2 and sMMOH is the orientation of the Glu that is equivalent to 
E236 in CmlI. In RNR-R2 it is in a monodentate orientation very similar to that seen in Fe-AurF. 
In oxidized RNR-R2, a μ-oxo bridge is also present in the same site as in Fe-AurF. When the 
RNR-R2 cluster is reduced to the diferrous state, this Glu ligand assumes the bridging μ-1,3 mode 
like in CmlI. Similarly, in sMMOH, the Glu residue in this position (E243) undergoes a 
significant shift upon reduction of the cluster, from an Fe2-monodentate mode (like in Fe-AurF) 
to μ-1,1(1,2) (more like reduced CmlI)319, 343. In sMMOH, E243 has a major regulatory role in 
the catalytic cycle of the enzyme that is tied into the residue’s ability to undergo a carboxylate 
shift
109, 162
. It is interesting that although these enzymes are functionally very different, they can 
exhibit similar ligand rearrangements, a fact that highlights the evolutionary relationship of the 4-
helix bundle diiron enzymes
308, 331
. 
The differences in the clusters discussed above may also underlie the ability of CmlI to 
generate a stable peroxo species compared to these other enzymes. It is possible that the presence 
of an additional protein-derived His ligand to Fe1 and the different compressive forces on the 
diiron cluster are able to prevent the enzyme from accessing the more potent Fe
4+
 intermediates 
such as the oxidizing bis-μ-oxo Fe4+/Fe4+ (“Q”) in sMMOH or the Fe3+/Fe4+ compound “X” in 
RNR-R2
114, 272
. CmlI is unable to catalyze hydrocarbon C-H bond activation, unlike sMMOH and 
some variants of RNR-R2
123
. The different cluster geometries may also preferentially drive the 
formation of a μ-η1:η2 peroxo in CmlI instead of the cis μ-1,2 species generated in the other 
enzymes
75, 81, 120
. This may be caused by altering the relative positioning of the available 
coordination sites and/or the spacing between the metal ions. 
 
Speculation on the possible relevance of the carboxylate shift to the CmlI/AurF catalytic 
cycle. It is common for diiron clusters to undergo ligand rearrangements during reduction and 
while the enzyme progresses through the catalytic cycle. One form in which these rearrangements 
are manifested is through carboxylate shifts of first-sphere Asp or Glu ligands
53, 162, 166, 319, 340, 343
. 
Such structural changes can control the reactivity of the cluster towards O2
158, 166, 270, 271, 344
 and 
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drive interconversion of oxygenated intermediates to generate the reactive species
98, 101
. The 
conformational flexibility of E236 in CmlI and E327 in AurF is further evidence that the diiron 
cluster ligands have a significant degree of freedom. It is unknown whether the different 
coordination modes are relevant to the catalytic cycle, or whether it is simply an artifact of the 
crystallization. The structure of the CmlIΔ33 cluster reported here would be more consistent with 
a “traditional” cis μ-1,2 peroxo based on the relative orientation of the available binding sites. 
What is intriguing about the plasticity of E236 is that it appears to also be tied into a change in the 
protein’s secondary structure and a constriction or enlarging of the substrate channel. The fact 
that nearly the same structural change has been observed in two of these family members may 
suggest that it is more than a simple artifact, as the packing and crystallization conditions of the 
enzymes are not identical. A tentative hypothesis is that these structural changes represent a sort 
of catalytic regulation in this family of enzymes. In this model, rearrangement of E236 or E227 
during catalysis induces a concomitant constriction of the substrate channel and thereby act to 
gate substrate access to the cluster and later eject the oxidized product. The gating of substrate 
could represent a mechanism by which the enzyme protects the reactive peroxo species until the 
proper substrate is available. Further experiments will be needed to elucidate if and when these 
protein motions occur and how they affect substrate and O2 binding.  
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Conclusion 
 
The crystal structure of CmlI is an important step in furthering our understanding of biological N-
oxygenation reactions. Although the structure is quite similar to that of the aureothin-synthesizing 
AurF homolog, there are some interesting differences that could represent facets of a regulatory 
mechanism like those in other oxygenase enzymes. The presence of two bidentate bridging 
carboxylate ligands in the diferric state of CmlI is relatively unexpected as such bridging 
structures have only been observed in a few enzymes in the diferrous state. The ability of one of 
the CmlI carboxylate cluster ligands to assume different orientations has precedents in the diiron 
enzyme literature. The shifting of carboxylate ligands is intimately tied into catalytic regulation of 
or progression through the cycle. Further experiments will be needed to test whether the observed 
carboxylate shift in CmlI is of functional relevance. 
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CONCLUSION 
 
The results presented herein represent a significant step forward in our understanding of the 
enzymology of the three enzymes and the basic principles underlying biological O2 activation. 
The trapping of the two most critical oxygenated intermediates in the 3,4-PCD catalytic cycle 
validates decades of prior research and opens avenues for future study. The structures show that 
many of the mechanistic hypotheses forwarded by our group and others are likely to be correct. 
The next goals for the study of 3,4-PCD are to dissect the structural and catalytic roles of the 
auxiliary residues identified in Chapters 1 and 2 of this dissertation. Site-directed mutagenesis of 
these residues may even open the potential to trap intermediates with the native substrate PCA, 
and alter the enzyme activity and substrate specificity for industrial and environmental 
applications. Due to the crucial positioning of these enzymes in the global carbon cycle, it is also 
of import to test the hypothesis that the orientation of the alkylperoxo moiety relative to the 
substrate ring is determinant of the ring-cleavage site. 
The crystal structures of CmlA and CmlI perhaps raise more questions than answers at 
this point. However, the determination of their structures provides the foundation for future 
studies of these enzymes. The structure of CmlA has allowed us to produce hypotheses as to the 
mechanism by which the enzyme is regulated and targeted to a specific NRPS and amino acid 
substrate. It also allows us to generate site-directed mutants of this enzyme to test many of the 
hypotheses generated from the analysis of the structure. Perhaps most interestingly, the CmlA 
structure shows that nature has devised two completely independent solutions to the problem of 
biological C-H bond activation. The comparison of CmlA and CmlI to the bacterial 
multicomponent monooxygenases and other diiron enzymes allows us to learn more about the 
basic principles underlying the mechanism of O2 activation. This may then allow us to co-opt the 
enzymes for the synthesis of new chemicals useful to modern medicine, agriculture, and industry. 
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